NO171555B - ANALOGY PROCEDURE FOR THE PREPARATION OF NEW, THERAPEUTIC-ACTIVE, SUBSTITUTED ALKANPHENONES - Google Patents
ANALOGY PROCEDURE FOR THE PREPARATION OF NEW, THERAPEUTIC-ACTIVE, SUBSTITUTED ALKANPHENONES Download PDFInfo
- Publication number
- NO171555B NO171555B NO891286A NO891286A NO171555B NO 171555 B NO171555 B NO 171555B NO 891286 A NO891286 A NO 891286A NO 891286 A NO891286 A NO 891286A NO 171555 B NO171555 B NO 171555B
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- compound
- acetyl
- epoxy
- title
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 249
- -1 oxy, thio Chemical group 0.000 claims abstract description 27
- 150000003839 salts Chemical class 0.000 claims abstract description 22
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 4
- 239000001257 hydrogen Substances 0.000 claims abstract description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 4
- 150000003573 thiols Chemical class 0.000 claims abstract description 4
- 150000002118 epoxides Chemical class 0.000 claims abstract 2
- 150000002431 hydrogen Chemical group 0.000 claims abstract 2
- 239000007858 starting material Substances 0.000 claims description 59
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 3
- 159000000000 sodium salts Chemical class 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 6
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 439
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 303
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 259
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 116
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 108
- 150000004702 methyl esters Chemical class 0.000 description 96
- 235000019439 ethyl acetate Nutrition 0.000 description 86
- 239000003921 oil Substances 0.000 description 84
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 48
- 239000000243 solution Substances 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 23
- YDOABCJASHUBBW-UHFFFAOYSA-N 3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl-triphenylphosphanium;bromide Chemical compound [Br-].CCCC1=C(O)C(C(C)=O)=CC=C1OCCC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 YDOABCJASHUBBW-UHFFFAOYSA-N 0.000 description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 150000001299 aldehydes Chemical class 0.000 description 17
- 239000000843 powder Substances 0.000 description 17
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 239000004593 Epoxy Substances 0.000 description 16
- CQBBXJNOKFHOFL-UHFFFAOYSA-N 3-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl-triphenylphosphanium;bromide Chemical compound [Br-].C1=CC(C(C)=O)=C(O)C(CCC)=C1OC(CC)CC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 CQBBXJNOKFHOFL-UHFFFAOYSA-N 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000012230 colorless oil Substances 0.000 description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 12
- 229910002027 silica gel Inorganic materials 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- 239000013078 crystal Substances 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 150000002924 oxiranes Chemical class 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 229910052786 argon Inorganic materials 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- JSPLKZUTYZBBKA-UHFFFAOYSA-N trioxidane Chemical compound OOO JSPLKZUTYZBBKA-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 235000011121 sodium hydroxide Nutrition 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000004587 chromatography analysis Methods 0.000 description 6
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000014384 Type C Phospholipases Human genes 0.000 description 5
- 108010079194 Type C Phospholipases Proteins 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000008279 sol Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 102100037611 Lysophospholipase Human genes 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108010058864 Phospholipases A2 Proteins 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 125000004434 sulfur atom Chemical group 0.000 description 4
- CQCAYWAIRTVXIY-UHFFFAOYSA-N 2-(triphenyl-$l^{5}-phosphanylidene)acetaldehyde Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC=O)C1=CC=CC=C1 CQCAYWAIRTVXIY-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- LHRPTFNBBDAJTH-UHFFFAOYSA-N 3-(4-acetyl-3-hydroxy-2-propylphenoxy)butyl-triphenylphosphanium;bromide Chemical compound [Br-].C1=CC(C(C)=O)=C(O)C(CCC)=C1OC(C)CC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 LHRPTFNBBDAJTH-UHFFFAOYSA-N 0.000 description 3
- SXTYZTBCYILOSA-UHFFFAOYSA-N 3-[4-acetyl-3-hydroxy-2-(3,3,3-trifluoropropyl)phenoxy]propyl-triphenylphosphanium;bromide Chemical compound [Br-].FC(F)(F)CCC1=C(O)C(C(=O)C)=CC=C1OCCC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 SXTYZTBCYILOSA-UHFFFAOYSA-N 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- YSAVZVORKRDODB-PHDIDXHHSA-N diethyl (2r,3r)-2,3-dihydroxybutanedioate Chemical compound CCOC(=O)[C@H](O)[C@@H](O)C(=O)OCC YSAVZVORKRDODB-PHDIDXHHSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 150000002617 leukotrienes Chemical class 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 125000004149 thio group Chemical group *S* 0.000 description 3
- RXYPXQSKLGGKOL-UHFFFAOYSA-N 1,4-dimethylpiperazine Chemical compound CN1CCN(C)CC1 RXYPXQSKLGGKOL-UHFFFAOYSA-N 0.000 description 2
- XRIVSKPVAZDYRW-UHFFFAOYSA-N 1-[4-(3-bromopropoxy)-2-hydroxyphenyl]-2,2,2-trifluoroethanone Chemical compound OC1=CC(OCCCBr)=CC=C1C(=O)C(F)(F)F XRIVSKPVAZDYRW-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 2
- YZTLQLBGKZUMDN-UHFFFAOYSA-N 3-(4-acetyl-3-hydroxy-2-propylphenyl)sulfanylpropyl-triphenylphosphanium;bromide Chemical compound [Br-].CCCC1=C(O)C(C(C)=O)=CC=C1SCCC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 YZTLQLBGKZUMDN-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- DOZMBKAQBSBDQM-UHFFFAOYSA-N 3-[3-hydroxy-2-propyl-4-(2,2,2-trifluoroacetyl)phenoxy]propyl-triphenylphosphanium;bromide Chemical compound [Br-].CCCC1=C(O)C(C(=O)C(F)(F)F)=CC=C1OCCC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 DOZMBKAQBSBDQM-UHFFFAOYSA-N 0.000 description 2
- BWRCOPGFMVKIGA-UHFFFAOYSA-N 3-[3-hydroxy-4-(2,2,2-trifluoroacetyl)phenoxy]propyl-triphenylphosphanium;bromide Chemical compound [Br-].C1=C(C(=O)C(F)(F)F)C(O)=CC(OCCC[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BWRCOPGFMVKIGA-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- QVJDQIDKEAIBPD-UHFFFAOYSA-N 5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl-triphenylphosphanium;bromide Chemical compound [Br-].CCCC1=C(O)C(C(C)=O)=CC=C1OCCCCC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 QVJDQIDKEAIBPD-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- 206010006482 Bronchospasm Diseases 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- YSAVZVORKRDODB-UHFFFAOYSA-N Diethyl tartrate Chemical compound CCOC(=O)C(O)C(O)C(=O)OCC YSAVZVORKRDODB-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 102000015439 Phospholipases Human genes 0.000 description 2
- 108010064785 Phospholipases Proteins 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- RYUVVWFDDJTAFJ-RFZPGFLSSA-N [(2r,3r)-3-(3,3,3-trifluoropropyl)oxiran-2-yl]methanol Chemical compound OC[C@H]1O[C@@H]1CCC(F)(F)F RYUVVWFDDJTAFJ-RFZPGFLSSA-N 0.000 description 2
- VEVQFFVTOWDEGH-RKDXNWHRSA-N [(2r,3r)-3-[3-(trifluoromethyl)phenyl]oxiran-2-yl]methanol Chemical compound OC[C@H]1O[C@@H]1C1=CC=CC(C(F)(F)F)=C1 VEVQFFVTOWDEGH-RKDXNWHRSA-N 0.000 description 2
- VJHAPKJZBOYGOD-RNFRBKRXSA-N [(2r,3r)-3-butyloxiran-2-yl]methanol Chemical compound CCCC[C@H]1O[C@@H]1CO VJHAPKJZBOYGOD-RNFRBKRXSA-N 0.000 description 2
- VJHAPKJZBOYGOD-BQBZGAKWSA-N [(2s,3s)-3-butyloxiran-2-yl]methanol Chemical compound CCCC[C@@H]1O[C@H]1CO VJHAPKJZBOYGOD-BQBZGAKWSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000012042 active reagent Substances 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000007885 bronchoconstriction Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 238000011097 chromatography purification Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 229960001270 d- tartaric acid Drugs 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229960000901 mepacrine Drugs 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- JSGLRFSEKUNPRD-BQBZGAKWSA-N (2r,3s)-3-butyloxirane-2-carbaldehyde Chemical compound CCCC[C@@H]1O[C@H]1C=O JSGLRFSEKUNPRD-BQBZGAKWSA-N 0.000 description 1
- RALWFAOLPUWJRV-RFZPGFLSSA-N (2s,3r)-3-(3,3,3-trifluoropropyl)oxirane-2-carbaldehyde Chemical compound FC(F)(F)CC[C@H]1O[C@@H]1C=O RALWFAOLPUWJRV-RFZPGFLSSA-N 0.000 description 1
- JSGLRFSEKUNPRD-RNFRBKRXSA-N (2s,3r)-3-butyloxirane-2-carbaldehyde Chemical compound CCCC[C@H]1O[C@@H]1C=O JSGLRFSEKUNPRD-RNFRBKRXSA-N 0.000 description 1
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NOSBBCDFXYWJRS-UHFFFAOYSA-N 1-[4-(1-bromohexan-3-yloxy)-2-hydroxy-3-propylphenyl]ethanone Chemical compound CCCC(CCBr)OC1=CC=C(C(C)=O)C(O)=C1CCC NOSBBCDFXYWJRS-UHFFFAOYSA-N 0.000 description 1
- OZRRIFOHDUQJPS-UHFFFAOYSA-N 1-[4-(3-bromopropoxy)-2-hydroxy-3-(3,3,3-trifluoropropyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=C(OCCCBr)C(CCC(F)(F)F)=C1O OZRRIFOHDUQJPS-UHFFFAOYSA-N 0.000 description 1
- KJPIXTONJYFGSO-UHFFFAOYSA-N 1-[4-(3-bromopropoxy)-2-hydroxy-3-propylphenyl]-2,2,2-trifluoroethanone Chemical compound CCCC1=C(O)C(C(=O)C(F)(F)F)=CC=C1OCCCBr KJPIXTONJYFGSO-UHFFFAOYSA-N 0.000 description 1
- DRGBHKZRLWJAOU-UHFFFAOYSA-N 1-[4-(3-bromopropoxy)-2-hydroxy-3-propylphenyl]ethanone Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCBr DRGBHKZRLWJAOU-UHFFFAOYSA-N 0.000 description 1
- FEGCDIJLIRMOFJ-UHFFFAOYSA-N 1-[4-(4-bromobutan-2-yloxy)-2-hydroxy-3-propylphenyl]ethanone Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OC(C)CCBr FEGCDIJLIRMOFJ-UHFFFAOYSA-N 0.000 description 1
- LPZBIKWTPVHBRX-UHFFFAOYSA-N 1-[4-(5-bromopentoxy)-2-hydroxy-3-propylphenyl]ethanone Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCCCBr LPZBIKWTPVHBRX-UHFFFAOYSA-N 0.000 description 1
- IMCYUCSOVTZWGW-UHFFFAOYSA-N 1-[4-(5-bromopentylsulfanyl)-2-hydroxy-3-propylphenyl]ethanone Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1SCCCCCBr IMCYUCSOVTZWGW-UHFFFAOYSA-N 0.000 description 1
- QVZFYYJKORWFAB-UHFFFAOYSA-N 1-[5-(3-bromopropoxy)-2-hydroxy-3-propylphenyl]ethanone Chemical compound CCCC1=CC(OCCCBr)=CC(C(C)=O)=C1O QVZFYYJKORWFAB-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical group CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 1
- FGOJCPKOOGIRPA-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 5-oxoazepane-1,4-dicarboxylate Chemical compound CCOC(=O)C1CCN(C(=O)OC(C)(C)C)CCC1=O FGOJCPKOOGIRPA-UHFFFAOYSA-N 0.000 description 1
- HMXJOWDZAJWLTF-UHFFFAOYSA-N 2h-chromene-2-carboxylic acid Chemical compound C1=CC=C2C=CC(C(=O)O)OC2=C1 HMXJOWDZAJWLTF-UHFFFAOYSA-N 0.000 description 1
- IMNZJVABGOSBSV-UHFFFAOYSA-N 3-(3-acetyl-4-hydroxy-5-propylphenoxy)propyl-triphenylphosphanium;bromide Chemical compound [Br-].CC(=O)C1=C(O)C(CCC)=CC(OCCC[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 IMNZJVABGOSBSV-UHFFFAOYSA-N 0.000 description 1
- TUHXUXSDXDPRPI-UHFFFAOYSA-N 3-(4-acetyl-3-hydroxy-2-propylphenoxy)hexyl-triphenylphosphanium;bromide Chemical compound [Br-].C=1C=C(C(C)=O)C(O)=C(CCC)C=1OC(CCC)CC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 TUHXUXSDXDPRPI-UHFFFAOYSA-N 0.000 description 1
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenylpropanol Natural products OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- JPWGFIBIOINYGV-UHFFFAOYSA-N 5-(4-acetyl-3-hydroxy-2-propylphenoxy)hexyl-triphenylphosphanium;bromide Chemical compound [Br-].C1=CC(C(C)=O)=C(O)C(CCC)=C1OC(C)CCCC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 JPWGFIBIOINYGV-UHFFFAOYSA-N 0.000 description 1
- SJKANUHMBPCNBN-UHFFFAOYSA-N 5-(4-acetyl-3-hydroxy-2-propylphenyl)sulfanylpentyl-triphenylphosphanium;bromide Chemical compound [Br-].CCCC1=C(O)C(C(C)=O)=CC=C1SCCCCC[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 SJKANUHMBPCNBN-UHFFFAOYSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010027654 Allergic conditions Diseases 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000001358 L(+)-tartaric acid Substances 0.000 description 1
- 235000011002 L(+)-tartaric acid Nutrition 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910018954 NaNH2 Inorganic materials 0.000 description 1
- 208000011623 Obstructive Lung disease Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- CBVIYQISIWXPFD-RKDXNWHRSA-N [(2r,3r)-3-(3-chlorophenyl)oxiran-2-yl]methanol Chemical compound OC[C@H]1O[C@@H]1C1=CC=CC(Cl)=C1 CBVIYQISIWXPFD-RKDXNWHRSA-N 0.000 description 1
- XODMEJFEJYAAQS-NXEZZACHSA-N [(2r,3r)-3-(3-methoxyphenyl)oxiran-2-yl]methanol Chemical compound COC1=CC=CC([C@@H]2[C@H](O2)CO)=C1 XODMEJFEJYAAQS-NXEZZACHSA-N 0.000 description 1
- SWGFEEOVOVYCSV-NXEZZACHSA-N [(2r,3r)-3-(3-methylphenyl)oxiran-2-yl]methanol Chemical compound CC1=CC=CC([C@@H]2[C@H](O2)CO)=C1 SWGFEEOVOVYCSV-NXEZZACHSA-N 0.000 description 1
- FWXCXEWINNSLOW-RKDXNWHRSA-N [(2r,3r)-3-[2-(trifluoromethyl)phenyl]oxiran-2-yl]methanol Chemical compound OC[C@H]1O[C@@H]1C1=CC=CC=C1C(F)(F)F FWXCXEWINNSLOW-RKDXNWHRSA-N 0.000 description 1
- SOPZXTKDIDFGCK-RKDXNWHRSA-N [(2r,3r)-3-[4-(trifluoromethyl)phenyl]oxiran-2-yl]methanol Chemical compound OC[C@H]1O[C@@H]1C1=CC=C(C(F)(F)F)C=C1 SOPZXTKDIDFGCK-RKDXNWHRSA-N 0.000 description 1
- PVALSANGMFRTQM-RKDXNWHRSA-N [(2r,3r)-3-phenyloxiran-2-yl]methanol Chemical compound OC[C@H]1O[C@@H]1C1=CC=CC=C1 PVALSANGMFRTQM-RKDXNWHRSA-N 0.000 description 1
- FWXCXEWINNSLOW-IUCAKERBSA-N [(2s,3s)-3-[2-(trifluoromethyl)phenyl]oxiran-2-yl]methanol Chemical compound OC[C@@H]1O[C@H]1C1=CC=CC=C1C(F)(F)F FWXCXEWINNSLOW-IUCAKERBSA-N 0.000 description 1
- VEVQFFVTOWDEGH-IUCAKERBSA-N [(2s,3s)-3-[3-(trifluoromethyl)phenyl]oxiran-2-yl]methanol Chemical compound OC[C@@H]1O[C@H]1C1=CC=CC(C(F)(F)F)=C1 VEVQFFVTOWDEGH-IUCAKERBSA-N 0.000 description 1
- SOPZXTKDIDFGCK-IUCAKERBSA-N [(2s,3s)-3-[4-(trifluoromethyl)phenyl]oxiran-2-yl]methanol Chemical compound OC[C@@H]1O[C@H]1C1=CC=C(C(F)(F)F)C=C1 SOPZXTKDIDFGCK-IUCAKERBSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000008331 benzenesulfonamides Chemical class 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229960000182 blood factors Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- XCEUHXVTRJQJSR-UHFFFAOYSA-N bromo(phenyl)phosphane Chemical compound BrPC1=CC=CC=C1 XCEUHXVTRJQJSR-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- ZUMNJDGBYXHASJ-UHFFFAOYSA-N ethyl 2-[5-[4-(3-methylsulfonylphenyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]acetate Chemical compound CCOC(=O)CN1N=C(C(F)(F)F)C=C1C1=CC=C(C=2C=C(C=CC=2)S(C)(=O)=O)C=C1 ZUMNJDGBYXHASJ-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- NPGXGGYLZFSIBD-NXEZZACHSA-N methyl 3-[(2r,3r)-3-(hydroxymethyl)oxiran-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC([C@@H]2[C@H](O2)CO)=C1 NPGXGGYLZFSIBD-NXEZZACHSA-N 0.000 description 1
- NPGXGGYLZFSIBD-UWVGGRQHSA-N methyl 3-[(2s,3s)-3-(hydroxymethyl)oxiran-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC([C@H]2[C@@H](O2)CO)=C1 NPGXGGYLZFSIBD-UWVGGRQHSA-N 0.000 description 1
- HSJFBBYZKRQFKA-UHFFFAOYSA-N methyl 4-(3-formyloxiran-2-yl)butanoate Chemical compound COC(=O)CCCC1OC1C=O HSJFBBYZKRQFKA-UHFFFAOYSA-N 0.000 description 1
- MXOMLDWEYREFGE-UHFFFAOYSA-N methyl 4-oxo-7-sulfanylchromene-2-carboxylate Chemical compound C1=C(S)C=C2OC(C(=O)OC)=CC(=O)C2=C1 MXOMLDWEYREFGE-UHFFFAOYSA-N 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- XMQSELBBYSAURN-UHFFFAOYSA-M triphenyl(propyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCC)C1=CC=CC=C1 XMQSELBBYSAURN-UHFFFAOYSA-M 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
Foreliggende oppfinnelse vedrører en fremstillingen av terapeutisk aktive, substituerte alkanfenoner med den generelle formelen The present invention relates to the preparation of therapeutically active, substituted alkanephenones with the general formula
hvori Ri betyr Ci-C4-alkyl eller fluorert Ci-C4-alkyl, wherein R 1 means C 1 -C 4 alkyl or fluorinated C 1 -C 4 alkyl,
I?2 betyr hydrogen, C^-C/i-alkyl eller fluorert C^-C^alkyl, I?2 means hydrogen, C₁-C₁-alkyl or fluorinated C₁-C₁alkyl,
X betyr oksy eller tio, alk betyr C^-Cy-alkylen, n betyr 1 eller 2, R3 betyr fenyl, som er usubstituert eller substituert med Ci-C4~alkyl, fluorert C^-C^alkyl, C1-C4-alkoksy, karboksy, Ci-C4~alkoksykarbonyl og/eller halogen, eller R3 betyr C^-Cy-alkyl, o),0) ,co-trif luor-C^-Cy-alkyl, karboksy-Ci-C4-alkyl eller Ci-C4-alkoksykarbonyl-Ci-C4-alkyl, X means oxy or thio, alk means C^-Cy alkylene, n means 1 or 2, R 3 means phenyl, which is unsubstituted or substituted by C 1-C 4 alkyl, fluorinated C 1-C 4 alkyl, C 1-C 4 alkoxy . -C4-Alkoxycarbonyl-C1-C4-Alkyl,
og R4 betyr karboksy, Ci-C4-alkoksykarbonyl eller N-(ben-zensulfonyl)-karbamoyl, og salter derav. and R 4 means carboxy, C 1 -C 4 alkoxycarbonyl or N-(benzenesulfonyl)carbamoyl, and salts thereof.
Den romlige utformningen av den ovenfor angitte formel I er, for de foretrukne forbindelsene, hvori O-atomet av hydroksyl-gruppen er i relativ trans-konfigurasjon med S-atomet, slik å forstå at symbolene på den første linjen ligger over, den tredje linjen under papirplanet (eller omvendt), hvilket for den angitte formelen tilsvarer den motsatte konfigurasjonen, (RS)-(SR), ifølge Kahn-Ingold-Prelog-konvensjonen for svovelatomet som er forbundet med karbonatomet (C-S-), og for karbonatomet som bærer hydroksygruppen (C-OH). Derved er, når n står for 2, enantiomerene med S(C-S-), R(C-OH)-konfigurasjonen spesielt foretrukket og, når n står for 1, er enantiomerene med R(C-S-), S(C-OH)-konfigurasjonen spesielt foretrukket. I den med symbolet -(CH=CH)n angitte vinylen- hhv. buta-1,3-dienylenresten foreligger dobbeltbindingen hhv. den fra C-atomet forbundet med resten alk utgående dobbeltbinding av butadienylresten fortrinnsvis, men ikke nødvendigvis, i cis-konfigurasjon, vanligvis betegnet med (Z), hvorved de andre dobbeltbindingene da fortrinnsvis, men heller ikke nødvendigvis, har trans-konfigurasjon, vanligvis betegnet med (E). The spatial arrangement of the above formula I is, for the preferred compounds, in which the O atom of the hydroxyl group is in relative trans configuration with the S atom, so as to understand that the symbols of the first line lie above, the third line below the plane of the paper (or vice versa), which for the given formula corresponds to the opposite configuration, (RS)-(SR), according to the Kahn-Ingold-Prelog convention for the sulfur atom attached to the carbon atom (C-S-), and for the carbon atom bearing the hydroxy group (C-OH). Thereby, when n stands for 2, the enantiomers with the S(C-S-), R(C-OH) configuration are particularly preferred and, when n stands for 1, the enantiomers with R(C-S-), S(C-OH) -configuration particularly preferred. In the vinyl indicated with the symbol -(CH=CH)n - or the buta-1,3-dienylene residue has the double bond or the double bond of the butadienyl residue originating from the C atom connected to the residue alk is preferably, but not necessarily, in cis configuration, usually denoted by (Z), whereby the other double bonds then preferably, but also not necessarily, have trans configuration, usually denoted with (E).
Forbindelsen av formel I og deres salter oppviser fordelak-tige farmakologiske egenskaper, spesielt en utpreget leukotrienantagonisme. The compound of formula I and their salts exhibit advantageous pharmacological properties, in particular a pronounced leukotriene antagonism.
Følgelig hemmer de f.eks. in vitro i konsentrasjonsområdet fra 0,001 til 1,0 jjmol/1 den ved leukotrien-D4 (LTD4) induserte kontraksjonen av en glatt muskel. Denne såkalte LTD4-antagonismen bestemmes eksperimentelt f.eks. på følgende måte: I segmenter, som er tatt fra ileum i et marsvin av vekt 300-400 g og som er inkubert i et organbad i "Tyrode"-oppløsning ved 38° C under gassbehandling med en blanding av 95% oksygen og 5% karbondioksyd i en mengde på 1 g, utløses kontraksjoner med syntetisk leukotrien D4 (som kaliumsalt) og registreres isotonisk. Graden av hemming som oppnås ved stoffet som undersøkes bestemmes etter en forinkubering på 2 minutter og angis som IC50, dvs. konsentrasjonen hvorved testkontraksjonen reduseres med 5056. Forbindelsen av formel I viser også in vivo utmerket virksomhet. Følgelig kunne det, ved in vivo bronkokonstriksjons-standardforsøket på marsvin, ved aerosoladministrering av en oppløsning inne-holdende 0,0001 til 1 vekt-# av stoffet som skulle under-søkes, påvises en tydelig LTD4-antagoniserende effekt. Consequently, they inhibit e.g. in vitro in the concentration range from 0.001 to 1.0 jjmol/1 that of leukotriene-D4 (LTD4) induced the contraction of a smooth muscle. This so-called LTD4 antagonism is determined experimentally, e.g. in the following manner: In segments taken from the ileum of a guinea pig weighing 300-400 g and incubated in an organ bath in "Tyrode" solution at 38° C under gas treatment with a mixture of 95% oxygen and 5% carbon dioxide in an amount of 1 g, contractions are triggered with synthetic leukotriene D4 (as potassium salt) and recorded isotonically. The degree of inhibition achieved by the test substance is determined after a pre-incubation of 2 minutes and is given as IC50, i.e. the concentration at which the test contraction is reduced by 5056. The compound of formula I also shows in vivo excellent activity. Accordingly, in the in vivo bronchoconstriction standard test on guinea pigs, by aerosol administration of a solution containing 0.0001 to 1 wt-# of the substance to be investigated, a clear LTD4 antagonizing effect could be demonstrated.
(Beskrivelsen av forsøksfremgangsmåten finnes i vedlegg etter forsøkene). (The description of the experimental procedure can be found in the appendix after the experiments).
Overraskende oppviser mange forbindelser av formel I også en utpreget hemmevirkning på andre fysiologisk viktige enzymsys-temer. Følgelig observerte man hemming av fosfolipase A fra menneskelige leukocytter i det undersøkte konsentrasjonsområdet på ca. 0,5-50 pmol/l. (Den eksperimentelle fremgangsmåten for denne bestemmelsen er nærmere beskrevet 1 vedlegget etter eksemplene). Videre ble det observert hemming av fosfolipase C fra menneskelige trombocytter i det undersøkte konsentrasjonsområdet på 1-100 pmol/1. Surprisingly, many compounds of formula I also exhibit a pronounced inhibitory effect on other physiologically important enzyme systems. Consequently, inhibition of phospholipase A from human leukocytes was observed in the investigated concentration range of approx. 0.5-50 pmol/l. (The experimental procedure for this determination is described in more detail in Appendix 1 after the examples). Furthermore, inhibition of phospholipase C from human platelets was observed in the examined concentration range of 1-100 pmol/1.
På grunn av disse verdifulle farmakologiske egenskapene kan forbindelsene av formel I fremstilt ifølge oppfinnelse finne terapeutisk anvendelse overalt hvor virkningen av leukotriener fører til sykdomstilstander, og mildne eller oppheve disse. Følgelig kan de eksempelvis anvendes for behandling av allergiske tilstander og sykdommer, som spesielt astma, men også høysnue samt obstruktive lungesykdommer innbe-fattende systisk fibrose. Videre er de, på grunn av den anti-inflammatoriske virksomheten, egnede som betennelseshemmende midler, spesielt som eksterne (topiske) hudflogistatika for behandlingen av betente dermatoser av enhver genese, som ved lette hudirritasjoner, kontaktdermatitt, eksantemer og forbrenninger, samt som slimhinneflogistatika for behandlingen av mukosabetennelser, f.eks. i øynene, nesen, leppene, munnen og genital-, henholdsvis analområdet. Videre kan de anvendes som solbeskyttelsesmiddel. Den høye hemmende virksomheten på forskjellige blodfaktorer peker videre på muligheten av terapeutisk anvendelse av forbindelsen av formel I innenfor indikasjonsområdet trombose og regulering av flytbarheten for blod. Because of these valuable pharmacological properties, the compounds of formula I produced according to the invention can find therapeutic application wherever the action of leukotrienes leads to disease states, and mitigate or abolish them. Consequently, they can, for example, be used for the treatment of allergic conditions and diseases, such as asthma in particular, but also hay fever and obstructive lung diseases including cystic fibrosis. Furthermore, due to their anti-inflammatory activity, they are suitable as anti-inflammatory agents, especially as external (topical) skin phlogistics for the treatment of inflamed dermatoses of any genesis, such as in light skin irritations, contact dermatitis, exanthems and burns, as well as mucosal phlogistics for the treatment of mucosal inflammations, e.g. in the eyes, nose, lips, mouth and genital or anal area. Furthermore, they can be used as a sun protection agent. The high inhibitory activity on various blood factors further points to the possibility of therapeutic application of the compound of formula I within the indication area of thrombosis and regulation of the fluidity of blood.
Gruppen X er fortrinnsvis bundet i para-stilling til R^-C(=0)-gruppen, det vil si forbindelsene av formelen hvori R}, R2, X, alk, n, R3 og R4 har de angitte betydningene. The group X is preferably attached in the para-position to the R^-C(=0) group, that is to say the compounds of the formula in which R}, R 2 , X, alk, n, R 3 and R 4 have the indicated meanings.
Spesielt foretrukket er det at det med svovelatomet forbundede kjede-C-atomet fortrinnsvis har (S)- og det hydroksy-gruppe-bærende kjede-C-atomet har fortrinnsvis (R)-konfigurasjon, og den med resten alk forbundede dobbeltbindingen foreligger fortrinnsvis i cis-konfigurasjon og den andre ytterligere dobbeltbindingen fortrinnsvis i trans-konfigurasjon, og salter derav, spesielt farmasøytisk anvendbare salter. It is particularly preferred that the chain C atom connected to the sulfur atom preferably has (S) and the hydroxy group-bearing chain C atom preferably has (R) configuration, and the double bond connected to the residue alk is preferably in cis-configuration and the second additional double bond preferably in trans-configuration, and salts thereof, especially pharmaceutically usable salts.
Fremgangsmåten ifølge oppfinnelsen for fremstilling av forbindelser av formel I og deres salter bygger på i og for seg kjente fremgangsmåter og er kjennetegnet ved at man omsetter et epoksyd av formelen The process according to the invention for the production of compounds of formula I and their salts is based on methods known per se and is characterized by reacting an epoxide of the formula
hvori Ri, R2, X, alk, n og R3 har de ovenfor angitte betydningene, med en tiol av formelen wherein R 1 , R 2 , X, alk, n and R 3 have the above meanings, with a thiol of the formula
hvori R4 har de ovenfor angitte betydningene, eller et salt derav, og om ønsket omvandles en ifølge fremgangsmåten oppnådd forbindelse til en annen forbindelse av formel I, en ved fremgangsmåten oppnådd stereoisomerblanding oppdeles i komponentene og/eller en ved fremgangsmåten oppnådd fri forbindelse overføres til et salt eller et ved fremgangsmåten in which R4 has the meanings given above, or a salt thereof, and if desired, a compound obtained according to the method is converted into another compound of formula I, a stereoisomer mixture obtained by the method is divided into its components and/or a free compound obtained by the method is transferred to a salt or a by the procedure
oppnådd salt overføres til den frie forbindelsen eller til et annet salt. the salt obtained is transferred to the free compound or to another salt.
Omsetningen av epoksyder II med tioler III foregår under konfigurasjonsomvandling ved bindingen med C-atomet som inngår i tiogruppen og under konfigurasjonsopprettholdelse ved C-atomet som bærer hydroksygruppen. For å komme frem til de foretrukne forbindelsene med motsatt konfigurasjon ved disse to C-atomene utgår man følgelig fortrinnsvis fra de tilsvarende trans-epoksydene II. Derved oppnår man med utgangspunkt i R,R-epoksyder II forbindelser med S(C-OH), R(C-OH)-konfigurasjon, hhv. med utgangspunkt fra S,S-epoksyder II forbindelse I med R(C-S), S(C-OH)-konfigurasjon. Omsetningen foregår under i og for seg kjente betingelser ved temperaturer fra -20°C til +50"C, fortrinnsvis ved romtemperatur, dvs. 18° C til 25° C, og først og fremst i et basisk miljø, eksempelvis i nærvær av et amin, spesielt et tertiært alifatisk, arylalifatisk eller mettet heterocyklisk amin, som trialkylamin (f.eks. trietylamin, eller etyl-diisopropyl-amin), dialkyl-benzylamin (f.eks. N,N-dimetylbenzylamin), N,N-dialkylanilin (f.eks. N,N-dimetylanilin) hhv. N-metyl-eller N-etylpiperidin eller N,N'-dimetylpiperazin. Vanligvis gjennomføres omsetningen i et indifferent organisk oppløs-ningsmiddel, som en laverealkanol, f.eks. metanol eller etanol. The reaction of epoxides II with thiols III takes place during configuration conversion at the bond with the C atom that forms part of the thio group and during configuration maintenance at the C atom that carries the hydroxy group. In order to arrive at the preferred compounds with the opposite configuration at these two C atoms, one therefore preferably starts from the corresponding trans-epoxides II. Thereby, starting from R,R-epoxides II, compounds with S(C-OH), R(C-OH) configuration are obtained, resp. starting from S,S-epoxides II compound I with R(C-S), S(C-OH) configuration. The reaction takes place under known conditions at temperatures from -20°C to +50°C, preferably at room temperature, i.e. 18°C to 25°C, and primarily in a basic environment, for example in the presence of a amine, especially a tertiary aliphatic, arylaliphatic or saturated heterocyclic amine, such as trialkylamine (e.g. triethylamine, or ethyl diisopropylamine), dialkylbenzylamine (e.g. N,N-dimethylbenzylamine), N,N-dialkylaniline (e.g. N,N-dimethylaniline) or N-methyl or N-ethylpiperidine or N,N'-dimethylpiperazine Usually the reaction is carried out in an indifferent organic solvent, such as a lower alkanol, e.g. methanol or ethanol.
Det som utgangsstoff anvendte epoksydet av den ovenfor angitte formel II kan særlig fremstilles ved den samme fremgangsmåten som anvendes ved syntesen av leukotriener. Ved en typisk generell syntesemåte for forbindelse II, hvori n står for 1, går man f.eks. ut fra et aldehyd av formelen The epoxide of the above-mentioned formula II used as starting material can in particular be produced by the same method as is used in the synthesis of leukotrienes. In a typical general synthesis method for compound II, where n stands for 1, one goes, e.g. from an aldehyde of the formula
hvori A og R3 har de ovenfor angitte betydningene, hvorved en eventuelt tilstedeværende fri karboksylgruppe R3 foreligger i en som ester beskyttet form, f.eks. som laverealkylester. Denne forbindelsen kondenseres med formylmetylentrifenylfosforan (eller en ekvivalent reagens), hvorved den tilsvarende trans-3-R3~<p>ro<p->2-enalforbindelsen av formelen dannes. Denne forbindelsen epoksyderes deretter på i og for seg kjent måte, fortrinnsvis under svakt alkaliske betingelser (f.eks. i nærvær av alkalikarbonater) med vandig hydrogenperoksyd, hvorved det oppnås en trans. dvs. 2(RS),3-(RS)-epoksy-3-R3~propanal av formelen Epoksyaldehydet VI kan deretter omsettes ved kondensasjon med et fosfoniumhalogenid in which A and R 3 have the above-mentioned meanings, whereby an optionally present free carboxyl group R 3 exists in a protected form as an ester, e.g. as lower alkyl esters. This compound is condensed with formylmethylenetriphenylphosphorane (or an equivalent reagent), whereby the corresponding trans-3-R3~<p>ro<p->2-enal compound of the formula is formed. This compound is then epoxidized in a manner known per se, preferably under slightly alkaline conditions (e.g. in the presence of alkali carbonates) with aqueous hydrogen peroxide, whereby a trans. i.e. 2(RS),3-(RS)-epoxy-3-R3~propanal of the formula The epoxy aldehyde VI can then be reacted by condensation with a phosphonium halide
hvori R^, R2 og alk har de angitte betydningene og Hal utgjør et halogenatom, fortrinnsvis brom, og en base, f.eks. natriumamid, i tetrahydrofuran til det tilsvarende epoksydet II, hvori R4 betyr forestret karboksy og n står for 1. in which R 1 , R 2 and alk have the indicated meanings and Hal constitutes a halogen atom, preferably bromine, and a base, e.g. sodium amide, in tetrahydrofuran to the corresponding epoxide II, in which R4 means esterified carboxy and n stands for 1.
Forbindelser VII fremstilles spesielt ved omsetning av en tilsvarende forbindelse av formelen med trifenylfosfin på vanlig måte. Forbindelse VIII, hvori X betyr oksy eller tio, oppnås eksempelvis ved at man kondenserer tilsvarende forbindelser av formelen Compounds VII are prepared in particular by reacting a corresponding compound of the formula with triphenylphosphine in the usual way. Compound VIII, in which X means oxy or thio, is obtained, for example, by condensing corresponding compounds of the formula
og Hal-alk-CH2-Hal (X), and Hal-alk-CH2-Hal (X),
på vanlig måte med hverandre. in the usual way with each other.
En annen fremgangsmåte for fremstilling av forbindelse II består i at man epoksyderer trans-3-R3-2-enol av formelen Another method for preparing compound II consists in epoxidizing trans-3-R3-2-enol of the formula
hvori R 3 har den ovenfor angitte betydningen, fritt karboksy som substituent for R3 er fortrinnsvis beskyttet i en esterform, eksempelvis ved hjelp av tertiærbutylhydroperoksyd i nærvær av titantetraisopropanolat og en D- hhv. L-vin-syredilaverealkylester, ved anvendelse av en D-vinsyreester oppnår man derved overveiende 2R,3R-epoksy-3-R3~propanol XIIa, hhv. ved anvendelsen av en L-vinsyreester overveiende den tilsvarende 2S,3S-epoksy-3-R3-propanol Xllb. in which R 3 has the above meaning, free carboxy as a substituent for R 3 is preferably protected in an ester form, for example by means of tertiary butyl hydroperoxide in the presence of titanium tetraisopropanolate and a D- or L-tartaric acid dilave alkyl ester, by using a D-tartaric acid ester, one thereby obtains predominantly 2R,3R-epoxy-3-R3~propanol XIIa, respectively. by the use of an L-tartaric acid ester predominantly the corresponding 2S,3S-epoxy-3-R3-propanol Xllb.
Disse oksyderes deretter, eksempelvis ved behandling med oksalylklorid/dimetylsulfoksyd og deretter med trietylamin, til tilsvarende epoksydaldehyd VI, som deretter kan omsettes med det tilsvarende fosfoniumsaltet VII til det tilsvarende epoksydet II, hvori R3 betyr forestret karboksy og n står for 1. These are then oxidized, for example by treatment with oxalyl chloride/dimethylsulfoxide and then with triethylamine, to the corresponding epoxide aldehyde VI, which can then be reacted with the corresponding phosphonium salt VII to the corresponding epoxide II, in which R3 means esterified carboxy and n stands for 1.
Derved oppnår man overveiende epoksyd II, hvori dobbeltbindingen har den foretrukne cis-stereotaksien. Dersom man anvender en D-vinsyreester oppnår man, som nevnt, overveiende forbindelse II, hvori epoksygruppen oppviser R,R-konfigurasjon, hhv. S,S-enantiomerer når omsetningen gjennomføres i nærvær av L-vinsyreestere. Thereby, one mainly obtains epoxide II, in which the double bond has the preferred cis-stereotaxy. If you use a D-tartaric acid ester, you obtain, as mentioned, predominantly compound II, in which the epoxy group exhibits R,R configuration, resp. S,S-enantiomers when the reaction is carried out in the presence of L-tartaric acid esters.
Ved fremstillingen av epoksydet II, hvori n står for 2, overføres eksempelvis epoksyalkoholen Xlla hhv. Xllb først ved behandling med N,N'-dicykloheksylkarbodiimid og dimetylsulfoksyd i nærvær av trifluoreddiksyre og pyridin og deretter med trifenylfosforanylidenacetaldehyd først til de tilsvarende 4R,5R- hhv. 4S,5S-4,5-epoksy-5-R3-pent-2-enal-forbindelsene av formelene XHIa hhv. XHIb In the production of the epoxide II, where n stands for 2, the epoxy alcohol Xlla or Xllb first by treatment with N,N'-dicyclohexylcarbodiimide and dimethyl sulfoxide in the presence of trifluoroacetic acid and pyridine and then with triphenylphosphoranylidene acetaldehyde first to the corresponding 4R,5R- or The 4S,5S-4,5-epoxy-5-R3-pent-2-enal compounds of the formulas XHIa or XHIb
som deretter omsettes videre med fosfoniumhalogenid VII til tilsvarende epoksyd II, hvori n står for 2. Derved oppnås fortrinnsvis slike forbindelser hvori den med resten alk which is then further reacted with phosphonium halide VII to the corresponding epoxide II, in which n stands for 2. This preferably results in such compounds in which the residue alk
forbundede dobbeltbindingen oppviser cis-stereotaksi og den med oksiranringen forbundede dobbeltbindingen oppviser trans-stereotaksi. linked double bond exhibits cis-stereotaxis and the double bond linked to the oxirane ring exhibits trans-stereotaxis.
Forbindelser oppnådd ved fremgangsmåten kan om ønsket overføres til andre forbindelser av formel I. Compounds obtained by the method can, if desired, be transferred to other compounds of formula I.
Eksempelvis kan man hydrolysere forestrede eller amiderte karboksygrupper til fritt hydroksy, fortrinnsvis under basiske betingelser, f.eks. i nærvær av natronlut, og fortrinnsvis i et med vann blandbart organisk oppløsningsmid-del, som tetrahydrofuran, dioksan eller en lavere alkanol, som metanol eller etanol. Med utgangspunkt i forbindelser I, hvori R3 betyr forestret karboksy, som laverealkoksykarbonyl, og R3 inneholder slike som substituenter, kan hydrolysen styres på en slik måte at selektivt bare R3 eller både R4 og også laverealkoksykarbonylsubstituenten av R3 hydrolyseres til karboksy. Dersom man anvender en ekvimolar natronlut og velger milde reaksjonsbetingelser, f.eks. 0,5 til 2 timers omrøring ved romtemperatur, hydrolyseres praktisk talt bare alkoksykarbonyl R4, mens under mer drastiske betingelser, f.eks. ved lengre reaksjonstider eller under oppvarming, både R4 og også alkoksykarbonylgruppen i R3 hydrolyseres til karboksy. For example, esterified or amidated carboxy groups can be hydrolysed to free hydroxy, preferably under basic conditions, e.g. in the presence of caustic soda, and preferably in a water-miscible organic solvent, such as tetrahydrofuran, dioxane or a lower alkanol, such as methanol or ethanol. Starting from compounds I, in which R 3 means esterified carboxy, such as lower alkoxycarbonyl, and R 3 contains such as substituents, the hydrolysis can be controlled in such a way that selectively only R 3 or both R 4 and also the lower alkoxy carbonyl substituent of R 3 are hydrolyzed to carboxy. If you use an equimolar sodium hydroxide solution and choose mild reaction conditions, e.g. 0.5 to 2 hours of stirring at room temperature, practically only the alkoxycarbonyl R4 is hydrolysed, while under more drastic conditions, e.g. with longer reaction times or during heating, both R4 and also the alkoxycarbonyl group in R3 are hydrolyzed to carboxy.
Omvendt kan man forestre karboksy R4 samt en karboksysubsti-tuent for R3 på vanlig måte. Conversely, carboxy R4 and a carboxy substituent for R3 can be esterified in the usual way.
Fritt eller forestret karboksy R4 og sådant som substituent for R3 kan videre amideres på vanlig måte, eksempelvis ved behandling med ammoniakk eller et mono- eller dilaverealkyl-amin. Eksempelvis kan man overføre karboksy R4 på vanlig måte, f.eks. i nærvær av et karbodiimidsalt, f.eks. av N-etyl-N'-(3-dimetylaminopropyl)-karbodiimid-hydroklorid, og 4-. dimetylaminopyridin, med et eventuelt substituert benzensulfonamid til den tilsvarende N-benzensulfamidoylkarbamylgrup-pen. Free or esterified carboxy R4 and such as a substituent for R3 can further be amidated in the usual way, for example by treatment with ammonia or a mono- or dilave alkyl amine. For example, carboxy R4 can be transferred in the usual way, e.g. in the presence of a carbodiimide salt, e.g. of N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide hydrochloride, and 4-. dimethylaminopyridine, with an optionally substituted benzenesulfonamide to the corresponding N-benzenesulfamidoylcarbamyl group.
Naturligvis kan man også oppdele oppnådde diastereomerblandinger på grunnlag av forskjellige fysikalske egenskaper for komponentene i de individuelle komponentene, og/eller oppdele oppnådde enantiomerblandinger ved vanlige racematadskillel-sesfremgangsmåter i de individuelle enantiomerene. Naturally, one can also divide obtained diastereomer mixtures on the basis of different physical properties of the components into the individual components, and/or divide obtained enantiomeric mixtures by usual racemate separation procedures into the individual enantiomers.
Når individuelle diastereomerer er ønskede, så kan fordel-aktig på et hvilket som helst trinn, en individuell diastereomer av et utgangsstoff anvendes, eller dannes fra et i form av en diastereomer foreliggende utgangsstoff ved stereoselektive reaksjonsbetingelser eller optisk aktive reagenser, fortrinnsvis en diastereomer, eller racemiske diastereomerblandinger kan adskilles ved fysikalske adskil-lelsesfremgangsmåter, eventuelt under anvendelse av optisk aktive hjelpestoffer, i de individuelle diastereomerene. When individual diastereomers are desired, then advantageously at any stage, an individual diastereomer of a starting material can be used, or formed from a starting material present in the form of a diastereomer by stereoselective reaction conditions or optically active reagents, preferably a diastereomer, or racemic diastereomer mixtures can be separated by physical separation methods, possibly using optically active auxiliaries, into the individual diastereomers.
I stereokjemisk forstand gjennomføres imidlertid både kondensasjonen av komponentene II og III, samt også fremstillingen av utgangsstoffene hovedsakelig på en slik måte at man alltid anvender stereotaktisk enhetlige utgangsstoffer, om mulig gjennomfører reaksjonene stereoselektivt, f.eks. ved anvendelse av stereotaktisk enhetlige, optisk aktive reagenser og/eller hjelpestoffer, og isolerer stereotaktisk enhetlige produkter fra reaksjonsblandingene umiddelbart etter reaksjonen. Følgelig adskilles f.eks. ved fremstillingen av de umettede utgangsstoffene, eventuelt dannede det cis- og trans-isomerer straks fra hverandre, hvorved de vanlige fysikalske adskillelsesfremgangsmåtene, som spesielt kromatografi, er velegnede. I hovedreaksjonen anvendes fortrinnsvis det stereomere epoksydet II med den i slutt-stoffet foretrukne stereotaksien for dobbeltbindingen(e) og også i racemisk form (som ofte dannes ved varianten med epoksydering av forbindelsen V med hydrogenperoksyd) eller fortrinnsvis som individuell diastereomer med den i slutt-stoffet I foretrukne konfigurasjonen ved (C-S-)-C-atom av motsatt konfigurasjon ved bindingen som S-atomet inngår med oksiran-C-atomet. In a stereochemical sense, however, both the condensation of components II and III, as well as the preparation of the starting materials, are mainly carried out in such a way that stereotactically uniform starting materials are always used, if possible the reactions are carried out stereoselectively, e.g. by using stereotactically uniform, optically active reagents and/or auxiliaries, and isolates stereotactically uniform products from the reaction mixtures immediately after the reaction. Consequently, e.g. in the preparation of the unsaturated starting materials, it possibly formed cis- and trans-isomers immediately from each other, whereby the usual physical separation methods, such as chromatography in particular, are suitable. In the main reaction, the stereomeric epoxide II is preferably used with the stereotaxy preferred in the final product for the double bond(s) and also in racemic form (which is often formed by the variant with epoxidation of the compound V with hydrogen peroxide) or preferably as an individual diastereomer with the final the substance In the preferred configuration at the (C-S-)-C atom of the opposite configuration at the bond that the S atom enters into with the oxirane C atom.
Videre kan man overføre oppnådde salter, eksempelvis ved syrebehandling, til de frie syrene hhv. oppnådde frie syrer ved basebehandling til salter. Furthermore, salts obtained, for example by acid treatment, can be transferred to the free acids or obtained free acids by base treatment to salts.
På grunn av det nære slektskapet mellom de nye forbindelsene i fri form og i form av salter, skal i det ovenstående og etterfølgende under fri forbindelse eller salter derav også forstås de tilsvarende saltene hhv. frie forbindelsene. Due to the close relationship between the new compounds in free form and in the form of salts, in the above and subsequently under free compound or salts thereof shall also be understood the corresponding salts or free connections.
De følgende eksemplene belyser foreliggende oppfinnelse nærmere. The following examples illustrate the present invention in more detail.
Eksempel 1: ( IR . 2S )- l- hydroksy- l-( 3- trif luormetvlfenvl )- 8 -( 4- acetvl- 3-hydroksy- 2- propyl- fenoksy )- okta- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyrernetylester Example 1: ( IR . 2S )-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3( E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Oppløsningen av 0,93 g (1R,2R)-1,2-epoksy-l-(3-trifluormetyl-f enyl)-8-(4-acetyl-3-hydroksy-2-propy1-fenoksy)-okta-3(E),5(Z)-dien i 25 ml metanol omrøres under argon med 0,80 g trietylamin og 0,62 g 7-merkaptokromon-2-karboksylsyremetylester i 20 timer ved romtemperatur og inndampes. Resten oppløses i eddikester og filtreres over kiselgel. Filtratet vaskes 1 gang med 2n-saltsyre og 3 ganger med soler, tørkes over magnesiumsulfat og inndampes. Rensing av resten ved kromatografi over kiselgel med heksan/eddikester (1:1) ga forbindelsen i overskriften av smeltepunkt 62-63°C; The solution of 0.93 g of (1R,2R)-1,2-epoxy-1-(3-trifluoromethyl-phenyl)-8-(4-acetyl-3-hydroxy-2-propyl-1-phenoxy)-octa-3 The (E),5(Z)-diene in 25 ml of methanol is stirred under argon with 0.80 g of triethylamine and 0.62 g of 7-mercaptochromone-2-carboxylic acid methyl ester for 20 hours at room temperature and evaporated. The residue is dissolved in vinegar and filtered over silica gel. The filtrate is washed 1 time with 2n-hydrochloric acid and 3 times with sol, dried over magnesium sulphate and evaporated. Purification of the residue by chromatography over silica gel with hexane/ethyl acetate (1:1) gave the title compound of mp 62-63°C;
[a]D2<0> (metanol, 0, 135%) = 103 ± 7,4° UV (metanol): Xmax (<c>) = 216 (50'000), 235/sh, 271 (27'940), 285/sh; 325 (12900). [a]D2<0> (methanol, 0, 135%) = 103 ± 7.4° UV (methanol): Xmax (<c>) = 216 (50'000), 235/sh, 271 (27'940 ), 285/sh; 325 (12900).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2R. 3R)- 2. 3- epoksy- 3-( 3- trifluormetylfenyl)- propanol Under absolutt vannfrle betingelser og argonatmosfære blandes oppløsningen av 4,62 ml tetraisopropyl-ortotitanat i 100 ml metylenklorid avkjølt til -70°C, med 3,2 ml D(-) vinsyredietylester og 5,45 g 3-(3-trifluormetylfenyl)-prop-2(E)-enol i litt metylenklorid. Etter 10 minutters omrøring ved -70° C tilsettes 21,5 ml 3 molar tertiærbutylhydroperoksydoppløsning i toluen, hvorved temperaturen stiger til -60°C. Temperaturen får iløpet av 2 timer stige langsomt til 0°C, den resulterende gule oppløsningen helles langsomt i en oppløs-ning av 14,5 g jern(II)-sulfat og 5,8 g L(+)-vinsyre i 60 ml vann (avkjøling! eksoterm) og det omrøres i 30 minutter ved 5-10°C. Den vandige fasen fraskilles og ekstraheres med eter. De samlede organiske ekstraktene tørkes over natriumsulfat og inndampes. Resten oppløses i 90 ml eter, avkjøles til 0-5°C, blandes med en suspensjon av 2,32 g natriumhydrok-syd i 60 ml sol og omrøres i 1 time ved 0-5°C. Den vandige fasen fraskilles og ekstraheres med eter. De samlede eterfasene tørkes over natriumsulfat og inndampes. Resten renses kromatografisk på kiselgel med heksan/eddikester (3:2). Forbindelsene i overskriften oppnås på denne måten som fargeløs olje; IR (CH2CI2): 3550, 3430, 2950, 2880, 2830, 1310, 1150, 1110, 1050 cm-1;[a]D2<0> (metanol, 0,17556) = 42,3 ± 5,7°; Rf = 0,30 (heksan/eddikester 3:2). b) ( 4R. 5R)- 4. 5- epoksv- 5-( 3- trifluormetylfenvl)- pent- 2( ET- enal Oppløsningen av 4,5 g (2R,3R)-2,3-epoksy-3-(3-trifluormetylfenyl)-propanol i 105 ml dimetylsulfoksyd omrøres under argon med 1,7 ml pyridin, 0,77 ml trifluoreddiksyre og 12,75 g N,N-dicykloheksylkarbodiimid i 6 timer ved romtemperatur. Etter tilsats av 8,25 g formylmetylentrifenylfosforan omrøres det i ytterligere 20 timer ved romtemperatur, blandes med 320 ml eddikester og det helles etter 10 minutter på 320 ml sol. Den dannede suspensjonen omrøres i 5 minutter og filtreres. I filtratet ekstraheres den vandige fasen 2 ganger med eddikester. De samlede organiske fasene vaskes 3 ganger med soler, tørkes over natriumsulfat og inndampes. Resten filtreres med eter/heksan (4:1) over kiselgel. Filtratet inndampes og resten renses ved kromatografi på kiselgel med heksan/eddikester (3:1). Forbindelsen i overskriften oppnås på denne måten som klar, gul olje; IR (CH2C12): 2780, 2695, 1670, 1620, 1305, 1145, 1105 cm-<1>; Rf = 0,31 (heksan/eddikester 3:1) [a]D<20> (kloroform, 0,245#) - 144,5 ± 4,1°. a) ( 2R. 3R)- 2. 3- epoxy- 3-( 3- trifluoromethylphenyl)- propanol Under absolutely anhydrous conditions and an argon atmosphere, the solution of 4.62 ml of tetraisopropyl orthotitanate in 100 ml of methylene chloride cooled to -70°C is mixed, with 3.2 ml of D(-) tartaric diethyl ester and 5.45 g of 3-(3-trifluoromethylphenyl)-prop-2(E)-enol in a little methylene chloride. After 10 minutes of stirring at -70°C, 21.5 ml of 3 molar tertiary butyl hydroperoxide solution in toluene is added, whereby the temperature rises to -60°C. The temperature is allowed to rise slowly to 0°C over the course of 2 hours, the resulting yellow solution is poured slowly into a solution of 14.5 g of iron(II) sulfate and 5.8 g of L(+)-tartaric acid in 60 ml of water (cooling! exothermic) and it is stirred for 30 minutes at 5-10°C. The aqueous phase is separated and extracted with ether. The combined organic extracts are dried over sodium sulfate and evaporated. The residue is dissolved in 90 ml of ether, cooled to 0-5°C, mixed with a suspension of 2.32 g of sodium hydroxide in 60 ml of sol and stirred for 1 hour at 0-5°C. The aqueous phase is separated and extracted with ether. The combined ether phases are dried over sodium sulphate and evaporated. The residue is purified chromatographically on silica gel with hexane/acetic acid (3:2). The compounds in the title are thus obtained as colorless oil; IR (CH2Cl2): 3550, 3430, 2950, 2880, 2830, 1310, 1150, 1110, 1050 cm-1; [α]D2<0> (methanol, 0.17556) = 42.3 ± 5.7°; Rf = 0.30 (hexane/acetic ester 3:2). b) (4R.5R)-4.5-epoxy-5-(3-trifluoromethylphenyl)-pent-2(ET-enal) The solution of 4.5 g of (2R,3R)-2,3-epoxy-3-( 3-trifluoromethylphenyl)-propanol in 105 ml of dimethylsulfoxide is stirred under argon with 1.7 ml of pyridine, 0.77 ml of trifluoroacetic acid and 12.75 g of N,N-dicyclohexylcarbodiimide for 6 hours at room temperature. After adding 8.25 g of formylmethylenetriphenylphosphorane, stir for a further 20 hours at room temperature, mixed with 320 ml of acetic acid and poured after 10 minutes into 320 ml of sol. The resulting suspension is stirred for 5 minutes and filtered. In the filtrate, the aqueous phase is extracted 2 times with acetic acid. The combined organic phases are washed 3 times with sol, dried over sodium sulfate and evaporated. The residue is filtered with ether/hexane (4:1) over silica gel. The filtrate is evaporated and the residue is purified by chromatography on silica gel with hexane/acetic ester (3:1). The title compound is obtained on this manner as clear, yellow oil; IR (CH2C12): 2780, 2695, 1670, 1620, 1305, 1145, 1105 cm-<1>; Rf = 0.31 (hexane/acetic ester 3:1) [α]D<20> (chloroform, 0.245#) - 144.5 ± 4.1°.
c) 3-( 4- acetyl- 3- h. ydroksy- 2- propylf enoksy) propyl- trifenyl-fosfoniumbromid c) 3-( 4- acetyl- 3- h. hydroxy- 2- propylphenoxy) propyl- triphenyl- phosphonium bromide
Oppløsningen av 27 g 3-(4-acetyl-3-hydroksy-2-propylfenoksy)propylbromid i 50 ml toluen oppvarmes med 21,85 g trifenylfosfon i 20 timer til tilbakeløp. Den dannede suspensjonen avkjøles til romtemperatur, blandes med 200 ml eter og omrøres i 1 time. Det fargeløse bunnfallet frasuges, vaskes med eter og tørkes. Forbindelsen i overskriften viser et smeltepunkt på 211-212°C. The solution of 27 g of 3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl bromide in 50 ml of toluene is heated with 21.85 g of triphenylphosphone for 20 hours to reflux. The resulting suspension is cooled to room temperature, mixed with 200 ml of ether and stirred for 1 hour. The colorless precipitate is filtered off with suction, washed with ether and dried. The compound in the title shows a melting point of 211-212°C.
d) ( IR. 2R)- l. 2- epoksv- l-( 3- trifluormetylfenvl)- 8-( 4- acetvl- 3-hydroksy- 2- propylfenoksy)- okta- 3( E). 5( Z)- dien d) (IR. 2R)-1.2-epoxy-1-(3-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E). 5(Z)- diene
Suspensjonen av 5,55 g 3-(4-acetyl-3-hydroksy-2-propylfenoksy)propyl-trifenylfosfoniumbromid i 80 ml tetrahydrofuran omrøres med 0,78 g NaNH2 og 60 mg kalium-tert.butanolat under argon i 1 time ved romtemperatur, avkjøles til 0-5°C, blandes i løpet av 5 minutter med 1,7 g (4R,5R)-4,5-epoksy-5-(3-trifluormetylfenyl)-pent-2(E)-enal i 20 ml tetrahydrofuran og deretter i 2 timer ved romtemperatur. Den dannede suspensjonen helles på fosfatbuffer (pH 7) og ekstraheres med eter. De samlede eterekstraktene vaskes med fosfatbuffer pE 7, tørkes over natriumsulfat og inndampes. Resten opptas i heksan/eddikester/trietylamin (24:71:5) og filtreres over kiselgel som på forhånd er vasket med denne oppløsningsmid-delblandingen. Filtratet inndampes og gir forbindelsen i overskriften som klar, gul olje; Rf = 0,75 (heksan/eddikester 3:2). The suspension of 5.55 g of 3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl-triphenylphosphonium bromide in 80 ml of tetrahydrofuran is stirred with 0.78 g of NaNH2 and 60 mg of potassium tert.butanolate under argon for 1 hour at room temperature , cooled to 0-5°C, mixed during 5 minutes with 1.7 g of (4R,5R)-4,5-epoxy-5-(3-trifluoromethylphenyl)-pent-2(E)-enal in 20 ml of tetrahydrofuran and then for 2 hours at room temperature. The resulting suspension is poured onto phosphate buffer (pH 7) and extracted with ether. The combined ether extracts are washed with phosphate buffer pE 7, dried over sodium sulphate and evaporated. The residue is taken up in hexane/acetic ester/triethylamine (24:71:5) and filtered over silica gel which has previously been washed with this solvent mixture. The filtrate is evaporated to give the title compound as a clear, yellow oil; Rf = 0.75 (hexane/acetic ester 3:2).
Eksempel 2: ( IR . 2S)- l- hydroksv- l-( 3- trifluormetylfenyl )- 8-( 4- acetyl- 3-hydroksy- 2- pr opylf enoksy )- okta- 3( E). 5( Z )- dien- 2- yl- 7- tio- 4-okso- 4H-" benzopyran- 2 - karboksyl syr e- natriumsalt Example 2: ( IR . 2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E). 5( Z )-dien-2-yl-7-thio-4-oxo-4H-" benzopyran-2-carboxylic acid e- sodium salt
0,7 g (IR,2S)-l-hydroksy-l-(3-trifluormetylfenyl)-8-(4-acetyl-3-hydroksy-2-propylfenoksy)-okta-3(E),5(Z)-dien-2-yl-7-1 io-4 -okso-4H-l-benzopy r an-2-karboksyl syrerne tylester oppløses under argon i 20 ml tetrahydrofuran, blandes med 5,1 ml 0,2n-natronlut og omrøres i 1 time ved romtemperatur. Inndamping og kromatografisk rensing av resten på en "Reversed Phase"-kiselgelsøyle (f.eks. Merck "Lichroprep RP-8") med metanol/vann (3:1) gir forbindelsen i overskriften, smeltepunkt 207-209°C, [a]D<20> (0,5456, metanol) = 96,3 ± 1,9° 0.7 g (IR,2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E),5(Z)- dien-2-yl-7-1io-4-oxo-4H-1-benzopyran-2-carboxylic acids ethyl ester is dissolved under argon in 20 ml of tetrahydrofuran, mixed with 5.1 ml of 0.2n-sodium hydroxide solution and stirred in 1 hour at room temperature. Evaporation and chromatographic purification of the residue on a "Reversed Phase" silica gel column (eg Merck "Lichroprep RP-8") with methanol/water (3:1) gives the title compound, mp 207-209°C, [a ]D<20> (0.5456, methanol) = 96.3 ± 1.9°
UV (metanol): Xmax (c) = 220 (488840), 235/sh, 267 (25940), 285 (22900), 324/sh. UV (methanol): Xmax (c) = 220 (488840), 235/sh, 267 (25940), 285 (22900), 324/sh.
Eksempel 3: ( IS . 2R )- l- hydroksv- l-( 3- trl f luormetvlfenvl )- 8-( 4- acetyl- 3-h. vdr oksy- 2- pr opylf enoksy )- okta- 3( E). 5 ( Z )- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyremetylester Example 3: ( IS . 2R )- 1- hydroxy- 1-( 3- trl fluoromethvulfenyl )- 8-( 4- acetyl- 3-h. vdroxy- 2- propylphenoxy )- octa- 3( E) . 5 ( Z )-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1) fra (1S,2S)-1,2-epoksy-l-(3-trifluormetylfenyl)-8-(4-acetyl-3-hydroksy-2-propylfenoksy)-okta-3(E),5(Z)-dien; smp. 68-69°C. The compound in the title is prepared analogously to example 1) from (1S,2S)-1,2-epoxy-1-(3-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E ),5(Z)-diene; m.p. 68-69°C.
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2S, 3S)- 2. 3- epoksy- 3-( 3- trifluormetylfenyl)- propanol a) ( 2S, 3S)- 2. 3- epoxy- 3-( 3- trifluoromethylphenyl)- propanol
Forbindelsen i overskriften fremstilles som beskrevet i The compound in the heading is produced as described in
eksempel la), men under anvendelse av L(+)-vinsyredietylester; fargeløs olje; IR (CH2C12): 3590, 3480,2920, 2870, 1330, 1165, 1125, 1070 cm-<1>; [a]D20 (metanol, 0 ,17556) = -41,7 ± 5,7°; Rf = 0,34 (heksan/eddikester 1:1). example la), but using L(+)-tartaric acid diethyl ester; colorless oil; IR (CH 2 Cl 2 ): 3590, 3480, 2920, 2870, 1330, 1165, 1125, 1070 cm-<1>; [α]D 2 O (methanol, 0.17556) = -41.7 ± 5.7°; Rf = 0.34 (hexane/acetic ester 1:1).
b) ( 4S. 5S1- 4. 5- epoksv- 5-( 3- trifluormetylfenvl1- pent- 2( É 1- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) b) ( 4S. 5S1- 4. 5- epoxyv- 5-( 3- trifluoromethylphenyl1- pent- 2( É 1- enal) The compound in the title is prepared analogously to example lb)
fra epoksyalkoholen fremstilt ifølge a); klar, gul olje; IR(CH2C12): 2780, 2695, 1670, 1620, 1305, 1145, 1110 cm-<1>; [a]D<20> (kloroform, 0,1556) = -158,0 ± 6,7°; Rf = 0,4 (heksan/eddikester 4:1). from the epoxy alcohol prepared according to a); clear, yellow oil; IR(CH 2 Cl 2 ): 2780, 2695, 1670, 1620, 1305, 1145, 1110 cm-<1>; [α]D<20> (chloroform, 0.1556) = -158.0 ± 6.7°; Rf = 0.4 (hexane/acetic acid 4:1).
c) ( 1S. 2S1- 1. 2- epoksv- l-( 3- trifluormetylfenvl)- 8-( 4- acetvl- 3-hvdroksy- 2- propylfenoksy)- okta- 3( E). 5( Z)- dien c) (1S.2S1-1.2-epoxy-1-(3-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E).5(Z)-diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra epoksyaldehydet fremstilt ifølge b); klarbrun olje; Rf = 0,61 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the epoxy aldehyde prepared according to b); light brown oil; Rf = 0.61 (hexane/acetic ester 3:2).
Eksempel 4: ( IS . 2R1- 1- hydroksv-( 3- trifluormetylfenyl)-8-( 4- acetyl- 3-hydroksv- 2- propylfenoksv)- okta- 3( E) . 5( Z )- dien- 2- vl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 4: ( IS . 2R1- 1- hydroxyz-(3- trifluoromethylphenyl)-8-( 4- acetyl- 3-hydroxyz- 2- propylphenoxyz)- octa- 3( E ). 5( Z )- diene- 2- vl- 7- thio- 4-oxo- 4H- l- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren fremstilt ifølge eksempel 3; smp. 210-212°C, [a]D<20> (MeOH, 0,1856) = -86,1 <+> 5,6° UV (MeOH): Xmax (c) = 220 (42820); 235/sh; 267 (26660); 285 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester prepared according to example 3; m.p. 210-212°C, [α]D<20> (MeOH, 0.1856) = -86.1 <+> 5.6° UV (MeOH): Xmax (c) = 220 (42820); 235/sh; 267 (26660); 285
(23760); 320 (15800). (23760); 320 (15800).
Eksempel 5: ( IR . 2S 1 - 1- hvdroksy- l- ( 3- tr i f luormetylf enyl )- 6-( 4- acetyl- 3-hyd r ok sv- 2- propylfenoksy)- heks- 3( Z)- en- 2- yl- 7- tio- 4- okso- 4H-l- benzopvran- 2- karboksylsyremetylester Example 5: ( IR . 2S 1 - 1-hydroxyl- ( 3-trifluoromethylphenyl )- 6-( 4- acetyl- 3-hydroxy sv- 2- propylphenoxy)- hex- 3( Z )- en- 2- yl- 7- thio- 4- oxo- 4H-1- benzopvran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (IR,2R)-l,2-epoksy-l-(3-trifluormetylfenyl)-6-(4-acetyl-3-hydroksy-2-propylfenoksy)-heks-3(Z)-en; klar, gul seig olje; [a]D2<0> (MeOH, 0 ,11556) = 57 ,4 ± 8,7°; UV (MeOH): Xmax (c) = 220/sh; 271 (5280); 285/sh; 320 (2800). The compound in the title is prepared analogously to example 1 from (IR,2R)-1,2-epoxy-1-(3-trifluoromethylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z) -one; clear, yellow viscous oil; [α]D2<O> (MeOH, 0.11556) = 57.4 ± 8.7°; UV (MeOH): Xmax (c) = 220/sh; 271 (5280); 285/sh; 320 (2800).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2S. 3R )- 2 . 3- er>oksv- 3-( 3- trif luormetylf envl )- propanol Oppløsningen av 1,1 g oksalylklorid i 15 ml metylenklorid a) ( 2S. 3R )- 2 . 3- er>oxv- 3-( 3- trifluoromethylphenyl )- propanol The solution of 1.1 g of oxalyl chloride in 15 ml of methylene chloride
avkjøles under argon til -65 til -70°C og blandes i løpet av 2 minutter med 1,5 g dimetylsulfoksyd i 5 ml metylenklorid. Etter 10 minutters omrøring ved -65 til -70°C tilsettes dråpevis 1,7 g (2R,3R)-2,3-epoksy-3-(3-trifluormetylfenyl)-propanol i 15 ml metylenklorid. Etter ytterligere 30 minutters omrøring tilsettes det dråpevis 4 g trietylamin, hvorved temperaturen stiger til -40°C. Temperaturen får stige til 0°C, og reaksjonsblandingen helles på fosfatbuffer (pH 8). Den organiske fasen fraskilles, og den vandige fasen ekstraheres med metylenklorid. De samlede organiske ekstraktene vaskes 2 ganger med soler, tørkes over natriumsulfat og inndampes. Kromatografi av resten på kiselgel med heksan/eddikester (7:3) gir forbindelsen i overskriften som fargeløs olje; cooled under argon to -65 to -70°C and mixed during 2 minutes with 1.5 g of dimethylsulfoxide in 5 ml of methylene chloride. After stirring for 10 minutes at -65 to -70°C, 1.7 g of (2R,3R)-2,3-epoxy-3-(3-trifluoromethylphenyl)-propanol in 15 ml of methylene chloride is added dropwise. After a further 30 minutes of stirring, 4 g of triethylamine are added dropwise, whereby the temperature rises to -40°C. The temperature is allowed to rise to 0°C, and the reaction mixture is poured onto phosphate buffer (pH 8). The organic phase is separated, and the aqueous phase is extracted with methylene chloride. The combined organic extracts are washed twice with sol, dried over sodium sulphate and evaporated. Chromatography of the residue on silica gel with hexane/ethyl acetate (7:3) gives the title compound as a colorless oil;
IR (metylenklorid): 2820, 1730, 1330, 1165, 1125, 1070 cm-<1>. Rf = 0,36 (heksan/eddikester 3:2). [a]])<20> (kloroform, 0,20$) = 17,5 ± 5°. IR (methylene chloride): 2820, 1730, 1330, 1165, 1125, 1070 cm-<1>. Rf = 0.36 (hexane/acetic ester 3:2). [a]])<20> (chloroform, 0.20$) = 17.5 ± 5°.
b) ( IR. 2R)- 1. 2- epoksy- l-( 3- trifluormetylfenvl)- 6-( 4- acetvl- 3-hydroksy- 2- propylfenoksy)- heks- 3( Z)- en b) (IR. 2R)-1.2-epoxy-1-(3-trifluoromethylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z)-ene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra epoksyaldehydet fremstilt ifølge a); klar, gul olje; Rf = 0,69 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the epoxy aldehyde prepared according to a); clear, yellow oil; Rf = 0.69 (hexane/acetic ester 3:2).
Eksempel 6: ( IR . 2S )- l- hydroksy- l-( 3- trif luormetylf enyl )- 6-( 4- acetyl- 3-hyd r oksy- 2- propylfenoksy)- heks- 3( Z)- en- 2- yl- 7- tio- 4- okso- 4H-l- benzopyran- 2- karboksylsyre- natriumsalt Example 6: ( IR . 2S )-1-hydroxy-1-(3-trifluoromethylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z)-ene- 2- yl- 7- thio- 4- oxo- 4H-1- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 5; smp. 222-224°C; [oc]D<20> (MeOH, 0,13556) = 62,2 ± 7,4°. UV (MeOH): <x>max (c) = 267 (22060); 285 (21140); 318/sh. The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 5; m.p. 222-224°C; [oc]D<20> (MeOH, 0.13556) = 62.2 ± 7.4°. UV (MeOH): <x>max (c) = 267 (22060); 285 (21140); 318/sh.
Eksempel 7: ( IS . 2R )- l- hvdroksv- l- ( 3- trl f luormetylf envl )- 6-( 4- acetvl- 3-hvdroksy- 2- propylfenoksv- heks- 3( Z)- en- 2- yl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksvlsvremetvlester Example 7: ( IS . 2R )-1-hydroxyl- (3-trifluoromethylphenyl)-6-(4-acetl-3-hydroxy-2-propylphenoxy-hex-3(Z)-ene-2- yl- 7- thio- 4- oxo- 4H- 1-benzopyran- 2- carboxyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1S,2S)-1,2-epoksy-l-(3-trifluormetylfenyl)-6-(4-acetyl-3~hydroksy-2-propylfenoksy)-heks-3(Z)-en; fargeløst pulver av smeltepunkt 69-71°C. The compound in the title is prepared analogously to example 1 from (1S,2S)-1,2-epoxy-1-(3-trifluoromethylphenyl)-6-(4-acetyl-3~hydroxy-2-propylphenoxy)-hex-3(Z) -one; colorless powder of melting point 69-71°C.
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2R. 3S)- 2. 3- epoksv- 3-( 3- trifluormetylfenvl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel 5a) a) (2R.3S)-2.3-epoxy-3-(3-trifluoromethylphenyl)-propanol The compound in the title is prepared analogously to example 5a)
fra (2S,3S)-2,3-epoksy-3-(3-trifluormetylfenyl)-propanol. Klar, gul væske; IR (CH2C12): 2820, 1730, 1330, 1165, 1130, 1070 cm-<1>; [a]D<20> (kloroform, 0 ,205é) = 0,0 ± 5; [a]20365 (kloroform, 0 ,2056) = 475,0 + 5,0°; Rf = 0,44 (heksan/eddikester 7:3). from (2S,3S)-2,3-epoxy-3-(3-trifluoromethylphenyl)-propanol. Clear, yellow liquid; IR (CH 2 Cl 2 ): 2820, 1730, 1330, 1165, 1130, 1070 cm-<1>; [a]D<20> (chloroform, 0 .205é) = 0.0 ± 5; [a]20365 (chloroform, 0 .2056) = 475.0 + 5.0°; Rf = 0.44 (hexane/acetic acid 7:3).
b) ( IS. 2S)- l. 2- epoksv- l-( 3- trifluormetylfenvl)- 6-( 4- acetyl- 3-hydroksy- 2- propylfenoksy)- heks- 3( Z)- en b) (IS. 2S)-1.2-epoxy-1-(3-trifluoromethylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z)-ene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra det tilsvarende epoksyaldehydet fremstilt ifølge a). Klar, gul olje; Rf = 0,43 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the corresponding epoxy aldehyde prepared according to a). Clear, yellow oil; Rf = 0.43 (hexane/acetic ester 3:2).
Eksempel 8: ( IS. 2R)- l- hvdroksy- l-( 3- trif luormetylf envl )- 6-( 4- acetvl- 3-hydr ok sy- 2- propylfenoksy)- heks- 3( Z)- en- 2- yl- 7- tio- 4- okso- 4H-l- benzopyran- 2- karboksylsyre- natriumsalt Example 8: (IS. 2R)-1-hydroxy-1-(3-trifluoromethylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z)-ene- 2- yl- 7- thio- 4- oxo- 4H-1- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 7; smp. 239-241°C; [a]D<20> (metanol, 0,1556) = -60,7 ± 6,7°; UV(metanol): xmax (c) = 216 (44080); 268 (22520); 285 (21640) 320/sh. Eksempel 9: ( lR. 2S)- l- hydroksy- l-( 3- metylfenyl)- 8-( 4- acetyl- 3- hvdroksv- 2-propylfenoksy )- okta- 3( E ). 5 ( Z )- dien- 2- vl- 7- tio- 4- okso- 4H- l-benzopvran- 2- karboksylsyrenretylester The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 7; m.p. 239-241°C; [α]D<20> (methanol, 0.1556) = -60.7 ± 6.7°; UV(methanol): xmax (c) = 216 (44080); 268 (22520); 285 (21640) 320/sh. Example 9: (1R.2S)-1-hydroxy-1-(3-methylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E). 5 (Z)-diene-2-vl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid nrethyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-metylfenyl)-8-(4-acetyl-3-hydroksy-2-propylfenoksy)-okta-3(E),5(Z)-dien; klart, gult pulver av smp. 71-72°C; [a]D<20> = 81,7 ± 8,7° (MeOH, 0,11556); UV(MeOH): Xmax (c) = 217 (53680); 235/sh; 271 (29120); 285/sh; 325 (13200). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-methylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E) ,5(Z)-diene; clear, yellow powder of m.p. 71-72°C; [α]D<20> = 81.7 ± 8.7° (MeOH, 0.11556); UV(MeOH): X max (c) = 217 (53680); 235/sh; 271 (29120); 285/sh; 325 (13200).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2R. 3R)- 2. 3- epoksy- 3-( 3- metylfenyl)- propanol a) ( 2R. 3R)- 2. 3- epoxy- 3-( 3- methylphenyl)- propanol
Forbindelsen i overskriften fremstilles analogt eksempel la) The compound in the heading is prepared analogously to example la)
fra 3-(3-metylfenyl)-prop-2(E)-enol; fargeløs, seig olje; IR (CH2C12): 3560, 3410, 2880, 2830, 1590, 1050 cm-<1>; Rf = 0,39 (heksan/eddikester 1:1); [oc]D<20> = 38,9 ± 5,3° (kloroform, 0,19$). from 3-(3-methylphenyl)-prop-2(E)-enol; colorless, viscous oil; IR (CH 2 Cl 2 ): 3560, 3410, 2880, 2830, 1590, 1050 cm-<1>; Rf = 0.39 (hexane/acetic ester 1:1); [oc]D<20> = 38.9 ± 5.3° (chloroform, 0.19$).
b) ( 4R. 5R)- 4. 5- epoksy- 5-( 3- metylfenyl)- pent- 2( E)- enal b) ( 4R. 5R)- 4. 5- epoxy- 5-( 3- methylphenyl)- pent- 2( E)- enal
Forbindelsen i overskriften fremstilles analogt eksempel lb) The compound in the heading is prepared analogously to example lb)
fra epoksyalkoholen fremstilt ifølge a); klart, gult pulver, smp. 60-61°C; IR (CH2C12): 2920, 2820, 2740, 1690, 1640, 1610, 1155, 1130 cm-<1>; Rf = 0,34 (heksan/eddikester 4:1). from the epoxy alcohol prepared according to a); clear, yellow powder, m.p. 60-61°C; IR (CH 2 Cl 2 ): 2920, 2820, 2740, 1690, 1640, 1610, 1155, 1130 cm-<1>; Rf = 0.34 (hexane/acetic ester 4:1).
c) ( IR. 2R)- l. 2- epoksy- l-( 3- metvi fenvl)- 8-( 4- acetvl- 3-hvdroksy- 2- propyl- fenoksy)- okta- 3( E). 5( Z)- dien c) ( IR. 2R )- 1. 2- epoxy- 1-( 3- methylphenyl)- 8-( 4- acetyl- 3-hydroxy- 2- propyl- phenoxy)- octa- 3( E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra det tilsvarende epoksyaldehydet ifølge a); klar, gul olje; Rf = 0,63 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the corresponding epoxy aldehyde according to a); clear, yellow oil; Rf = 0.63 (hexane/acetic ester 3:2).
Eksempel 10: ( lR. 2S)- l- hvdroksv- l- f3- metvlfenvl)- 8-( 4- acetvl- 3- hvdroksv- 2-propy1fenoksy)- okta- 3( E) . 5 ( Z )- dien- 2- vl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsyre- natriumsalt Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 9; beige pulver av smp. 217°C (dekomponering); [ot]j)<2>° (metanol, 0,1556) - 71,3 ± 6,7°; UV (metanol): Xmax (<c>) = 219 (51520); 234/sh; 267 (26460); 284 (23280); 322/sh. Example 10: (1R.2S)-1-hydroxy-1-f3-methylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E). 5 ( Z )-diene-2-vl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 9; beige powder of m.p. 217°C (decomposition); [ot]j)<2>° (methanol, 0.1556) - 71.3 ± 6.7°; UV (methanol): Xmax (<c>) = 219 (51520); 234/sh; 267 (26460); 284 (23280); 322/sh.
Eksempel 11: ( IS. 2R)- l- hvdroksv- l-( 3- metvlfenvl)- 8-( 4- acetvl- 3- hvdroksy- 2-propvlfenoksy)- okta- 3( E). 5 ( Z )-dien-2-vl-7-tio-4-okso-4H-l-benzopyran- 2- karboksylsyremetylester Example 11: (IS. 2R)-1-hydroxy-1-(3-methylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E). 5 ( Z )-dien-2-vl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
rr
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1S,2S)-1,2-epoksy-l-(m-tolyl)-8-(4-acetyl-3-hydroksy-2-propylfenoksy)-okta-3(E) ,5(Z)-dien; [cx]D<20> (MeOH, 0,14856) — 75,7 ± 6,8°; UV (MeOH): <X>max (c) = 217 (51760); 240/sh; 271 The compound in the title is prepared analogously to example 1 from (1S,2S)-1,2-epoxy-1-(m-tolyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E) ,5(Z)-diene; [cx]D<20> (MeOH, 0.14856) — 75.7 ± 6.8°; UV (MeOH): <X>max (c) = 217 (51760); 240/sh; 271
(27860); 290/sh; 328 (12600). (27860); 290/sh; 328 (12600).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2S. 3S)- 2. 3- epoksy- 3-( 3- metylfenyl)- propanol a) ( 2S. 3S)- 2. 3- epoxy- 3-( 3- methylphenyl)- propanol
Forbindelsen i overskriften fremstilles analogt eksempel la) The compound in the heading is prepared analogously to example la)
fra 3-(3-metylfenyl)-prop-2(E)-enol, men under anvendelse av L(+) vinsyredietylester; fargeløs olje; IR (CH2C12): 3550, 3470, 2940, 2880, 2830, 1590, 1050 cm-<1>; Rf = 0,31 (heksan/- eddikester 3:2). from 3-(3-methylphenyl)-prop-2(E)-enol, but using L(+) tartaric acid diethyl ester; colorless oil; IR (CH 2 Cl 2 ): 3550, 3470, 2940, 2880, 2830, 1590, 1050 cm-<1>; Rf = 0.31 (hexane/-acetic ester 3:2).
b) ( 4S. 5S)- 4. 5- epoksy- 5-( 3- metvlfenyl)- pent- 2( E)- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) b) (4S.5S)-4.5-epoxy-5-(3-methylphenyl)-pent-2(E)-enal The compound in the title is prepared analogously to example lb)
fra epoksyalkoholen ifølge a); klar, gul olje; IR (CH2C12): 2920, 2820, 2740, 1690, 1640, 1610, 1155, 1120, 1085 cm-<1>; Rf = 0,29 (heksan/eddikester 4:1). from the epoxy alcohol according to a); clear, yellow oil; IR (CH 2 Cl 2 ): 2920, 2820, 2740, 1690, 1640, 1610, 1155, 1120, 1085 cm-<1>; Rf = 0.29 (hexane/acetic ester 4:1).
c) ( 1S. 2S)- l. 2- epoksv- 1-( 3- metvlfenvl)- 8-( 4- acetyl- 3-hvdroksy- 2- propyl- fenoksy)- okta- 3( E). 5( Z1- dien c) (1S.2S)-1.2-epoxy-1-(3-methylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5( the Z1 die
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra epoksyaldehydet ifølge b); klar, gul olje; Rf = 0,51 (heksan/eddikester 7:3). The compound in the title is prepared analogously to example ld) from the epoxy aldehyde according to b); clear, yellow oil; Rf = 0.51 (hexane/acetic acid 7:3).
Eksempel 12: ( lS. 2R)- l- hvdroksy- l-( 3- metvlfenyl)- 8-( 4- acetyl- 3- hvdroksy- 2-propvl f enoksy )- okta- 3( E ). 5 ( Z )- dien- 2- yl- 7- tlo- 4- okso- 4H- l-benzopyran- 2- karboksylsyre- natriumsalt Example 12: (1S. 2R)-1-hydroxy-1-(3-methylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E). 5 ( Z )-dien-2-yl-7-tlo-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra den tilsvarende metylesteren fremstilt ifølge eksempel 11; smp. 197-198°C; [a]D<20> (0,1456 metanol) 72,1 ± 7,1°, UV (MeOH): Xmax (c) = 218 (50700); 235/sh; 267 (25780), 285 The compound in the title is prepared analogously to example 1 from the corresponding methyl ester prepared according to example 11; m.p. 197-198°C; [α]D<20> (0.1456 methanol) 72.1 ± 7.1°, UV (MeOH): Xmax (c) = 218 (50700); 235/sh; 267 (25780), 285
(22600); 321 (15000). (22600); 321 (15000).
Eksempel 13: ( lR. 2S)- l- hydroksy- l-( 3- metylfenyl)- 6-( 4- acetyl- 3- hvdroksy- 2-propylf enoksy)- heks- 3( Z )- en- 2- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyrernetylester Example 13: (1R.2S)-1-hydroxy-1-(3-methylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z)-en-2-yl - 7- thio- 4- oxo- 4H- 1- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-tolyl)-6-(4-acetyl-3-hydroksy-2-propylfenoksy)-heks-3(Z)-en; fargeløst pulver av smp. 136-138°C; [a]D<20> = 28,1 ± 7,4° (metanol, 0 ,13556) UV (metanol): *max (c) = 271 (26020); 282/sh; 323 (13700). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-tolyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z) -one; colorless powder of m.p. 136-138°C; [a]D<20> = 28.1 ± 7.4° (methanol, 0 .13556) UV (methanol): *max (c) = 271 (26020); 282/sh; 323 (13700).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2S. 3R)- 2. 3- epoksv- 3-( 3- metvlfenyl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel 5a) a) ( 2S. 3R)- 2. 3- epoxyv- 3-( 3- methylphenyl)- propanol The compound in the title is prepared analogously to example 5a)
fra (2R,3R)-2,3-epoksy-3-(3-metylfenyl)-propanol; klar, gul olje. IR (metylenklorid): 2920, 2820, 1730, 1610, 1140, 1070 cm-<1>; Rf = 0,49 (heksan/eddikester 3:2). from (2R,3R)-2,3-epoxy-3-(3-methylphenyl)-propanol; clear, yellow oil. IR (methylene chloride): 2920, 2820, 1730, 1610, 1140, 1070 cm-<1>; Rf = 0.49 (hexane/acetic acid 3:2).
b) ( IR . 2R ) - 1. 2- epoksv- 1-( 3- metvlfenvl)- 6-( 4- acetvl- 3-hydroksy- 2- propyl- fenoksy)- heks- 3( Z)- en b) ( IR . 2R ) - 1. 2- epoxyv- 1-( 3- methylphenyl)- 6-( 4- acetvl- 3-hydroxy- 2- propyl- phenoxy)- hex- 3( Z)- one
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra det tilsvarende epoksyaldehydet ifølge a); klar, gul olje; Rf = 0,73 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the corresponding epoxy aldehyde according to a); clear, yellow oil; Rf = 0.73 (hexane/acetic ester 3:2).
Eksempel 14: ( lR. 2S)- l- hvdroksv- l-( 3- metvlfenvl)- 6-( 4- acetvl- 3- hvdroksv- 2-prop. vlfenoksy)- heks- 3( Z)- en- 2- yl- 7- tio- 4- okso- 4H- l- benzopvran- 2- karboksylsyre- natriumsalt Example 14: (1R.2S)-1-hydroxy-1-(3-methylphenyl)-6-(4-acetyl-3-hydroxy-2-prop.ylphenoxy)-hex-3(Z)-ene-2- yl- 7- thio- 4- oxo- 4H- l- benzopvran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 13; beige pulver av smp. 238-240°C; [a]D<20> (metanol, 0,13556) = 31,1 ± 7,4°; UV (Metanol): Xmax (c) = 268 (21800); 285 (20860); 322/sh. The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 13; beige powder of m.p. 238-240°C; [α]D<20> (methanol, 0.13556) = 31.1 ± 7.4°; UV (Methanol): Xmax (c) = 268 (21800); 285 (20860); 322/sh.
Eksempel 15: ( IR . 2S )- l- hydroksy- l-( 3- metoksykarbonylfenyl)- 8-( 4- acetyl- 3-hvdroksv- 2- propvlf enoksy )- okta- 3( E) . 5( Z )- dien- 2- vl- 7- tio- 4-okso- 4E- l- benzopyran- 2- karboksylsyremetylester Example 15: ( IR . 2S )-1-hydroxyl-1-(3-methoxycarbonylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E). 5( Z )-diene- 2- vl- 7- thio- 4-oxo- 4E- l- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-metoksykarbonylfenyl)-8-(4-ace ty 1 -3 - hyd r ok sy-2-propyl f enoksy )-okta-3(E) ,5(Z)-dien; [a]D20 (metanol, 0,1456) = 27,9 ± 7,1°; UV (metanol): Xmax (c) - 221 (53560); 234/sh; 270 (28980): 285/sh; 326 (13860). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-methoxycarbonylphenyl)-8-(4-acety 1-3-hydroxy-2-propylphenoxy) -octa-3(E),5(Z)-diene; [α]D 2 O (methanol, 0.1456) = 27.9 ± 7.1°; UV (methanol): Xmax (c) - 221 (53560); 234/sh; 270 (28980): 285/sh; 326 (13860).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2R. 3R)- 2. 3- epoksy- 3-( 3- metoksykarbonylfenyl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel la) a) ( 2R. 3R)- 2. 3- epoxy- 3-( 3- methoxycarbonylphenyl)- propanol The compound in the title is prepared analogously to example la)
fra (E)-3-metoksykarbonylkanelalkohol; svakt gulfarget olje; Rf = 0,3 (heksan/eddikester 1:1). from (E)-3-methoxycarbonylcinnamon alcohol; slightly yellow colored oil; Rf = 0.3 (hexane/acetic acid 1:1).
b ) ( 4R . 5R) - 4 . 5- epoksy- 5- f 3- metoksykarbonylfenyl )- pent- 2( E )-enal b ) ( 4R . 5R) - 4 . 5-epoxy-5-f 3-methoxycarbonylphenyl)-pent-2(E)-enal
Forbindelsen i overskriften fremstilles analogt eksempel lb) fra den tilsvarende epoksyalkoholen; klar, gul olje, Rf = 0,35 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example 1b) from the corresponding epoxy alcohol; clear, yellow oil, Rf = 0.35 (hexane/acetic ester 3:2).
c) ( IR. 2R)- 1. 2- epoksv- l-( 3- metoksvkarbonvlfenvl)- 8-( 4- acetyl-3- hvdroksy- 2- propylfenoksy)- okta- 3( E). 5( Z)- dien c) ( IR. 2R )- 1. 2- epoxy- 1-( 3- methoxycarbonylphenyl)- 8-( 4- acetyl-3- hydroxy- 2- propylphenoxy)- octa- 3( E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra det tilsvarende epoksyaldehydet ifølge b); seig gul olje; Rf = 0,50 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the corresponding epoxy aldehyde according to b); tough yellow oil; Rf = 0.50 (hexane/acetic ester 3:2).
Eksempel 16: ( IR. 2S )- l- hydroksy- l-( 3- metoksykarbonylfenyl)- 8-( 4- acetyl- 3-hvdr oksy- 2- pr opvl f enoksy )- okta- 3( E) . 5( Z)- dien- 2- vl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 16: ( IR. 2S )-1-hydroxyl-1-(3-methoxycarbonylphenyl)-8-(4-acetyl-3-hvdroxy-2-pr opvl f enoxy )-octa-3( E) . 5( Z)-diene- 2- vl- 7- thio- 4-oxo- 4H- l- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra (IR,2S)-1-hydroksy-1-(3-metoksykarbonylfenyl)-8-(4-acetyl-3-hydroksy-2-propylfenoksy)-okta-3(E),5(Z)-dien-2-yl-7-1 i o-4-okso-4H-l -benzo py r an -2-karboksyl syrerne tyl ester fremstilt ifølge eksempel 15; klarbrunt pulver av smp. 181°C (dekomponering); [a]D<20> (metanol, 0,1556) = 32,0 ± 6,7°; UV (metanol): Xmax (c) = 222 (51600); 232/sh; 267 (24160), 284 The compound in the title is prepared analogously to example 2 from (IR,2S)-1-hydroxy-1-(3-methoxycarbonylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E),5 (Z)-dien-2-yl-7-1 in o-4-oxo-4H-1-benzopyran-2-carboxylic acids ethyl ester prepared according to example 15; light brown powder of m.p. 181°C (decomposition); [α]D<20> (methanol, 0.1556) = 32.0 ± 6.7°; UV (methanol): Xmax (c) = 222 (51600); 232/sh; 267 (24160), 284
(22940); 320/sh; 400/sh. (22940); 320/sh; 400/sh.
Eksempel 17: ( IS . 2R )- l- hvdroksy- l-( 3- metoksykarbonylfenyl)- 8-( 4- acetvl- 3-hydr oksy- 2- pr opylf enoksy )- okta- 3( E). 5 ( Z )- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyrernetylester Example 17: ( IS . 2R )-1-hydroxy-1-(3-methoxycarbonylphenyl)-8-(4-acetvl-3-hydroxy-2-propylphenoxy)-octa-3( E). 5 ( Z )-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1S,2S)-1,2-epoksy-l-(3-metoksykarbonylfenyl)-8-(4-acetyl-3-hydroksy-2-propylfenoksy)-okta-3(E),5(Z)-dien; smp. 77-78°C (fargeløst pulver); [a]D<20> (metanol, 0,1556) - -52 ,7 ± 6,7°; UV (metanol): Xmax (c) = 221 (57420); 235/sh; 271 The compound in the title is prepared analogously to example 1 from (1S,2S)-1,2-epoxy-1-(3-methoxycarbonylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E) ,5(Z)-diene; m.p. 77-78°C (colorless powder); [α]D<20> (methanol, 0.1556) - -52.7 ± 6.7°; UV (methanol): Xmax (c) = 221 (57420); 235/sh; 271
(29980); 288/sh; 326 (14320). (29980); 288/sh; 326 (14320).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2S. 3S)- 2. 3- epoksy- 3-( 3- metoksvkarbonvlfenvl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel la) a) ( 2S. 3S)- 2. 3- epoxy- 3-( 3- methoxycarbonylphenyl)- propanol The compound in the title is prepared analogously to example la)
fra (E)-3-metoksykarbonylkanelalkohol, men under anvendelse av L(+) vinsyredietylester; fargeløs olje; Rf = 0,48 (heksan/eddikester 1:1). from (E)-3-methoxycarbonylcinnamic alcohol, but using L(+) tartaric acid diethyl ester; colorless oil; Rf = 0.48 (hexane/acetic ester 1:1).
b) ( 4S. 5S)- 4 . 5- epoksv- 5-( 3- metoksvkarbonvlfenvl)- pent- 2-( E)-enal b) ( 4S. 5S)- 4 . 5- epoxy- 5-( 3- methoxycarbonylphenyl)- pent- 2-( E )-enal
Forbindelsen i overskriften fremstilles analogt eksempel lb fra den tilsvarende epoksyalkoholen; fargeløs olje; IR (metylenklorid): 3050, 2990, 2945, 2820, 2730, 1725, 1695, 1640, 1290, 1255 cm-<1>; Rf = 0,34 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example 1b from the corresponding epoxy alcohol; colorless oil; IR (methylene chloride): 3050, 2990, 2945, 2820, 2730, 1725, 1695, 1640, 1290, 1255 cm-<1>; Rf = 0.34 (hexane/acetic ester 3:2).
c) ( IS. 2S)- 1. 2- epoksv- l-( 3- metoksvkarbonvlfenvl)- 8-( 4- acetvl-3- hvdroksy- 2- propvlfenoksv)- okta- 3( E). 5( Z)- dien c) ( IS. 2S )- 1. 2- epoxy- 1-( 3- methoxycarbonylphenyl)- 8-( 4- acetyl-3- hydroxy- 2- propylphenoxy)- octa- 3( E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra det tilsvarende epoksyaldehydet ifølge b); klar, gul olje; Rf = 0,54 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the corresponding epoxy aldehyde according to b); clear, yellow oil; Rf = 0.54 (hexane/acetic ester 3:2).
Eksempel 18: ( IS . 2R )- l- hvdroksv- l-( 3- metoksvkarbonvlfenvl)- 8-( 4- acetyl- 3-hvdroksy- 2- propylfenoksv )- okta- 3( E). 5( Z)- dien- 2- vl- 7- tio- 4-okso- 4H- l- benzopvran- 2- karboksylsyre- natriumsalt Example 18: ( IS . 2R )-1-hydroxy-1-(3-methoxycarbonylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3( E). 5( Z)-diene- 2- vl- 7- thio- 4-oxo- 4H- 1- benzopvran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 17; beige pulver av smp. 174-176°C; [a]D<20> (metanol, 0,15556) = -80,6 ± 6,5°; UV (metanol): Xmax (c) = 223 (59300); 235 sh; 267 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 17; beige powder of m.p. 174-176°C; [α]D<20> (methanol, 0.15556) = -80.6 ± 6.5°; UV (methanol): Xmax (c) = 223 (59300); 235 shs; 267
(27300); 284 (24800); 321 (16200). (27300); 284 (24800); 321 (16200).
Eksempel 19: ( IR . 2S )- l- hvdroksy- l-( 3- metoksvkarbonvlfenvl)- 6-( 4- acetvl- 3-hvd r ok sv- 2- propylfenoksy)- heks- 3( Z)- en- 2- yl- 7- tio- 4- okso- 4H-l- benzopyran- 2- karboksylsyrenretylester Example 19: ( IR . 2S )- 1-hydroxy- 1-( 3- methoxycarbonylphenyl)- 6-( 4- acetvl- 3-hvdr ok sv- 2- propylphenoxy)- hex- 3( Z)-ene- 2 - yl- 7- thio- 4- oxo- 4H-1- benzopyran- 2- carboxylic acid nrethyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-metoksykarbonylfenyl)-6-(4-acetyl-3-hydroksy-2-propylfenoksy)-heks-3(Z)-en; fargelø s olje: [oc]D20 = (metanol, 0,1156) - 24,5 ± 9,1°; UV (metanol): xmax (c) " 270 (22400); 322 (12000). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-methoxycarbonylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z) -one; colorless oil: [oc]D20 = (methanol, 0.1156) - 24.5 ± 9.1°; UV (methanol): xmax (c) " 270 (22400); 322 (12000).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2S. 3R)- 2. 3- epoksy- 3-( 3- metoksykarbonylfenyl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel 5a) a) ( 2S. 3R)- 2. 3- epoxy- 3-( 3- methoxycarbonylphenyl)- propanol The compound in the title is prepared analogously to example 5a)
fra (2R.3R)-2,3-epoksy-3-(3-metoksykarbonylfenyl)-propanol; klar, gul olje; IR (metylenklorid): 2950, 2820, 1725, 1610, 1590, 1430, 1290, 1255 cm-<1>; Rf = 0,33 (heksan/eddikester 3:2). from (2R,3R)-2,3-epoxy-3-(3-methoxycarbonylphenyl)-propanol; clear, yellow oil; IR (methylene chloride): 2950, 2820, 1725, 1610, 1590, 1430, 1290, 1255 cm-<1>; Rf = 0.33 (hexane/acetic acid 3:2).
b) ( IR. 2R)- 1. 2- epoksv- l-( 3- metoksvkarbonvlfenvl)- 6-( 4- acetyl-3- hydroksv- 2- propylfenoksy)- heks- 3( Z)- en b) ( IR. 2R )- 1. 2- epoxy- 1-( 3- methoxycarbonylphenyl)- 6-( 4- acetyl-3- hydroxy- 2- propylphenoxy)- hex- 3( Z )- one
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra epoksyaldehydet ifølge a); klar, gul olje; Rf = 0,39 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the epoxy aldehyde according to a); clear, yellow oil; Rf = 0.39 (hexane/acetic ester 3:2).
Eksempel 20: ( IR . 2S )- l- hvdroksy- l-( 3- metoksvkarbonvlfenvl)- 6-( 4- acetvl- 3-hydr oksy- 2- propylfenoksy)- heks- 3( Z)- en- 2- yl- 7- tio- 4- okso- 4H-l- benzopyran- 2- karboksvlsyre- natriumsalt ( A), og Example 20: ( IR . 2S )-1-hydroxy-1-(3-methoxycarbonylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z)-en-2-yl - 7- thio- 4- oxo- 4H-1- benzopyran- 2- carboxylic acid sodium salt ( A), and
( IR. 2S)- l- hvdroksy- l-( 3- karboksyfenyl )- 6-( 4- acetyl- 3-hydr oksy- 2- propylfenoksy)- heks- 3( Z)- en- 2- vl- 7- tio- 4- okso- 4H-l- benzopyran- 2- karboksylsyre- dinatriumsalt ( B) ( IR. 2S )- l- hydroxy- l-( 3- carboxyphenyl )- 6-( 4- acetyl- 3- hydroxy- 2- propylphenoxy)- hex- 3( Z)- en- 2- vl- 7- thio- 4- oxo- 4H-l- benzopyran- 2- carboxylic acid disodium salt ( B)
Oppløsningen av 0,5 g (lR,2S)-l-hydroksy-l-(3-metoksykarbonylfenyl)-6-(4-acetyl-3-hydroksy-2-propylfenoksy)-heks-3( Z )-en-2-yl-7-1 io-4-okso-4H-1-benzopyran-2-karboksy 1-syremetylester ifølge eksempel 19 i 20 ml tetrahydrofuran omrøres under argon i 40 timer med 7,5 ml 0,2n natronlut ved romtemperatur og inndampes deretter. Resten renses ved kromatografi på "Lichroprep RP-8", Merck med metanol/vann (3:1), og gir i fraksjonene 2-5 forbindelsen B i overskriften; smp. 262-264C0;[a]D2<0> (metanol, 0,10556) = 17,1 ± 9,5°; UV (metanol): Xmax (c) = 268 (19680); 284 (19060); 325/sh; og i fraksjonene 8-12 forbindelsen Å i overskriften; smp. 155°C (dekomponering); [cx]])<20> (metanol, 0,12$) = 22,5 ± 8,3°; UV (metanol): Xmax (c) = 268 (26200); 286 (29220); 325/sh. The solution of 0.5 g of (1R,2S)-1-hydroxy-1-(3-methoxycarbonylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3( Z )-ene-2 -yl-7-1io-4-oxo-4H-1-benzopyran-2-carboxylic acid 1-methyl ester according to example 19 in 20 ml of tetrahydrofuran is stirred under argon for 40 hours with 7.5 ml of 0.2N caustic soda at room temperature and evaporated thereafter. The residue is purified by chromatography on "Lichroprep RP-8", Merck with methanol/water (3:1), and gives in fractions 2-5 the compound B in the title; m.p. 262-264C0;[α]D2<0> (methanol, 0.10556) = 17.1 ± 9.5°; UV (methanol): Xmax (c) = 268 (19680); 284 (19060); 325/sh; and in fractions 8-12 the compound Å in the heading; m.p. 155°C (decomposition); [cx]])<20> (methanol, 0.12$) = 22.5 ± 8.3°; UV (methanol): Xmax (c) = 268 (26200); 286 (29220); 325/sh.
Eksempel 21: ( IS . 2R ) - l- hvdroksv- l-( 3- metoksykarbonylfenvl)- 6-( 4- acetvl- 3-hvdroksy- 2- propylfenoksy)- heks- 3( Z)- en- 2- y1- 7- tio- 4- okso- 4H-l- benzopyran- 2- karboksvlsyremetylester Example 21: ( IS . 2R )-1-hydroxy-1-(3-methoxycarbonylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z)-ene-2-y1- 7- thio- 4- oxo- 4H-1- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1S,2S)-1,2-epoksy-l-(3-karboksymetylfenyl)-6-(4-acetyl-3-hydroksy-2-propylfenoksy)-heks-3(Z)-en; fargeløs olje, som størkner i kjøleskap, smp. gO-<g>i^C; [a]])<20> = -41,5 ± 7,7°The compound in the title is prepared analogously to example 1 from (1S,2S)-1,2-epoxy-1-(3-carboxymethylphenyl)-6-(4-acetyl-3-hydroxy-2-propylphenoxy)-hex-3(Z) -one; colorless oil, which solidifies in a refrigerator, m.p. gO-<g>i^C; [a]])<20> = -41.5 ± 7.7°
(0,1356 metanol); UV (metanol): Xmax (c) = 271 (25120); 322 (0.1356 methanol); UV (methanol): Xmax (c) = 271 (25120); 322
(13280). (13280).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2R. 3S)- 2 . 3- epoksy- 3-( 3- metoksykarbonylfenyl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel 5 a) ( 2R. 3S)- 2 . 3-epoxy-3-(3-methoxycarbonylphenyl)propanol The compound in the title is prepared analogously to example 5
fra (2S,3S)-2,3-epoksy-3-(3-metoksykarbonylfenyl)-propanol; fargeløs olje; IR (metylenklorid): 2910, 2780, 1705, 1590, 1570, 1415, 1270, 1235 cm-<1>; Rf = 0,36 (heksan/eddikester 3:2). from (2S,3S)-2,3-epoxy-3-(3-methoxycarbonylphenyl)-propanol; colorless oil; IR (methylene chloride): 2910, 2780, 1705, 1590, 1570, 1415, 1270, 1235 cm-<1>; Rf = 0.36 (hexane/acetic ester 3:2).
b) f IS. 2S) - 1. 2- epoksv- l-( 3- metoksykarbonylfenvl)- 6-( 4- acetyl-3- hydroksy- 2- propylfenoksy)- heks- 3( Z)- en b) f IS. 2S) - 1. 2- epoxy- 1-(3- methoxycarbonylphenyl)- 6-( 4- acetyl-3- hydroxy- 2- propylphenoxy)- hex- 3( Z)- ene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra det tilsvarende epoksyaldehydet ifølge a); fargeløs olje, ikke nærmere karakterisert. The compound in the title is prepared analogously to example ld) from the corresponding epoxy aldehyde according to a); colorless oil, not further characterized.
Eksempel 22: ( IS. 2R )- l- hvdroksy- l-( 3- metoksvkarbonylfenyl)- 6-( 4- acetvl- 3-hvdroksy- 2- propylfenoksy )- heks- 3( Z ^ en^- vl^- tio^- okso^ H-l- benzopyran^- karboksylsyre- natriumsalt Example 22: ( IS. 2R )-1-hydroxy-1-(3-methoxycarbonylphenyl)-6-(4-acetvl-3-hydroxy-2-propylphenoxy)-hex-3( Z ^en^-vl^-thio ^- oxo^ H-l- benzopyran^- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 21; beige pulver av smp. 208-210°C; [a]D<20> (metanol, 0,1256) = -41,7 ± 8,3°, UV (metanol): Xmax (c) = 268 (21060); 285 (21540); 325/sh. The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 21; beige powder of m.p. 208-210°C; [a]D<20> (methanol, 0.1256) = -41.7 ± 8.3°, UV (methanol): Xmax (c) = 268 (21060); 285 (21540); 325/sh.
Eksempel 23: ( 4R. 5S)- 1. 1. l- trifluor- 4- hydroksv- ll-( 4- acetvl- 3- hydroksy- 2-propylf enoksy)- undeka- 6( E). 8( Z)- dien- 5- vl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksvlsyremetylester Example 23: (4R.5S)-1.1.1-trifluoro-4-hydroxy-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-6(E). 8( Z )-diene- 5- vl- 7- thio- 4- oxo- 4H- 1-benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1) fra (4R,5R)-4,5-epoksy-l,1,1-trifluor-ll-(4-acetyl-3-hydroksy-2-propylfenoksy)-undeka-6.(E) ,8(Z)-dien; beige pulver av smp. 64-66°C, [a]D<20> (metanol, 0 ,1556) = 147,3 <+> 6,7". UV (metanol): Xmax (c) = 220 (48960); 270 (28500); 283/sh; 325 The compound in the title is prepared analogously to example 1) from (4R,5R)-4,5-epoxy-1,1,1-trifluoro-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-6. E) ,8(Z)-diene; beige powder of m.p. 64-66°C, [a]D<20> (methanol, 0 .1556) = 147.3 <+> 6.7". UV (methanol): Xmax (c) = 220 (48960); 270 (28500) ); 283/sh; 325
(13400). (13400).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2R. 3R)- 2 . 3- epoksy- 6. 6. 6- trifluor- heksanol Forbindelsen i overskriften fremstilles analogt eksempel la) a) ( 2R. 3R)- 2 . 3- epoxy- 6. 6. 6- trifluorohexanol The compound in the title is prepared analogously to example la)
fra 6 ,6 ,6-trif luor-heks-2(E)-enol; fargeløs olje; [oc]d<20 >(kloroform, 0,1756) = 35,9 ± 5,9°; IR (metylenklorid): 3550, 3420, 2950, 2890, 2830, 1125 cm-<1>. from 6,6,6-trifluorohex-2(E)-enol; colorless oil; [oc]d<20 >(chloroform, 0.1756) = 35.9 ± 5.9°; IR (methylene chloride): 3550, 3420, 2950, 2890, 2830, 1125 cm-<1>.
b) ( 4R. 5R)- 4. 5- epoksy- 8. 8. 8- trifluor- okt- 2( E)- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) b) ( 4R. 5R)- 4. 5- epoxy- 8. 8. 8- trifluoro- oct- 2( E)- enal The compound in the title is prepared analogously to example lb)
fra den tilsvarende epoksyalkoholen ifølge a); klar, gul olje; IR (CE2C12): 3050, 2980, 2930, 2820, 2730, 1695, 1645, 1450, 1150, 1100 cm-<1>; Rf = 0,41 (heksan/eddikester = 3:2). from the corresponding epoxy alcohol according to a); clear, yellow oil; IR (CE2C12): 3050, 2980, 2930, 2820, 2730, 1695, 1645, 1450, 1150, 1100 cm-<1>; Rf = 0.41 (hexane/acetic ester = 3:2).
c) ( 4R. 5R)- 4. 5- epoksy- l. 1. 1- trifluor- ll- f4- acetyl- 3- hvdroksv-2- propylfenoksy)- undeka- 6( E), 8( Z)- dien c) (4R.5R)-4.5-epoxy-1.1.1-trifluoro-II-f4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-6(E),8(Z)-diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra epoksyaldehydet ifølge b); klar, gul olje; Rf = 0,48 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the epoxy aldehyde according to b); clear, yellow oil; Rf = 0.48 (hexane/acetic acid 3:2).
Eksempel 24: ( 4R . 5S )- l. 1. 1- trifluor- 4- hvdroksy- ll-( 4- acetvl- 3- hydroksy- 2-propylf enoksy )- undeka- 6( E) . 8( Z )- dien- 5- yl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksvlsyre- natriumsalt Example 24: (4R.5S)-1.1.1-trifluoro-4-hydroxy-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-6(E). 8(Z)-dien-5-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 23; beige pulver av smp. 198-20CC; [a]D<20> (metanol, 0,1556) = 127,3 ± 6,7°; UV (metanol): Xmax (c) = 221 (48820); 230/sh; 267 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 23; beige powder of m.p. 198-20CC; [α]D<20> (methanol, 0.1556) = 127.3 ± 6.7°; UV (methanol): Xmax (c) = 221 (48820); 230/sh; 267
(25400), 285 (23080); 322/sh. (25400), 285 (23080); 322/sh.
Eksempel 25: ( 4S . 5R )- l . 1. 1- trifluor- 4- hydroksy- ll-( 4- acetyl- 3- hydroksy- 2-propylf enoksy)- undeka- 6( E). 8( Z)- dien- 5- vl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsyremetylester Example 25: ( 4S . 5R )- l . 1. 1-trifluoro-4-hydroxy-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-6(E). 8(Z)-diene-5-vl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (4S,5S)-4,5-epoksy-l,1,l-trifluor-ll-(4-acetyl-3-hydroksy-2-propylfenoksy)-undeka-6(E),8(Z)-dien; fargeløst pulver av smp. 69-71°C; [a]D<20> -153,3 ± 67° (metanol, 0,1556). UV (metanol): Xmax (c) = 220 (49560); 235/sh; 270 (29220); 285/sh; 325 (12990). The compound in the title is prepared analogously to example 1 from (4S,5S)-4,5-epoxy-1,1,1-trifluoro-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-6(E) ,8(Z)-diene; colorless powder of m.p. 69-71°C; [α]D<20> -153.3 ± 67° (methanol, 0.1556). UV (methanol): Xmax (c) = 220 (49560); 235/sh; 270 (29220); 285/sh; 325 (12990).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2S. 3S)- 2. 3- epoksv- 6. 6. 6- trifluor- heksanol a) ( 2S. 3S)- 2. 3- epoxyv- 6. 6. 6- trifluorohexanol
Forbindelsen i overskriften fremstilles analogt eksempel la) The compound in the heading is prepared analogously to example la)
fra 6,6,6-trifluor-heks-2(E)-enol, men under anvendelse av L(+) vinsyredietylester; fargeløs olje; [cOd<20> (kloroform, from 6,6,6-trifluorohex-2(E)-enol, but using L(+) tartaric diethyl ester; colorless oil; [cOd<20> (chloroform,
0,1756) = -25,9 ± 5,9°; IR (metylenklorid): 3550, 3430, 2940, 2880, 2830, 1125 cm-<1>. 0.1756) = -25.9 ± 5.9°; IR (methylene chloride): 3550, 3430, 2940, 2880, 2830, 1125 cm-<1>.
b) ( 4S. 5S1- 4. 5- epoksy- 8. 8. 8- trifluor- okt- 2( E)- enal Forbindelsen i overskiften fremstilles analogt eksempel lb) b) ( 4S. 5S1- 4. 5- epoxy- 8. 8. 8- trifluoro- oct- 2( E)- enal The compound in the upper shift is prepared analogously to example lb)
fra den tilsvarende epoksyalkoholen ifølge a), klar, gul olje; IR (metylenklorid): 3050, 2990, 2930, 2820, 2730, 1695, 1645, 1450, 1150, 1100 cm-<1>; Rf = 0,36 (heksan/eddikester 3:2). from the corresponding epoxy alcohol according to a), clear, yellow oil; IR (methylene chloride): 3050, 2990, 2930, 2820, 2730, 1695, 1645, 1450, 1150, 1100 cm-<1>; Rf = 0.36 (hexane/acetic ester 3:2).
c) ( 4S. 5S)- 4. 5- epoksv- l. 1. 1- trifluor- ll-( 4- acetvl- 3- hvdroksy-2- propylfenoksy)- undeka- 6( E). 8( Z)- dien c) (4S.5S)-4.5-epoxy-1.1.1-trifluoro-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-6(E). 8(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra det tilsvarende epoksyaldehydet ifølge b); klar,gul olje. The compound in the title is prepared analogously to example ld) from the corresponding epoxy aldehyde according to b); clear, yellow oil.
Eksempel 26: ( 4S . 5R )- l. 1. l- trifluor- 4- hvdroksv- ll-( 4- acetvl- 3- hydroksv- 2-propylf enoksy)- undeka- 6( E). 8( Z)- dien- 5- vl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsvre- natrlumsalt Example 26: (4S.5R)-1.1.1-trifluoro-4-hydroxy-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-6(E). 8( Z)-diene- 5- vl- 7- thio- 4- oxo- 4H- 1-benzopyran- 2- carboxyl vrene- sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 25; beige pulver av smp. 201-203°C; [a]D<20> (metanol, 0,1556) = -117,3 ± 6,7°; UV (metanol): Xmax (c) = 222 (48320); 233/sh; 267 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 25; beige powder of m.p. 201-203°C; [α]D<20> (methanol, 0.1556) = -117.3 ± 6.7°; UV (methanol): Xmax (c) = 222 (48320); 233/sh; 267
(26440); 285 (24440); 330/sh. (26440); 285 (24440); 330/sh.
Eksempel 27: ( 4R . 5S1- 1. 1. 1- trif luor- 4- hvdroksy- 9-( 4- acetvl- 3- hydroksv- 2-propylf enoksy)- non- 6-( Z)- en- 5- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyremetylester Example 27: (4R.5S1-1.1.1-trifluoro-4-hydroxy-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-non-6-(Z)-ene-5- yl- 7- thio- 4- oxo- 4H- 1- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (4R,5R)-4,5-epoksy-l,1,1-trifluor-9-(4-acetyl-3-hydroksy-2-propylfenoksy)-non-6(Z)-en; fargeløs, seig olje; IR (metylenklorid): 3530, 2920, 2890, 2820, 1720, 1640, 1605, 1585 cm-1. The compound in the title is prepared analogously to example 1 from (4R,5R)-4,5-epoxy-1,1,1-trifluoro-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-non-6(Z) -one; colorless, viscous oil; IR (methylene chloride): 3530, 2920, 2890, 2820, 1720, 1640, 1605, 1585 cm-1.
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2S. 3R)- 2. 3- epoksy- 6. 6. 6- trifluor- heksanol Forbindelsen i overskriften fremstilles analogt eksempel 5a) a) ( 2S. 3R)- 2. 3- epoxy- 6. 6. 6- trifluorohexanol The compound in the title is prepared analogously to example 5a)
fra (2R,3R)-2,3-epoksy-6,6,6-trifluor-heksanol; fargeløs væske av kokepunkt 80-81°C/26 mbar. ; [a]j)<20> (kloroform, 0,1556) 10,7 <+> 6,7° . from (2R,3R)-2,3-epoxy-6,6,6-trifluorohexanol; colorless liquid of boiling point 80-81°C/26 mbar. ; [a]j)<20> (chloroform, 0.1556) 10.7 <+> 6.7° .
b) ( 4R . 5R )- 4. 5- epoksy- l. 1. 1- trifluor- 9-( 4- acetvl- 3- hvdroksv-2- propylfenoksy)- non- 6( Z)- en b) (4R.5R)-4.5-epoxy-1.1.1-trifluoro-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-non-6(Z)-ene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra epoksyaldehydet ifølge a); klar, gul olje. The compound in the title is prepared analogously to example ld) from the epoxy aldehyde according to a); clear, yellow oil.
Eksempel 28: ( 4R . 5S )- l. 1 . 1- trif luor- 4- hvdroksv- 9-( 4- acetvl- 3- hvdroksy- 2-propvlfenoksy)- non- 6( Z)- en- 5- y1- 7- tio- 4- okso- 4H- l- benzopyran-2- karboksylsyre- natriumsalt Example 28: ( 4R . 5S )- l. 1 . 1- trifluoro- 4- hydroxy- 9-( 4- acetvl- 3- hydroxy- 2- propylphenoxy)- non- 6( Z)- en- 5- y1- 7- thio- 4- oxo- 4H- l- benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 27; klart, gult pulver av smp. 204-206°C; [a]D<20> (metanol, 0,1556) = 42,7 ± 6,7°, UV (metanol): Xmax (c) = 218 (36920); 268 (20280); 285 (20180); 325/sh. The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 27; clear, yellow powder of m.p. 204-206°C; [a]D<20> (methanol, 0.1556) = 42.7 ± 6.7°, UV (methanol): Xmax (c) = 218 (36920); 268 (20280); 285 (20180); 325/sh.
Eksempel 29: ( 5R . 6S )- 5- hydroksy- 12-( 4- acetyl- 3- hydroksy- 2- propylfenoksy)-dodec- 7 ( Z)- en- 6- yl- 7- tio- 4- okso- 4E- l- benzopyran- 2- karboksyl-svremetvlester Example 29: (5R.6S)-5-hydroxy-12-(4-acetyl-3-hydroxy-2-propylphenoxy)-dodec-7(Z)-en-6-yl-7-thio-4-oxo- 4E-l-benzopyran-2-carboxyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (5R,6R)-5,6-epoksy-12-(4-acetyl-3-hydroksy-2-propylfenoksy )-dodec-7-(Z)-en; klar, gul olje; Rf = 0,37 (heksan/- eddikester 1:1). The compound in the title is prepared analogously to example 1 from (5R,6R)-5,6-epoxy-12-(4-acetyl-3-hydroxy-2-propylphenoxy)-dodec-7-(Z)-ene; clear, yellow oil; Rf = 0.37 (hexane/acetic acid 1:1).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) 5-( 4- acetyl- 3- hydroksy- 2- propylfenoksyIpentvl- trifenvlfos-foniumbromid a) 5-(4-acetyl-3-hydroxy-2-propylphenoxyIpentyl-triphenylphosphonium bromide
Forbindelsen i overskriften fremstilles som i eksempel lc) fra 5-(4-acetyl-3-hydroksy-2-propylfenoksy)pentylbromid; fargeløse krystaller av smp. 82-85°C. The compound in the title is prepared as in example lc) from 5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl bromide; colorless crystals of m.p. 82-85°C.
b) ( 2S. 3R)- 2. 3- epoksv- heptanal b) ( 2S. 3R)- 2. 3- epoxyv-heptanal
Forbindelsen i overskriften fremstilles analogt eksempel 5a) The compound in the heading is prepared analogously to example 5a)
fra (2R,3R)-2,3-epoksyheptanol; [a]D<20> = -99,4 ± 0,1°. from (2R,3R)-2,3-epoxyheptanol; [a]D<20> = -99.4 ± 0.1°.
c) ( 5R . 6R) - 5 . 6- epoksy- 12-( 4- acetyl- 3- hydroksy- 2- propylf enoksy )- dodec- 7-( Z)- en c) ( 5R . 6R) - 5 . 6- epoxy- 12-( 4- acetyl- 3- hydroxy- 2- propylphenoxy )- dodec- 7-( Z)- ene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra epoksyaldehydet ifølge a), klar, gul olje. The compound in the title is prepared analogously to example ld) from the epoxy aldehyde according to a), clear, yellow oil.
Eksempel 30: ( 5R . 6S )- 5- hydroksv- 12-( 4- acetyl- 3- hydroksy- 2- propylfenoksy)-dodec- 7 ( Z )- en- 6- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 30: (5R.6S)-5-hydroxy-12-(4-acetyl-3-hydroxy-2-propylphenoxy)-dodec-7(Z)-en-6-yl-7-thio-4-oxo- 4H-l-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge 29; smp. 192-194°C; [oc]d<20> (metanol, 0,12556) = +5,6 ± 8,0°; UV (metanol): Xmax (c) = 218 (218 (38000); 268 (22040); 285 (21120); 325 sh. The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to 29; m.p. 192-194°C; [oc]d<20> (methanol, 0.12556) = +5.6 ± 8.0°; UV (methanol): Xmax (c) = 218 (218 (38000); 268 (22040); 285 (21120); 325 sh.
Eksempel 31: ( 5S . 6R1- 5- hvdroksy- 12-( 4- acetyl- 3- hydroksy- 2- propylfenoksy )-dodec- 7 ( Z )- en- 6- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyremetylester Example 31: (5S.6R1-5-hydroxy-12-(4-acetyl-3-hydroxy-2-propylphenoxy)-dodec-7(Z)-en-6-yl-7-thio-4-oxo-4H - l- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (5S,6S )-5,6-epoksy-12-(4-acetyl-3-hydroksy-2-propylfenoksy )-dodec-7-(Z)-en; klar, gul olje; Rf = 0,41 (heksan/- eddikester 1:1). The compound in the title is prepared analogously to example 1 from (5S,6S)-5,6-epoxy-12-(4-acetyl-3-hydroxy-2-propylphenoxy)-dodec-7-(Z)-ene; clear, yellow oil; Rf = 0.41 (hexane/acetic acid 1:1).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2R. 3S)- 2 . 3- epoksv- heptanal a) ( 2R. 3S)- 2 . 3- epoxyv-heptanal
Forbindelsen i overskriften fremstilles analogt eksempel 5a) The compound in the heading is prepared analogously to example 5a)
fra (2S,3S)-2,3-epoksy-heptanol; [a]D<20> = +104,3 ± 0,4°. from (2S,3S)-2,3-epoxyheptanol; [a]D<20> = +104.3 ± 0.4°.
b ) ( 5S . 6S )- 5 . 6- epoksy- 12-( 4- acetyl - 3- hydroksy- 2- propylfen-oksv)- dodec- 7( Z)- en b) (5S. 6S)-5. 6- epoxy- 12-( 4- acetyl- 3- hydroxy- 2- propylphen-oxv)- dodec- 7( Z)- ene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra epoksyaldehydet ifølge a); klar, gul olje, Rf = 0,42 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example ld) from the epoxy aldehyde according to a); clear, yellow oil, Rf = 0.42 (hexane/acetic ester 3:2).
Eksempel 32: ( 5S . 6R )- 5- hydroksy- 12-( 4- acetyl- 3- hydroksy- 2- propylfenoksy)-dodec- 7 ( Z)- en- 6- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsvre- natriumsalt Example 32: (5S.6R)-5-hydroxy-12-(4-acetyl-3-hydroxy-2-propylphenoxy)-dodec-7(Z)-en-6-yl-7-thio-4-oxo- 4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 31; smp. 192-194°C; [oc]D<20> (metanol, 0 ,14556) = 0 ± 6,9°; UV (metanol): *max (£) " 218 (37060); 268 (21760); 286 (20520); 325 sh. The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 31; m.p. 192-194°C; [oc]D<20> (methanol, 0 .14556) = 0 ± 6.9°; UV (methanol): *max (£) " 218 (37060); 268 (21760); 286 (20520); 325 sh.
Eksempel 33: ( 4R . 5S 1- 1. 1. 1- trifluor- 4- hydroksv- ll-( 4- acetvl- 3- hydroksv- 2-pr opylf enoksy )- undec- 6( Z ) - en- 5- yl - 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyremetylester Example 33: ( 4R . 5S 1- 1. 1. 1- trifluoro- 4- hydroxy- ll-( 4- acetvl- 3- hydroxy- 2- propylphenoxy )- undec- 6( Z ) - en- 5- yl - 7- thio- 4- oxo- 4H- 1- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (4R,5R)-4,5-epoksy-l,1,1-trifluor-ll-(4-acetyl-3-hydroksy-2-propylfenoksy)-undec-6(Z)-en, klar, gul olje; Rf = 0,47 (heksan/eddikester 1:1). The compound in the title is prepared analogously to example 1 from (4R,5R)-4,5-epoxy-1,1,1-trifluoro-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undec-6(Z) -a, clear, yellow oil; Rf = 0.47 (hexane/acetic ester 1:1).
Utgangsmaterialet fremstilles f.eks. analogt eksempel ld) fra (2S,3R)-2,3-epoksy-6,6,6-trifluor-heksanal; klar, gul olje. Eksempel 34: ( 4R. 5S)- 1. 1. 1- trifluor- 4- hvdroksy- ll-( 4- acetvl- 3- hvdroksv- 2-propyl f enoksy )- undec- 6( Z ) - en- 5- vi- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt The starting material is produced e.g. analogous example 1d) from (2S,3R)-2,3-epoxy-6,6,6-trifluorohexanal; clear, yellow oil. Example 34: (4R.5S)-1.1.1-trifluoro-4-hydroxy-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undec-6(Z)-ene-5- vi- 7- thio- 4- oxo- 4H- l- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 33; smp. 193-195°C; [a]D<20> (metanol, 0,135*) = +16,3 ± 7,4°; UV (MeOH): Xmax (e) = 218 (37380); 267 (21380); 286 (21020), 325/sh. The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 33; m.p. 193-195°C; [α]D<20> (methanol, 0.135*) = +16.3 ± 7.4°; UV (MeOH): X max (e) = 218 (37380); 267 (21380); 286 (21020), 325/sh.
Eksempel 35: ( 5R . 6S )- 5- hydroksy- 10-( 4- acetyl- 3- hydroksy- 2- propylfenoksv)-dec- 7( Z)- en- 6- yl- 7- okso- 4H- l- benzopyran- 2- karboksvlsyremetylester Example 35: (5R.6S)-5-hydroxy-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-dec-7(Z)-en-6-yl-7-oxo-4H-1- benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (5R,6R)-5,6-epoksy-10-(4-acetyl-3-hydroksy-2-propylfenoksy )-dec-7(Z)-en, klar, gul olje; [oc]D<20> (metanol, 0,135$) = +48,9 ± 7,4°, UV (metanol): <X>max (c) = 216 (38140); 271 The compound in the title is prepared analogously to example 1 from (5R,6R)-5,6-epoxy-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-dec-7(Z)-ene, clear, yellow oil; [oc]D<20> (methanol, 0.135$) = +48.9 ± 7.4°, UV (methanol): <X>max (c) = 216 (38140); 271
(24040); 285/sh, 322 (12700). (24040); 285/sh, 322 (12700).
Utgangsmaterialet fremstilles f.eks. analogt eksempel ld) fra (2S,3R)-2,3-epoksy-heptanal; klar, gul olje. Rf = 0,45 (heksan/eddikester 7:3). The starting material is produced e.g. analogous example 1d) from (2S,3R)-2,3-epoxy-heptanal; clear, yellow oil. Rf = 0.45 (hexane/acetic acid 7:3).
Eksempel - 36: ( 5R . 6S ) - 5- hvdroksy- 10-( 4- acetyl- 3- hydroksv- 2- propylfenoksy)-dec- 7( Z)- en- 6- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksvlsvre Example - 36: (5R.6S)-5-hydroxy-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-dec-7(Z)-en-6-yl-7-thio-4-oxo - 4H-1-benzopyran-2-carboxylic acid
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 35 og omvandles med saltsyre til fri syre, smp. 58-60°C; [a]p<20 >(metanol, 0,13056) = +36,2 ± 7,7°; UV (metanol): Xmax (<c>) = 218 (35240); 269 (20760); 283 (19800); 330 sh. The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 35 and is converted with hydrochloric acid to free acid, m.p. 58-60°C; [α]p<20 >(methanol, 0.13056) = +36.2 ± 7.7°; UV (methanol): Xmax (<c>) = 218 (35240); 269 (20760); 283 (19800); 330 shs.
Eksempel 37: ( 5S . 6R ) - 5- hvdroksv- 10-( 4- acetyl- 3- hvdroksy- 2- propylfenoksy)-dec- 7 ( Z )- en- 6- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyrernetylester Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (5S,6S)-5,6-epoksy-10-(4-acetyl-3-hydroksy-2-propylfenoksy )-dec-7(Z )-en, klar, gul olje; [cx]j)20 (metanol, 0,115$) = -50,4 ± 8,7°; UV (MeOH): Xmax (c) = 217 (38000); 271 (24100); 285 sh, 321 (12800). Example 37: (5S.6R)-5-hydroxy-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-dec-7(Z)-en-6-yl-7-thio-4-oxo- 4H-1-benzopyran-2-carboxylic acid methyl ester The compound in the title is prepared analogously to example 1 from (5S,6S)-5,6-epoxy-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-dec-7(Z )-en, clear, yellow oil; [cx]j)20 (methanol, 0.115$) = -50.4 ± 8.7°; UV (MeOH): Xmax (c) = 217 (38000); 271 (24100); 285 sh, 321 (12800).
Utgangsmaterialet fremstilles f.eks. analogt eksempel ld) fra (2R,3S)-2,3-epoksy-heptanal; klarbrun olje; Rf = 0,52 (heksan/eddikester 7:3). The starting material is produced e.g. analogous example 1d) from (2R,3S)-2,3-epoxy-heptanal; light brown oil; Rf = 0.52 (hexane/acetic acid 7:3).
Eksempel 38: ( 5S . 6R )- 5- hvdroksy- 10-( 4- acetyl- 3- hydroksy- 2- propylfenoksy)-dec- 7 ( Z )- en- 6- yl- 7- t io- 4- okso- 4H- l- benzopyran- 2- karboksylsvre- natriumsalt Example 38: (5S.6R)-5-hydroxy-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-dec-7(Z)-en-6-yl-7-thio-4-oxo - 4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren ifølge eksempel 37; smp. 224-226°C; [a]D<20> (metanol, 0,145$) = -29,0 ± 6,9°; UV (metanol): Xmax (c) = 219 (38760); 268 (21880); 285 (21260); 325 sh. The compound in the title is prepared analogously to example 2 from the corresponding methyl ester according to example 37; m.p. 224-226°C; [α]D<20> (methanol, 0.145$) = -29.0 ± 6.9°; UV (methanol): Xmax (c) = 219 (38760); 268 (21880); 285 (21260); 325 sh.
Eksempel 39: ( 5S . 6R ) - 5- hydroksy- 10-( 4- acetvl- 3- hydroksy- 2- propylfenoksy)-dec- 7( Z)- en- 6- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2-( N- benzensul-fonamldvl ) karboksamid Example 39: (5S.6R)-5-hydroxy-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-dec-7(Z)-en-6-yl-7-thio-4-oxo- 4H-1-benzopyran-2-(N-benzenesulfonamyl)carboxamide
Oppløsningen av 0,20 g (5S,6R)-5-hydroksy-10-(4-acetyl-3-hydroksy-2-propylfenoksy)-dec-7(Z)-en-6-yl-7-tio-4-okso-4H-l-benzopyran-2-karboksylsyre i 10 ml metylenklorid omrøres under argon med 60 mg benzensulfonamid, 44 mg 4-dimetylaminopyridin og 70 mg N-etyl-N'-(3-dimetylaminopropyl)-kar-bodiimid-hydroklorid i 24 timer ved romtemperatur. Den dannede oppløsningen fortynnes med 30 ml metylenklorid, vaskes 2 ganger med ln saltsyre og 2 ganger med soler, tørkes over magnesiumsulfat og inndampes. Kromatografi av resten på kiselgel med metylenklorid/metanol (9:1) gir forbindelsen i overskriften av smp. 140-142°C. The solution of 0.20 g of (5S,6R)-5-hydroxy-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-dec-7(Z)-en-6-yl-7-thio-4 -oxo-4H-1-benzopyran-2-carboxylic acid in 10 ml of methylene chloride is stirred under argon with 60 mg of benzenesulfonamide, 44 mg of 4-dimethylaminopyridine and 70 mg of N-ethyl-N'-(3-dimethylaminopropyl)-carbodiimide hydrochloride for 24 hours at room temperature. The resulting solution is diluted with 30 ml of methylene chloride, washed twice with 1N hydrochloric acid and twice with sols, dried over magnesium sulphate and evaporated. Chromatography of the residue on silica gel with methylene chloride/methanol (9:1) gives the title compound of m.p. 140-142°C.
Eksempel 40: ( 4RS. 5SR)- l- metoksykarbonyl- 4- hvdroksy- 9-( 4- acetyl- 3-hvdroksy- 2- propylfenoksy)- non- 6( Z)- en- 5- y1- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsyremetylester Example 40: (4RS.5SR)-1-methoxycarbonyl-4-hydroxy-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-non-6(Z)-ene-5-y1-7-thio- 4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (4RS,5RS)-4,5-epoksy-l-metoksykarbonyl-9-(4-acetyl-3-hydroksy-2-propylfenoksy)-non-6(Z)-en; fargeløs olje; [a]jj<20 >(metanol, 0,125$) = 0,0 ± 8,0°, UV (metanol): Xmax (<c>) <=> 270The compound in the title is prepared analogously to example 1 from (4RS,5RS)-4,5-epoxy-1-methoxycarbonyl-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-non-6(Z)-ene; colorless oil; [a]jj<20 >(methanol, 0.125$) = 0.0 ± 8.0°, UV (methanol): Xmax (<c>) <=> 270
(24000); 340 (13200). (24000); 340 (13200).
Utgangsmaterialet fremstilles f.eks. analogt eksempel ld) fra 5,6-epoksy-6-formylheksansyremetylester; klar, gul olje; Rf = 0,35 (heksan/eddikester 3:2). The starting material is produced e.g. analogous example ld) from 5,6-epoxy-6-formylhexanoic acid methyl ester; clear, yellow oil; Rf = 0.35 (hexane/acetic ester 3:2).
Eksempel 41: ( 4RS. 5SR)- 1- karboksy- 4- hydroksy- 9-( 4- acetyl- 3- hvdroksy- 2-propylfenoksy)- non- 6( Z)- en- 5- yl- 7- tio- 4- okso- 4H- l- benzopyran-2- karboksylsyre- dinatriumsalt Example 41: (4RS.5SR)-1-carboxy-4-hydroxy-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-non-6(Z)-en-5-yl-7-thio- 4-oxo-4H-1-benzopyran-2-carboxylic acid disodium salt
0,24 g av metylesteren ifølge eksempel 40 oppløses under argon i 15 ml tetrahydrofuran, blandes med 3,8 ml 0,2 n-natronlut og omrøres i 20 timer ved romtemperatur. Inndamping og kromatografisk rensing av resten på en "Reversed Phase"-kiselgelsøyle (f.eks. Merck "Lichroprep RP-8") med metanol/vann (7:3) gir forbindelsen i overskriften av smp. 248-250°C (dekomponering); UV (metanol): Xmax (c) = 218 0.24 g of the methyl ester according to example 40 is dissolved under argon in 15 ml of tetrahydrofuran, mixed with 3.8 ml of 0.2 n sodium hydroxide solution and stirred for 20 hours at room temperature. Evaporation and chromatographic purification of the residue on a "Reversed Phase" silica gel column (eg Merck "Lichroprep RP-8") with methanol/water (7:3) gives the title compound of m.p. 248-250°C (decomposition); UV (methanol): Xmax (c) = 218
(33900); 268 (18580); 284 (18240); 330 sh. (33900); 268 (18580); 284 (18240); 330 shs.
Eksempel 42: ( IR . 2S ) - 1- hy drok sv- 1- ( 3- trif luormetylf envl )- 10-( 4- acetvl- 3-hvdroks v- 2- pr op vi f enoksy )- deka- 3( E) . 5( Z )- dien- 2- vl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyrernetylester Example 42: ( IR . 2S ) - 1- hydroxy sv- 1- ( 3- trifluoromethylphenvl )- 10-( 4- acetvl- 3- hydroxy v- 2- pr op vi f phenoxy )- deca- 3( E) . 5( Z )-diene-2-vl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-trifluormetylfenyl)-10-(4-acetyl-3-hydroksy-2-propylfenoksy)-deka-3(E),5(Z)-dien; klar, gul olje. [a]D<20> (CHC13, 0,363$) = 46,5 ± 2,8°; UV (CHCI3): <X>max (c) - 270 (26500); 285 (24240); 322 (15200). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-trifluoromethylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3(E) ,5(Z)-diene; clear, yellow oil. [α]D<20> (CHC13, 0.363$) = 46.5 ± 2.8°; UV (CHCl 3 ): <X>max (c) - 270 (26500); 285 (24240); 322 (15200).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( IR . 2R )- l . 2- epoksv- 1- f3- trifluormetylfenvl )- 10-( 4- acetvl-3- hydroksy- 2- propylfenoksy)- deka- 3( E). 5( Z)- dien a) ( IR . 2R )- l . 2-epoxy-1-f3-trifluoromethylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3(E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 5-(4-acetyl-3-hydroksy-2-propylfenoksy)-pentyltrifenyl-fosfoniumbromid (eksempel 29a) og (4R,5R)-4,5-epoksy-5-(3-trifluormetylfenyl)-pent-2(E)-enal (eksempel lb); klar, gul olje; [a]D20 (CHC13, 0,224$) = 70,8 10°, Rf = 0,50 (heksan/eddikester = 1:1); IR (CH2C12): 2960, 2930, 2865, 1735, 1625, 1330, 1125 cm-<1>. The compound in the title is prepared analogously to example 1d) from 5-(4-acetyl-3-hydroxy-2-propylphenoxy)-pentyltriphenyl-phosphonium bromide (example 29a) and (4R,5R)-4,5-epoxy-5-(3- trifluoromethylphenyl)-pent-2(E)-enal (Example 1b); clear, yellow oil; [α]D 2 O (CHC 13 , 0.224$) = 70.8 10°, Rf = 0.50 (hexane/acetic ester = 1:1); IR (CH 2 Cl 2 ): 2960, 2930, 2865, 1735, 1625, 1330, 1125 cm-<1>.
Eksempel 43: ( IR , 2S )- l- hvdroksv- l-( 3- trif luormetylf envl )- 10-( 4- acetvl- 3-hvdroksy- 2- propylfenoksy)- deka- 3( E). 5( Z)- en- 2- vl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 43: (IR, 2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3(E). 5( Z)- en- 2- vl- 7- thio- 4-oxo- 4H- 1- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 42); smp. 217-219°C; [a]D<20> (MeOH; 0,160$) = 145,6 ± 6,3° UV (MeOH): Xmax (c) = 220 (50480); 230 (sh); 267 (26240); 284 (23000); 320 (sh). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 42); m.p. 217-219°C; [a]D<20> (MeOH; 0.160$) = 145.6 ± 6.3° UV (MeOH): Xmax (c) = 220 (50480); 230 (sh); 267 (26240); 284 (23000); 320 (sh).
Eksempel 44: ( IR . 2S )- 1- hvdroksv- 1- ( 3- metvlfenvl1- 10-( 4- acetvl- 3- hvdroksv-2- propylfenoksy)- deka- 3( E) , 5( )- dien- 2- yl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsyremetylester Example 44: ( IR . 2S )-1-hydroxy-1-(3-methylphenyl-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3( E), 5( )-diene-2 - yl- 7- thio- 4- oxo- 4H- l- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-metylfenyl)-10-(4-acetyl-3-hydroksy-2-propylfenoksy)-deka-3(E),5(Z)-dien; smp. 59-60°C; [a]D2<0> (CEC13, 0,163$) = 31,9 ± 6,1°; UV (CHCI3): Xmax (c) = 241 (31420); 286 (23060). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-methylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3(E) ,5(Z)-diene; m.p. 59-60°C; [α]D2<0> (CEC13, 0.163$) = 31.9 ± 6.1°; UV (CHCl 3 ): X max (c) = 241 (31420); 286 (23060).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( lR. 2R)- 1. 2- epoksy- l-( 3- metylfenvl ) - 10- ( 4- acetyl - 3-hvdroksy- 2- propylfenoksy)- deka- 3( E). 5( Z)- dien a) (1R.2R)-1.2-epoxy-1-(3-methylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3(E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 5-(4-acetyl-3-hydroksy-2-propylfenoksy)-penty11r i fenyl-fosfoniumbromid (eksempel 29a) og (4R,5R)-4,5-epoksy-5-(3-metylfenyl)-pent-2(E)-enal (eksempel 9b); klar, gul olje; [a]D2<0> (CHCI3, 0,273$) = 118,7° ± 3,7. Rf = 0,62 (heksan/- eddikester = 3:2). The compound in the title is prepared analogously to example 1d) from 5-(4-acetyl-3-hydroxy-2-propylphenoxy)-pentylyl in phenyl-phosphonium bromide (example 29a) and (4R,5R)-4,5-epoxy-5-( 3-methylphenyl)-pent-2(E)-enal (Example 9b); clear, yellow oil; [α]D2<0> (CHCl3, 0.273$) = 118.7° ± 3.7. Rf = 0.62 (hexane/acetic acid = 3:2).
Eksempel 45: ( IR , 2S)- l- hydroksv- l-( 3- metvlfenyl)- 10-( 4- acetvl- 3- hydroksv-2- propyl f enoksy )- deka- 3( E ). 5 ( Z )- dien- 2- yl- 7- tio- 4- 6kso- 4H-benzopyran- 2- karboksylsyre- natriumsalt Example 45: (IR, 2S)-1-hydroxy-1-(3-methylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3(E). 5 ( Z )-dien-2-yl-7-thio-4-6xo-4H-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 44); smp. 208-210°C; [oOd<20> (MeOH, 0,30$) = 50,7 ± 3,3°. UV (MeOH): Xmax (c) = 219 (52420); 230 (sh), 267 (26620); 285 (23520); 325 (sh). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 44); m.p. 208-210°C; [oOd<20> (MeOH, 0.30$) = 50.7 ± 3.3°. UV (MeOH): Xmax (c) = 219 (52420); 230 (sh), 267 (26620); 285 (23520); 325 (sh).
Eksempel 46; Example 46;
( IS . 2R )- l- hvdroksv- 1- ( 3- trif luormetylf envl )- 10-( 4- acetvl- 3-hvdr oksy- 2- pr op vi f enoksy )- deka- 3( E) . 5 ( 2 )- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyremetylester ( IS . 2R )- l- hvdroxv- 1- ( 3- trifluoromethylphenvl )- 10-( 4- acetvl- 3- hvdroxy- 2- pr op vi f enoxy )- deca- 3( E) . 5 (2)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1S,2S)-1,2-epoksy-l-(3-trifluormetylfenyl)-10-(4-acetyl-3-hydroksy-2-propylfenoksy)-deka-3(E),5(Z)-dien; seig masse; Rf = 0,48 (heksan/eddikester = 1:1). The compound in the title is prepared analogously to example 1 from (1S,2S)-1,2-epoxy-1-(3-trifluoromethylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3(E) ,5(Z)-diene; tough pulp; Rf = 0.48 (hexane/acetic ester = 1:1).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( IS . 2S ) - 1 . 2- epoksv- l-( 3- trifluormetylfenvl)- 10-( 4- acetvl-3- hvdroksv- 2- propylfenoksy)- deka- 3( E). 5( Z)- dien a) ( IS . 2S ) - 1 . 2-epoxy-1-(3-trifluoromethylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3(E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 5-(4-acetyl-3-hydroksy-2-propylfenoksy)-pentyltrifenyl-fosfoniumbromid (eksempel 29a) og (4S,5S)-4,5-epoksy-5-(3-trifluormetylfenyl)-pent-2(E)-enal (eksempel 3b); klar, gul olje; [ot]D<20> (kloroform, 0,454$) = -86,8 ± 2,2°; Rf = 0,46 (heksan/eddikester = 1:1). IR (metylenklorid): 2960, 2930, 1730, 1625, 1330, 1130 cm-<1>. The compound in the title is prepared analogously to example 1d) from 5-(4-acetyl-3-hydroxy-2-propylphenoxy)-pentyltriphenyl-phosphonium bromide (example 29a) and (4S,5S)-4,5-epoxy-5-(3- trifluoromethylphenyl)-pent-2(E)-enal (Example 3b); clear, yellow oil; [ot]D<20> (chloroform, 0.454$) = -86.8 ± 2.2°; Rf = 0.46 (hexane/acetic ester = 1:1). IR (methylene chloride): 2960, 2930, 1730, 1625, 1330, 1130 cm-<1>.
Eksempel 47: ( IS . 2R)- 1- hvdroksv- 1-( 3- trif luormetylf envl )- 10-( 4- acetvl- 3-hvdroksy- 2- pr opylf enoksy )- deka- 3( E). 5( Z )- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 47: ( IS . 2R)-1-hydroxy-1-(3-trifluoromethylphenyl)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-deca-3(E). 5( Z )-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 46); smp. 168-170°C; [cx]d<20> (metanol, 0,150$) = -66,7 ± 6,7°; UV (MeOH): *max (c) = 220 (49640), 230 (sh); 266 (25640); 285 (22140); 320 (sh). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 46); m.p. 168-170°C; [cx]d<20> (methanol, 0.150$) = -66.7 ± 6.7°; UV (MeOH): *max (c) = 220 (49640), 230 (sh); 266 (25640); 285 (22140); 320 (sh).
Eksempel 48: ( IR . 2S 1- 1 - hvdroksv- 1- ( 3- trif luormetylf envl )- 8- r4- acetyl- 3-hvdroksv- 2-( 3. 3. 3- trifluorpropyl 1- f enoksy"!- okta- 3( E 1. 5( Zl-dien- 2- vi- 7- tio- 4- okso- l- benzopyran- 2- karboksylsyremetylester Example 48: ( IR . 2S 1- 1 - hydroxy- 1-( 3- trifluoromethylphenyl )- 8- r4- acetyl- 3-hydroxy- 2-( 3. 3. 3- trifluoropropyl 1- phenoxy"!- octa- 3( E 1. 5( Zl-diene- 2- vi- 7- thio- 4- oxo- l- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-trifluormetylfenyl)-8-[4-acetyl-3-hydroksy-2-( 3,3,3-trif luorpropyl)-fenoksy]-okta-3(E),5(Z)-dien; klar, gul olje; Rf = 0,34 (heksan/eddikester = 1:1). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-trifluoromethylphenyl)-8-[4-acetyl-3-hydroxy-2-(3,3,3-trifluoropropyl) )-phenoxy]-octa-3(E),5(Z)-diene; clear, yellow oil; Rf = 0.34 (hexane/acetic ester = 1:1).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 1R. 2R)- 1. 2- epoksv- l-( 3- trifluormetvlfenvl)-8-r4-acetvl-3-hvdroksy- 2-( 3. 3. 3- trifluorpropyl)- fenoksvl- okta- 3( E). 5 ( 2 1-dien a) (1R.2R)-1.2-epoxy-1-(3-trifluoromethylphenyl)-8-r4-acetyl-3-hydroxy-2-(3.3.3- trifluoropropyl)-phenoxyl- octa-3( E). 5 ( 2 1-dien
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-[4-acetyl-3-hydroksy-2-(3,3,3-trifluorpropyl)-fenoksy]-propyltrifenylfosfoniumbromid og (4R,5R)-4,5-epoksy-5-(3-trifluormetylfenyl)-pent-2(E)-enal (eksempel lb); klar, gul olje; [oGd<20> (kloroform, 0,406$) = -58,6 <+> 2,5°; Rf - 0,45 (heksan/eddikester = 7:3). IR (metylenklorid): 2945, 1670, 1610, 1310, 1055 cm-<1>. The compound in the title is prepared analogously to example ld) from 3-[4-acetyl-3-hydroxy-2-(3,3,3-trifluoropropyl)-phenoxy]-propyltriphenylphosphonium bromide and (4R,5R)-4,5-epoxy-5 -(3-trifluoromethylphenyl)-pent-2(E)-enal (Example 1b); clear, yellow oil; [oGd<20> (chloroform, 0.406$) = -58.6 <+> 2.5°; Rf - 0.45 (hexane/acetic ester = 7:3). IR (methylene chloride): 2945, 1670, 1610, 1310, 1055 cm-<1>.
b) 3- f 4 - acetyl- 3- hvdroksv- 2-( 3. 3. 3- trifluorpropvl)- fenoksvl-propvl- trifenylfosfoniumbromid b) 3- f 4 - acetyl- 3- hydroxy- 2-( 3. 3. 3- trifluoropropyl)- phenoxyl-propyl- triphenylphosphonium bromide
Forbindelsen i overskriften fremstilles analogt eksempel lc) fra 3-[4-acetyl-3-hydroksy-2-(3,3,3-trifluorpropyl)-fenoksy]-propylbromid. Smp. 184-185'C. The compound in the title is prepared analogously to example 1c) from 3-[4-acetyl-3-hydroxy-2-(3,3,3-trifluoropropyl)-phenoxy]-propyl bromide. Temp. 184-185'C.
Eksempel 49: ( IR . 2S 1- 1- hvdroksv- 1- ( 3- trif luormetvlfenvl)- 8- T 4- acetyl- 3-hvdroksv- 2-( 3 . 3 . 3- trif luorpropyl 1- fenoksvl- okta- 3( E 1. 5( Zl-d i en- 2- vi - 7- t io- 4- okso- 4E- l- benzopyran- 2- karboksylsvre-natrinmsal t. Example 49: ( IR . 2S 1- 1- hydroxy- 1- ( 3- trifluoromethylphenyl)- 8- T 4- acetyl- 3- hydroxy- 2-( 3 . 3 . 3- trifluoropropyl 1- phenoxyl- octa- 3( E 1. 5( Zl-d in en- 2- vi - 7- t io- 4- oxo- 4E- l- benzopyran- 2- carboxylic acid-sodium salt t.
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 48); smp. 238-240°C; [a]D<20> (metanol, 0,150$) = 208 ± 6,6°; UV (MeOH): Xmax (c) = 216 (50040); 230 (sh); 267 (28960); 280 (sh); 320 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 48); m.p. 238-240°C; [α]D<20> (methanol, 0.150$) = 208 ± 6.6°; UV (MeOH): Xmax (c) = 216 (50040); 230 (sh); 267 (28960); 280 (sh); 320
(16020). (16020).
Eksempel 50: ( 1R. 2S)- 1- hvdroksv- l-( 3- metvlfenvl )- 8- r4- acetvl- 3- hvdroksy- 2-( 3. 3. 3- trif luorpropvl )- f enoksvl - okta- 3( E). 5 ( Z )- dien- 2- vl- 7-t i o- 4- okso- 4H- l- T3enzopvran- 2 - karboksyl syremetylester Example 50: (1R.2S)-1-hydroxyl-(3-methylphenyl)-8-r4-acetyl-3-hydroxy-2-(3.3.3-trifluoropropyl)-phenoxyl-octa-3 (E). 5 ( Z )-diene- 2- vl- 7-t i o- 4- oxo- 4H- l- T3enzopvran- 2 - carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-metylfenyl)-8-[4-acetyl-3-hydroksy-2-(3 ,3 ,3-t r i f luorpropyl)-f enoksy]-okta-3(E) ,5(Z)-dien; klar, gul seig olje; Rf = 0,41 (heksan/eddikester = 1:1). [a]D<20> (kloroform, 0,155$) - 32,3 ± 6,5°; UV (kloroform): <X>max (c) = 271 (32320); 318 (16100). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-methylphenyl)-8-[4-acetyl-3-hydroxy-2-(3,3,3-trifluoropropyl) )-phenoxy]-octa-3(E),5(Z)-diene; clear, yellow viscous oil; Rf = 0.41 (hexane/acetic ester = 1:1). [a]D<20> (chloroform, 0.155$) - 32.3 ± 6.5°; UV (chloroform): <X>max (c) = 271 (32320); 318 (16100).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( lR. 2R)- 1. 2- epoksv- l-( 3- metvlfenyl)- 8- r4- acetvl- 3-hvdroksv- 2-( 3. 3. 3- trifluorpropyl)- fenoksvl- okta- 3( E). 5( Z)-dien a) (1R.2R)-1.2-epoxyl-1-(3-methylphenyl)-8-r4-acetvl-3-hydroxyl-2-(3.3.3- trifluoropropyl)-phenoxyl- octa-3( E). 5( Z )-diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-[4-acetyl-3-hydroksy-2-(3,3,3-trifluorpropyl)-fenoksy]-propyltrifenylfosfoniumbromid (eksempel 48b) og (4R,5R)-4,5-epoksy-5-(3-metylfenyl)-pent-2(E)-enal (eksempel 9b), klar, gul olje; Rf = 0,38 (heksan/eddikester = 3:2). The compound in the title is prepared analogously to example ld) from 3-[4-acetyl-3-hydroxy-2-(3,3,3-trifluoropropyl)-phenoxy]-propyltriphenylphosphonium bromide (example 48b) and (4R,5R)-4,5 -epoxy-5-(3-methylphenyl)-pent-2(E)-enal (Example 9b), clear yellow oil; Rf = 0.38 (hexane/acetic ester = 3:2).
Eksempel 51: ( IR. 2S')- l- hvdroksy- l-( 3- metvlfenvl )- 8- r4- acetvl- 3- hydroksy- 2-( 3. 3. 3- trif luorpropvl)- f enoksvl- okta- 3( E). 5 ( Z )- dien- 2- vl- 7-tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 51: (IR. 2S')-1-hydroxy-1-(3-methylphenyl)-8-r4-acetvl-3-hydroxy-2-(3.3.3-trifluoropropyl)-phenoxyl-octa- 3(E). 5 ( Z )-diene- 2- vl- 7-thio- 4- oxo- 4H- l- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 50); smp. 233-235°C; [a]D<20> (metanol, 0,195$) = 69,7 ± 5,1°; UV (MeOH): <x>max (c) = 218 (52320); 230 (sh); 267 (29040); 280 (sh); 320 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 50); m.p. 233-235°C; [α]D<20> (methanol, 0.195$) = 69.7 ± 5.1°; UV (MeOH): <x>max (c) = 218 (52320); 230 (sh); 267 (29040); 280 (sh); 320
(16000). (16000).
Eksempel 52: ( IR . 2S) - 1- hvdroksv- 1- ( 2- tr i f luormetvlfenvl )- 8-( 4- acetvl- 3-hvdroksv- 2- propyl- fenoksy)- okta- 3( E). 5( Z )- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyremetylester Example 52: ( IR . 2S)-1-hydroxy-1-(2-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5( Z )-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(2-trifluormetylfenyl)-8-(4-acetyl-3-hydroksy-2-propylfenoksy)-okta-3(E),5(Z)-dien; smp. 66-68° C; Rf = 0,23 (heksan/eddikester = 3:2). [a]D<20> (metanol, 0,150$) = 22,0 ± 6,7°; UV (MeOH): Xmax (c) = 216 (50000); 238 (sh); 271 (27860); 285 (sh); 324 (13900). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(2-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E) ,5(Z)-diene; m.p. 66-68°C; Rf = 0.23 (hexane/acetic ester = 3:2). [α]D<20> (methanol, 0.150$) = 22.0 ± 6.7°; UV (MeOH): Xmax (c) = 216 (50000); 238 (sh); 271 (27860); 285 (sh); 324 (13900).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 1R. 2R1- 1. 2- epoksy- l-( 2- trifluormetvlfenyl)- 8-( 4- acetvl- 3-hvdroksy- 2- propyl- fenoksy)- okta- 3( E). 5( Z)- dien a) ( 1R. 2R1- 1. 2- epoxy- 1-( 2- trifluoromethylphenyl)- 8-( 4- acetvl- 3- hydroxy- 2- propyl- phenoxy)- octa- 3( E). 5( Z) - the day
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-propyltrifenyl-fosfoniumbromid (eksempel lc) og (4R,5R)-4,5-epoksy-5-(2-trif luormetylf enyl )-pent-2(E)-enal; klarbrun olje; [a]])<20 >(kloroform, 0,207$) = -5,8 <+> 4,8°; Rf = 0,25 (heksan/eddikester = 4:1). The compound in the title is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-propyltriphenyl-phosphonium bromide (example 1c) and (4R,5R)-4,5-epoxy-5-( 2-trifluoromethylphenyl)-pent-2(E)-enal; light brown oil; [a]])<20 >(chloroform, 0.207$) = -5.8 <+> 4.8°; Rf = 0.25 (hexane/acetic ester = 4:1).
b) ( 4R. 5R)- 4. 5- epoksv- 5-( 2- trifluormetylfenvl)- pent- 2( E)- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) b) (4R.5R)-4.5-epoxy-5-(2-trifluoromethylphenyl)-pent-2(E)-enal The compound in the title is prepared analogously to example lb)
fra (2R,3R)-2,3-epoksy-3-(2-trifluormetylfenyl)-propanol; gule krystaller; Rf = 0,36 (heksan/eddikester = 4:1). from (2R,3R)-2,3-epoxy-3-(2-trifluoromethylphenyl)-propanol; yellow crystals; Rf = 0.36 (hexane/acetic ester = 4:1).
[a]D2<0> (metanol, 0,165$) = 23,0 ± 6,1°; UV (MeOH): Xmax (c) = 216 (14400); 235 (17240). [α]D2<0> (methanol, 0.165$) = 23.0 ± 6.1°; UV (MeOH): Xmax (c) = 216 (14400); 235 (17240).
c) ( 2R. 3R)- 2. 3- epoksv- 3-( 2- trifluormetylfenyl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel la) c) ( 2R. 3R)- 2. 3- epoxyv- 3-( 2- trifluoromethylphenyl)- propanol The compound in the title is prepared analogously to example la)
fra 3-(2-trifluormetylfenyl)-prop-2(E)-enol; fargeløse krystaller; Rf = 0,38 (heksan/eddikester = 3:2); IR (metylenklorid): 3600, 3050, 2990, 2920, 2870, 1610, 1585, 1320, 1170, 1125 cm-<1>. from 3-(2-trifluoromethylphenyl)-prop-2(E)-enol; colorless crystals; Rf = 0.38 (hexane/acetic ester = 3:2); IR (methylene chloride): 3600, 3050, 2990, 2920, 2870, 1610, 1585, 1320, 1170, 1125 cm-<1>.
Eksempel 53: ( IR . 2S )- 1- hvdroksv- 1-( 2- tri fluormetylf envl )- 8-( 4- acetvl- 3-hydr oksy- 2- propyl- fenoksy)- okta- 3( E), 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 53: ( IR . 2S )-1-hydroxy-1-(2-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E), 5 ( Z )- dien- 2- yl- 7- thio- 4-oxo- 4H- 1- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 52); smp. 155-157°C; [a]D<20> (metanol, 0,180$) = 12,8 <+> 5,6°; UV (MeOH): <x>max (c) " 219 (48400); 230 (sh); 266 (25480); 284 (22540); 325 (sh). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 52); m.p. 155-157°C; [α]D<20> (methanol, 0.180$) = 12.8 <+> 5.6°; UV (MeOH): <x>max (c) " 219 (48400); 230 (sh); 266 (25480); 284 (22540); 325 (sh).
Eksempel 54: ( IS . 2R )- l- hvdroksv- 1-( 2- tr i f luormetvlfenvl )- 8-( 4- acetyl- 3-hvdr oksy- 2- propyl- fenoksy)- okta- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyremetylester Example 54: ( IS . 2R )-1-hydroxyl-1-(2-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1S,2S)-1,2-epoksy-l-(2-trifluormetylfenyl)-8-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-okta-3(E),5(Z)-dien; smp. 71-73°C; Rf = 0,25 (heksan/eddikester = 3:2). [a]D<20> (metanol, 0,170$) = -27,1 ± 5,9°; UV (MeOH): Xmax (c) = 216 (51040); 235 (sh); 271 (28140); 285 (sh); 324 (13500). The compound in the title is prepared analogously to example 1 from (1S,2S)-1,2-epoxy-1-(2-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3( E),5(Z)-diene; m.p. 71-73°C; Rf = 0.25 (hexane/acetic ester = 3:2). [α]D<20> (methanol, 0.170$) = -27.1 ± 5.9°; UV (MeOH): Xmax (c) = 216 (51040); 235 (sh); 271 (28140); 285 (sh); 324 (13500).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( IS. 2S)- 1. 2- epoksv- l-( 2- trifluormetylfenyl)- 8-( 4- acetyl- 3-hydroksy- 2- propyl- fenoksy)- okta- 3( E). 5( Z)- dien a) ( IS. 2S)- 1. 2- epoxyv- 1-( 2- trifluoromethylphenyl)- 8-( 4- acetyl- 3- hydroxy- 2- propyl- phenoxy)- octa- 3( E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)propyl-trifenyl-fosfoniumbromid (eksempel lc) og (4S,5S)-4,5-epoksy-5-(2-trifluormetylfenyl )-pent-2(E)-enal; rødaktig olje; [c<]d<20 >(kloroform, 0,207$) = 5,4 ± 4,8°; Rf = 0,29 (heksan/eddikester = 4:1). The compound in the title is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)propyl-triphenyl-phosphonium bromide (example 1c) and (4S,5S)-4,5-epoxy-5- (2-trifluoromethylphenyl)-pent-2(E)-enal; reddish oil; [c<]d<20 >(chloroform, 0.207$) = 5.4 ± 4.8°; Rf = 0.29 (hexane/acetic ester = 4:1).
b) ( 4S. 5S 1- 4. 5- epoksv- 5-( 2- trifluormetylfenvl)- pent- 2( E)-enal b) (4S.5S 1-4.5-epoxy-5-(2-trifluoromethylphenyl)-pent-2(E)-enal
Forbindelsen i overskriften fremstilles analogt eksempel lb) fra (2S,3S)-2,3-epoksy-3-(2-trifluormetylfenyl)-propanol; gule krystaller; Rf = 0,38 (heksan/eddikester = 4:1); [a]D<20 >(metanol, 0,180$) = -25,0 <+> 5,6°; UV (MeOH): Xmax (c) = 215 The compound in the title is prepared analogously to example 1b) from (2S,3S)-2,3-epoxy-3-(2-trifluoromethylphenyl)-propanol; yellow crystals; Rf = 0.38 (hexane/acetic ester = 4:1); [a]D<20 >(methanol, 0.180$) = -25.0 <+> 5.6°; UV (MeOH): Xmax (c) = 215
(13960); 236 (17060). (13960); 236 (17060).
c) ( 2S. 3S)- 2. 3- epoksv- 3-( 2- trifluormetylfenvl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel la) c) (2S.3S)-2.3-epoxy-3-(2-trifluoromethylphenyl)-propanol The compound in the title is prepared analogously to example la)
fra 3-(2-trifluormetylfenyl)-prop-2(E)-enol; fargeløse krystaller; Rf = 0,35 (heksan/eddikester = 3:2). IR (metylenklorid): 3600, 3050, 2990, 2920, 2870, 1610, 1585, 1320, 1170, 1125 cm-<1>. from 3-(2-trifluoromethylphenyl)-prop-2(E)-enol; colorless crystals; Rf = 0.35 (hexane/acetic ester = 3:2). IR (methylene chloride): 3600, 3050, 2990, 2920, 2870, 1610, 1585, 1320, 1170, 1125 cm-<1>.
Eksempel 55: ( IS . 2R )- l- hvdroksv- 1-( 2- tr i f luormetvlfenvl )- 8-( 4- acetvl- 3-hvdroksy- 2- propyl- fenoksy)- okta- 3( E), 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopvran- 2- karboksylsyre- natriumsalt Example 55: ( IS . 2R )-1-hydroxy-1-(2-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E), 5( Z)- dien- 2- yl- 7- thio- 4-oxo- 4H- 1- benzopvran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 54); smp. 182-184°C; Md20 (metanol, 0,205$) = -16,6 ± 4,9°; UV (MeOH): xmax (c) = 219 (47680); 235 (sh); 266 (24960); 284 (22100); 330 (sh). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 54); m.p. 182-184°C; Md 20 (methanol, 0.205$) = -16.6 ± 4.9°; UV (MeOH): x max (c) = 219 (47680); 235 (sh); 266 (24960); 284 (22100); 330 (sh).
Eksempel 56: f IR . 2S )- l- hvdroksv- 1- ( 4- trif luormetvlfenvl )- 8-( 4- acetvl- 3-hvdroksy- 2- propyl- fenoksy)- okta- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyremetylester Example 56: f IR . 2S )-1-hydroxy-1-(4-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (lR,2R)-l,2-epoksy-l-(4-trifluormetylfenyl)-8-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-okta-3(E),5(Z)-dien; smp. 68-70°C; Rf = 0,16 (heksan/eddikester = 3:2). [a]D<20> (metanol, 0,155$) = 110,3 ± 6,5°; UV (MeOH): <X>max (c) = 217 (52880); 236 (sh); 270 (28880), 285 (sh); 326 (13700). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(4-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3( E),5(Z)-diene; m.p. 68-70°C; Rf = 0.16 (hexane/acetic ester = 3:2). [α]D<20> (methanol, 0.155$) = 110.3 ± 6.5°; UV (MeOH): <X>max (c) = 217 (52880); 236 (sh); 270 (28880), 285 (sh); 326 (13700).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) f IR. 2R)- 1. 2- epoksv- l-( 4- trifluormetvlfenvl)- 8-( 4- acetvl- 3-hvdroksy- 2- propyl- fenoksy)- okta- 3( E). 5( Z)- dien a) f IR. 2R)- 1.2-epoxy-1-(4-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-propyl-trifenyl-fosfoniumbromid (eksempel lc) og (4R,5R)-4,5-epoksy-5-(4-trifluormetylfenyl )-pent-2(E)-enal; gul olje; [oc]d<20 >(kloroform, 0,220$) = 6,5 ± 4,5°; Rf = 0,35 (heksan/eddikester = 4:1). The compound in the title is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-propyl-triphenyl-phosphonium bromide (example 1c) and (4R,5R)-4,5-epoxy-5 -(4-trifluoromethylphenyl)-pent-2(E)-enal; yellow oil; [oc]d<20 >(chloroform, 0.220$) = 6.5 ± 4.5°; Rf = 0.35 (hexane/acetic ester = 4:1).
b) ( 4R. 5R)- 4. 5- epoksv- 5-( 4- trifluormetylfenvl)- pent- 2( E)- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) b) (4R.5R)-4.5-epoxy-5-(4-trifluoromethylphenyl)-pent-2(E)-enal The compound in the title is prepared analogously to example lb)
fra (2R,3R)-2,3-epoksy-3-(4-trifluormetylfenyl)-propanol; gule krystaller; smp. 67-70°C; Rf = 0,24 (heksan/eddikester = 4:1). [cx]d<20> (metanol, 0,150$) = 171,3 ± 6,7°; UV (MeOH): <x>max (O - 237 (19660). from (2R,3R)-2,3-epoxy-3-(4-trifluoromethylphenyl)-propanol; yellow crystals; m.p. 67-70°C; Rf = 0.24 (hexane/acetic ester = 4:1). [cx]d<20> (methanol, 0.150$) = 171.3 ± 6.7°; UV (MeOH): <x>max (O - 237 (19660).
c) ( 2R. 3R)- 2. 3- epoksv- 3-( 4- trifluormetylfenvl)- propano! Forbindelsen i overskriften fremstilles analogt eksempel la) c) (2R.3R)-2.3-epoxy-3-(4-trifluoromethylphenyl)-propano! The compound in the heading is prepared analogously to example la)
fra 3-(4-trifluormetylfenyl)-prop-2(E)-enol; fargeløse krystaller; Rf = 0,25 (heksan/eddikester = 3:2). IR (metylenklorid): 3550, 3010, 2950, 2880, 2830, 1605, 1310, 1150, 1110, 1050 cm-<1>. from 3-(4-trifluoromethylphenyl)-prop-2(E)-enol; colorless crystals; Rf = 0.25 (hexane/acetic ester = 3:2). IR (methylene chloride): 3550, 3010, 2950, 2880, 2830, 1605, 1310, 1150, 1110, 1050 cm-<1>.
Eksempel 57: ( IR . 2S )- 1- hvdroksv- 1-( 4- trif luormetvlfenvl )- 8-( 4- acetvl- 3-hydroksv- 2- propyl- fenoksy )- okta- 3( E). 5 ( Z )- dien- 2- yl- 7- tio- 4-okso- 4E- l- benzopyran- 2- karboksvlsvre- natriumsalt Example 57: ( IR . 2S )-1-hydroxy-1-(4-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5 (Z)-dien-2-yl-7-thio-4-oxo-4E-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 56); smp. 229-231°C; [cx]])20 (metanol, 0,160$) = 118,8 <+> 6,3°; UV (MeOH); <X>max (c) = 220 (53060); 235 (sh), 267 (27280); 284 (23880), 320 (16300). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 56); m.p. 229-231°C; [cx]])20 (methanol, 0.160$) = 118.8 <+> 6.3°; UV (MeOH); <X>max (c) = 220 (53060); 235 (sh), 267 (27280); 284 (23880), 320 (16300).
Eksempel 58; Example 58;
( IS . 2R )- l- hvdroksv- 1- ( 4- trif luormetvlfenvl )- 8-( 4- acetvl- 3-hydroksy- 3- propyl- fenoksv )- okta- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyremetylester ( IS . 2R )- 1- hydroxy- 1- ( 4- trifluoromethylphenyl )- 8-( 4- acetyl- 3-hydroxy- 3- propyl- phenoxy )- octa- 3( E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1S,2S)-1,2-epoksy-l-(4-trifluormetylfenyl)-8-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-okta-3(E),5(Z)-dien; smp. 67-69°C; Rf 0,13 (heksan/eddikester = 3:2). [o<]d<20> (metanol, 0,155$) = -109,7 ± 6,5°; UV (MeOH): Xmax (c) = 217 (52640); 235 (sh); 270 (28660); 285 (sh); 326 (13680). The compound in the title is prepared analogously to example 1 from (1S,2S)-1,2-epoxy-1-(4-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3( E),5(Z)-diene; m.p. 67-69°C; Rf 0.13 (hexane/acetic ester = 3:2). [o<]d<20> (methanol, 0.155$) = -109.7 ± 6.5°; UV (MeOH): X max (c) = 217 (52640); 235 (sh); 270 (28660); 285 (sh); 326 (13680).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 1S. 2S)- 1. 2- epoksv- l-( 4- trifluormetvlfenvl)- 8-( 4- acetvl- 3-hydroksy- 2- propyl- fenoksy)- okta- 3( E). 5( Z)- dlen a) (1S.2S)-1.2-epoxy-1-(4-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5(Z)- part
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-propyl-trifenyl-fosfoniumbromid (eksempel lc) og (4S,5S)-4,5-epoksy-5-(84-trif luormetylfenyl )-pent-2(E)-enal; rødlig olje; [a]])<20 >(kloroform, 0,199$) = -5,4 ± 5,0°; Rf = 0,23 (heksan/eddikester = 4:1). The compound in the title is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-propyl-triphenyl-phosphonium bromide (example 1c) and (4S,5S)-4,5-epoxy-5 -(84-trifluoromethylphenyl)-pent-2(E)-enal; reddish oil; [a]])<20 >(chloroform, 0.199$) = -5.4 ± 5.0°; Rf = 0.23 (hexane/acetic ester = 4:1).
b) ( 4S. 5S)- 4. 5- epoksv- 5-( 4- trifluormetylfenvl)- pent- 2( E)- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) b) (4S.5S)-4.5-epoxy-5-(4-trifluoromethylphenyl)-pent-2(E)- enal The compound in the title is prepared analogously to example lb)
fra (2S,3S)-2,3-epoksy-3-(4-trifluormetylfenyl)-propanol; gule krystaller; smp. 67-69°C; Rf = 0,18 (heksan/eddikester = 4:1). [a]D<20> (metanol, 0,150$) = -180,0 ± 6,7°; UV (MeOH): <x>max (O - 236 (19740). from (2S,3S)-2,3-epoxy-3-(4-trifluoromethylphenyl)-propanol; yellow crystals; m.p. 67-69°C; Rf = 0.18 (hexane/acetic ester = 4:1). [α]D<20> (methanol, 0.150$) = -180.0 ± 6.7°; UV (MeOH): <x>max (O - 236 (19740).
c) ( 2S. 3S)- 2. 3- epoksv- 3-( 4- trifluormetylfenvl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel la) c) (2S.3S)-2.3-epoxy-3-(4-trifluoromethylphenyl)-propanol The compound in the title is prepared analogously to example la)
fra 3-(4-trifluormetylfenyl)-prop-2(E)-enol; fargeløse krystaller; Rf = 0,23 (heksan/eddikester =3:2). IR (metylenklorid): 3550, 3010, 2950, 2880, 2830, 1605, 1310, 1150, 1110, 1050 cm"<1>. from 3-(4-trifluoromethylphenyl)-prop-2(E)-enol; colorless crystals; Rf = 0.23 (hexane/acetic ester = 3:2). IR (methylene chloride): 3550, 3010, 2950, 2880, 2830, 1605, 1310, 1150, 1110, 1050 cm"<1>.
Eksempel 59: ( IS . 2R 1- 1- hvdroksv- 1- f 4- trif luormetvlfenvl )- 8-( 4- acetyl- 3-hvdroksy- 2- propyl- fenoksy )- okta- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 59: ( IS . 2R 1-1-hydroxy-1-f 4-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3( E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 58); smp. 228-230°C; [a]D<20> (metanol, 0,175$) = -99,4 ± 5,7°; UV (MeOH): xmax (c) = 220 (49800); 235 (sh); 267 (25320); 284 (22200); 320 (15600). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 58); m.p. 228-230°C; [α]D<20> (methanol, 0.175$) = -99.4 ± 5.7°; UV (MeOH): xmax (c) = 220 (49800); 235 (sh); 267 (25320); 284 (22200); 320 (15600).
Eksempel 60: ( IR . 2S ) - 1 - hvdroksv- 1- ( 3- trif luormetylf envl)- 8-( 4- acetyl- 3-hydroksy- 2- propyl- fenoksy)- okta- 3( Z)- en- 2- vl- 7- tio- 4- okso- 4H-l- benzopyran- 2- karboksylsyremetvlester Example 60: (IR.2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(Z)-ene- 2- vl- 7- thio- 4- oxo- 4H-l- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-trifluormetylfenyl)-8-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-okta-3(Z)-en; fargeløs olje; Rf = 0,41 (heksan/eddikester = 1:1). [a]D<20> (kloroform, 0,150$) = 46,7 ± 6,7°; UV (MeOH): <X>max (c) = 271 (22760); 288 The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3( the Z) one; colorless oil; Rf = 0.41 (hexane/acetic ester = 1:1). [α]D<20> (chloroform, 0.150$) = 46.7 ± 6.7°; UV (MeOH): <X>max (c) = 271 (22760); 288
(20060); 270 (28880); 324 (14460). (20060); 270 (28880); 324 (14460).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 1R. 2R1- 1. 2- epoksv- l-( 3- trifluormetylfenyl1- 8-( 4- acetvl- 3-hvdroksy- 2- propyl- fenoksy)- okta- 3( Z)- en a) (1R.2R1-1.2-epoxy-1-(3-trifluoromethylphenyl1-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(Z)-ene)
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-pentyl-trifenyl-fosfoniumbromid (eksempel 29a) og (2S,3R)-2,3-epoksy-3-(3-trifluormetylfenyl)-propanol (eksempel 5a); klar, gul olje; [a]D<20> (kloroform, 0,221$) = 25,3 ± 4,5°; Rf = 0,56 (heksan/- eddikester = 3:2). The compound in the title is prepared analogously to example ld) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-pentyl-triphenyl-phosphonium bromide (example 29a) and (2S,3R)-2,3-epoxy-3 -(3-trifluoromethylphenyl)-propanol (Example 5a); clear, yellow oil; [α]D<20> (chloroform, 0.221$) = 25.3 ± 4.5°; Rf = 0.56 (hexane/acetic ester = 3:2).
Eksempel 61: ( IR . 2S 1 - 1 - hvdroksv- 1- ( 3- t ri f luormetvlfenvl )- 8-( 4- acetvl- 3-hydroksv- 2- propyl- fenoksy)- okta- 3( Z)- en- 2- yl- 7- tio- 4- okso- 4H-l- benzopvran- 2- karboksylsyre- natriumsalt Example 61: ( IR . 2S 1 - 1 - hydroxy- 1-( 3- trifluoromethylphenyl )- 8-( 4- acetyl- 3-hydroxy- 2- propyl-phenoxy)- octa- 3(Z)-ene - 2- yl- 7- thio- 4- oxo- 4H-l- benzopvran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 60); smp. 231-233°C; [odn<20> (metanol, 0,190$) = 51,1 ± 5,3°; UV (MeOH): <x>max (c) = 215 (42320); 267 (22220); 286 (20800); 320 (sh). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 60); m.p. 231-233°C; [odn<20> (methanol, 0.190$) = 51.1 ± 5.3°; UV (MeOH): <x>max (c) = 215 (42320); 267 (22220); 286 (20800); 320 (sh).
Eksempel 62: ( IR . 2S 1- 1- hvdroksv- 1-( 3- trif luormetvlfenvl )- 9-( 4- acetvl- 3-hydroksv- 2- propyl f enoksy )- nona- 3( E) . 5( Z )- dien- 2- vl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyrernetylester Example 62: ( IR . 2S 1- 1- hydroxy- 1-( 3- trifluoromethylphenyl )- 9-( 4- acetvl- 3- hydroxy- 2- propyl phenoxy )- nona- 3( E ) . 5( Z )- diene- 2- vl- 7- thio- 4-oxo- 4H- 1- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-trifluormetylfenyl)-9-(4-acetyl-3-hydroksy-2-propylfenoksy)-nona-3(E) ,5(Z)-dien; klar, gul seig olje; [oc]D<20> (kloroform, 0,155$) = 44,5 ± 6,5°; Rf = 0,50 (heksan/eddikester = 1:1); UV (CHC13): <X>max (c) = 270 The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-trifluoromethylphenyl)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-nona-3(E) ,5(Z)-diene; clear, yellow viscous oil; [oc]D<20> (chloroform, 0.155$) = 44.5 ± 6.5°; Rf = 0.50 (hexane/acetic ester = 1:1); UV (CHC13): <X>max (c) = 270
(26800); 284 (23100); 323 (14480). (26800); 284 (23100); 323 (14480).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) 3-( 4- acetyl- 3- hvdroksy- 2- propyl- fenoksy )- butyl- trifenyl-fosfoniumbromid a) 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-butyl-triphenyl-phosphonium bromide
Forbindelsen i overskriften fremstilles analogt eksempel lc fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-butylbromid. Smp. 167-169°C. The compound in the title is prepared analogously to example 1c from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-butyl bromide. Temp. 167-169°C.
b) ( 1R. 2R1- 1. 2- epoksy- l-( 3- trifluormetylfenvl)- 9-( 4- acetvl- 3-hvdroksy- 2- propylfenoksy)- nona- 3( E). 5( Z1- dien b) (1R.2R1-1.2-epoxy-1-(3-trifluoromethylphenyl)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-nona-3(E).5(Z1-diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 5-(4-acetyl-3-hydroksy-2-propylfenoksy)-butyl-trifenyl-fosfoniumbromid og (4R,5R)-4,5-epoksy-5-(3-trifluormetylfenyl )-pent-2(E)-enal (eksempel lb); klar, gul olje; [a]jj20 (kloroform, 0,308$) = 40,7 ± 3,2°; Rf = 0,70 (heksan/eddikester = 3:2); IR (metylenklorid): 2950, 2860, 1625, 1325, 1120 cm-1. The compound in the title is prepared analogously to example ld) from 5-(4-acetyl-3-hydroxy-2-propylphenoxy)-butyl-triphenyl-phosphonium bromide and (4R,5R)-4,5-epoxy-5-(3-trifluoromethylphenyl) -pent-2(E)-enal (Example 1b); clear, yellow oil; [α]jj20 (chloroform, 0.308$) = 40.7 ± 3.2°; Rf = 0.70 (hexane/acetic ester = 3:2); IR (methylene chloride): 2950, 2860, 1625, 1325, 1120 cm-1.
Eksempel 63: ( IR . 2S 1- 1- hvdroksv- 1-( 3- trif luormetvlfenvl )- 9-( 4- acetvl- 3-hydroksv- 2- propylf enoksy )- nona- 3( E) . 5( Z )- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 63: (IR. 2S 1-1-hydroxy-1-(3-trifluoromethylphenyl)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-nona-3(E).5(Z) - dien- 2- yl- 7- thio- 4-oxo- 4H- 1- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 62); smp. 204-206°C; [ot]]}20 (kloroform, 0,289$) = 8,0 ± 3,5'; [a]D<20> = 55,5 ± 6,5° (metanol, 0,155$); UV (metanol): Xmax (c) = 219 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 62); m.p. 204-206°C; [ot]]}20 (chloroform, 0.289$) = 8.0 ± 3.5'; [α]D<20> = 55.5 ± 6.5° (methanol, 0.155$); UV (methanol): Xmax (c) = 219
(49320); 232 (sh); 266 (25800); 285 (22060); 330 (sh). (49320); 232 (sh); 266 (25800); 285 (22060); 330 (sh).
Eksempel 64: ( IR . 2S)- 1 - hvdroksv- 1 -( 3- trif luormetylf envl )- ll-( 4- acetvl- 3-hvdroksv- 2- propvlfenoksy)- undeka- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyremetylester Example 64: (IR.2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-II-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-3(E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (IR,2R)-l,2-epoksy-l-(3-trifluormetylfenyl)-ll-(4-acetyl-3-hydroksy-2-propylfenoksy)-undeka-3(E),5(Z)-dien, klar, gul seig olje; [oc]D<20> (kloroform, 0,160$) = 48,1 ± 6,3°; Rf = 0,50 (heksan/eddikester =1:1). UV (CHC13): Xmax (c) = 270 The compound in the title is prepared analogously to example 1 from (IR,2R)-1,2-epoxy-1-(3-trifluoromethylphenyl)-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-3(E) ,5(Z)-diene, clear yellow viscous oil; [oc]D<20> (chloroform, 0.160$) = 48.1 ± 6.3°; Rf = 0.50 (hexane/acetic ester =1:1). UV (CHC13): Xmax (c) = 270
(27120); 286 (23300); 323 (14740). (27120); 286 (23300); 323 (14740).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) 3 - ( 4- acetyl- 3- hydroksy- 2- propyl- fenoksy ) heksyl- trifenyl-fosfoniumbromid a) 3 - ( 4- acetyl- 3- hydroxy- 2- propyl- phenoxy ) hexyl- triphenyl- phosphonium bromide
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)heksylbromid; forbindelsen krystalliserer meget langsomt. The compound in the title is prepared analogously to example 1 from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)hexyl bromide; the compound crystallizes very slowly.
b) ( IR . 2R )- l . 2- epoksv- l-( 3- trifluormetylfenvl)- ll-( 4- acetvl-3- hvdroksy- 2- propylfenoksy)- undeka- 3( E). 5( Z)- dien b) ( IR . 2R )- l . 2-epoxy-1-(3-trifluoromethylphenyl)-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-3(E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 5-(4-acetyl-3-hydroksy-2-propylfenoksy)heksyl-trifenyl-fosfoniumbromid og (4R,5R)-4,5-epoksy-5-(3-trifluormetylfenyl )-pent-2(E)-enal (eksempel lb); klar, gul olje; [ot]])<20 >(kloroform, 0,450$) - 41,1 ± 2,2°; Rf = 0,66 (heksan/eddikester = 3:2); IR (metylenklorid): 2960, 2860, 1625, 1325, 1120 cm-1. The compound in the title is prepared analogously to example 1d) from 5-(4-acetyl-3-hydroxy-2-propylphenoxy)hexyl-triphenyl-phosphonium bromide and (4R,5R)-4,5-epoxy-5-(3-trifluoromethylphenyl)- pent-2(E)-enal (Example 1b); clear, yellow oil; [ot]])<20 >(chloroform, 0.450$) - 41.1 ± 2.2°; Rf = 0.66 (hexane/acetic ester = 3:2); IR (methylene chloride): 2960, 2860, 1625, 1325, 1120 cm-1.
Eksempel 65: ( IR . 2S )- l- hvdroksv- 1-( 3- trif luormetylf envl )- ll-( 4- acetvl- 3-hydroksv- 2- propylfenoksy)- undeka- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 65: ( IR . 2S )-1-hydroxy-1-(3-trifluoromethylphenyl)-11-(4-acetyl-3-hydroxy-2-propylphenoxy)-undeca-3(E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 64); smp. 216-218°C; [a]D<20> (kloroform, 0,258$) = 34,9 ± 3,9°; [a]D<20> = 7,38 ± 6,3° (metanol, 0,160$): UV (metanol): Xmax (<c>) - 219 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 64); m.p. 216-218°C; [α]D<20> (chloroform, 0.258$) = 34.9 ± 3.9°; [a]D<20> = 7.38 ± 6.3° (methanol, 0.160$): UV (methanol): Xmax (<c>) - 219
(50140); 232 (sh); 266 (26120); 286 (22460); 320 (15600). (50140); 232 (sh); 266 (26120); 286 (22460); 320 (15600).
Eksempel 66: ( IR . 2S ) - 1 - hvdroksv- 1- f env 1- 8-( 4- acetvi- 3- hvdroksv- 2- propyi-fenoksv)- okta- 3( E ) . 5 ( Z )- dien- 2- vl- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyremetylester Example 66: ( IR . 2S )-1-hydroxy-1-phenoxy 1-8-(4-acetvi-3-hydroxy-2-propyl-phenoxy)-octa-3( E ) . 5 ( Z )-diene- 2- vl- 7- thio- 4- oxo- 4H- l- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (IR, 2R) -1,2-epoksy-l-fenyl-8-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-okta-3(E),5(Z)-dien; klart, gult skum; Rf = 0,41 (heksan/eddikester = 1:1); [a]D<20> = 47,3 2,6°The compound in the title is prepared analogously to example 1 from (IR, 2R)-1,2-epoxy-1-phenyl-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E),5 (Z)-diene; clear, yellow foam; Rf = 0.41 (hexane/acetic ester = 1:1); [a]D<20> = 47.3 2.6°
(kloroform, 0,385$). (chloroform, 0.385$).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( IR . 2R ) - 1 . 2- epoksv- l- fenvl- 8- f 4- acetvl- 3- hvdroksv- 2-propvl- fenoksv' l- okta- 3( E) . 5( Z)- dien a) ( IR . 2R ) - 1 . 2- epoksv-l- phenvl-8- f 4- acetvl- 3- hvdroksv- 2-propvl- phenoxv' l- octa- 3( E) . 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-propyl-trifenyl-fosf oniumbromid (eksempel lc) og (4R,5R)-4,5-epoksy-5-fenyl-pent-2(E)-enal; klar, gul olje; Rf = 0,60 (heksan/eddikester = 3:2). The compound in the title is prepared analogously to example ld) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-propyl-triphenyl-phosphonium bromide (example lc) and (4R,5R)-4,5-epoxy- 5-phenyl-pent-2(E)-enal; clear, yellow oil; Rf = 0.60 (hexane/acetic ester = 3:2).
b) ( 4R. 5R1- 4, 5- epoksy- 5- fenyl- pent- 2( E)- enal b) ( 4R. 5R1- 4, 5- epoxy- 5- phenyl- pent- 2( E)-enal
Forbindelsen i overskriften fremstilles analogt eksempel lb) The compound in the heading is prepared analogously to example lb)
fra (2R,3R)-2,3-epoksy-3-fenyl-propanol; gul olje; som krystalliserer ved henstand; Rf = 0,38 (heksan/eddikester = 3:2); [cx]D20 = 185 ± 5,0° (kloroform, 0,200$). from (2R,3R)-2,3-epoxy-3-phenyl-propanol; yellow oil; which crystallizes on standing; Rf = 0.38 (hexane/acetic ester = 3:2); [cx]D20 = 185 ± 5.0° (chloroform, $0.200).
c) ( 2R. 3R)- 2. 3- epoksv- 3- fenyl- propanol c) ( 2R. 3R)- 2. 3- epoxyv- 3- phenyl- propanol
Forbindelsen i overskriften fremstilles analogt eksempel la) The compound in the heading is prepared analogously to example la)
fra 3-fenyl-prop-2(E)-enol; fargeløs olje, som krystalliserer i kald tilstand. Rf = 0,49 (heksan/eddikester = 1:1); IR (metylenklorid): 3590, 3040, 2980, 2920, 2870, 1605, 1080, 1070 cm-<1>. [cx]d<20> (kloroform, 0,279$) = 47,7 <+> 3,6°. from 3-phenyl-prop-2(E)-enol; colorless oil, which crystallizes in the cold state. Rf = 0.49 (hexane/acetic ester = 1:1); IR (methylene chloride): 3590, 3040, 2980, 2920, 2870, 1605, 1080, 1070 cm-<1>. [cx]d<20> (chloroform, 0.279$) = 47.7 <+> 3.6°.
Eksempel 67: ( IR . 2S )- l- hydroksy- l- fenyl- 8-( 4- acetyl- 3- hydroksy- 2- propylf enoksy )- okta- 3( E ). 5 ( Z )- dien- 2- vl- 7- tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 67: ( IR . 2S )-1-hydroxy-1-phenyl-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3( E ). 5 ( Z )-diene- 2- vl- 7- thio- 4- oxo- 4H- l- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 66); smp. 219-221°C; [a]D<20> (kloroform, 0,160$) = 103,1 ± 6,3°; UV (metanol): Xmax (c) = 221 (51180); 232 (sh); 267 (27040); 284 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 66); m.p. 219-221°C; [α]D<20> (chloroform, 0.160$) = 103.1 ± 6.3°; UV (methanol): Xmax (c) = 221 (51180); 232 (sh); 267 (27040); 284
(23840); 321 (16200); UV (kloroform): Xmax (c) = 274 (26080); 286 (sh); 330 (sh). Eksempel 68: ( IR . 2S 1- 1- hvdroksv- 1- ( 3- tr i f luormetvlfenvl )- 8-( 3- acetvl- 4-hvdroksy- 5- propyl- fenoksy 1- okta- 3( E") . 5( Z )- dien- 2- vl- 7- tio- 4-okso- 4H- l- henzopyran- 2- karboksvisyrernetviester (23840); 321 (16200); UV (chloroform): Xmax (c) = 274 (26080); 286 (sh); 330 (sh). Example 68: ( IR . 2S 1- 1- hydroxy- 1- ( 3- trifluoromethylphenyl )- 8-( 3- acetvl- 4- hydroxy- 5- propyl- phenoxy 1- octa- 3( E ") . 5 ( Z )-diene- 2- vl- 7- thio- 4-oxo- 4H- l- henzopyran- 2- carboxylic acid esters
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-trifluormetylfenyl)-8-(3-acetyl-4-hydroksy-5-propyl-fenoksy)-okta-3(E),5(Z)-dien; Rf = 0,21 (heksan/etylacetat = 3:2). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-trifluoromethylphenyl)-8-(3-acetyl-4-hydroxy-5-propyl-phenoxy)-octa-3( E),5(Z)-diene; Rf = 0.21 (hexane/ethyl acetate = 3:2).
"Utgangsmaterialet fremstilles f.eks. som følger: "The starting material is produced, for example, as follows:
a) 3-( 3- acetvi- 3- 4- hvdroksv- 5- propyl- fenoksy)- propylbromid a) 3-( 3- acetvi- 3- 4- hydroxy- 5- propyl- phenoxy)- propyl bromide
Til en oppløsning av 5,8 g 2,5-dihydroksy-3-propyl-acetofenon To a solution of 5.8 g of 2,5-dihydroxy-3-propyl-acetophenone
og 6,1 ml 1,3-dibrompropan i 60 ml metyletylketon tilsettes det 6,2 g kaliumkarbonat og 0,5 g kaliumjodid. Reaksjonsblandingen oppvarmes i 24 timer til tilbakeløp. Deretter helles det på 300 ml isvann, surgjøres med saltsyre og ekstraheres med diklormetan (3 x 150 ml). De samlede ekstraktene vaskes med 50 ml vann og tørkes over natriumsulfat. Etter filtrering og inndamping i vakuum, kromatografe-res resten på 400 g kiselgel med diklormetan. I den første fraksjonen elueres forbindelsen i overskriften, som etter inndamping oppnås i form av klare, gule krystaller av smp. 69-70°C. and 6.1 ml of 1,3-dibromopropane in 60 ml of methyl ethyl ketone, 6.2 g of potassium carbonate and 0.5 g of potassium iodide are added. The reaction mixture is heated to reflux for 24 hours. It is then poured into 300 ml of ice water, acidified with hydrochloric acid and extracted with dichloromethane (3 x 150 ml). The combined extracts are washed with 50 ml of water and dried over sodium sulphate. After filtration and evaporation in a vacuum, the residue is chromatographed on 400 g of silica gel with dichloromethane. In the first fraction, the title compound is eluted, which after evaporation is obtained in the form of clear, yellow crystals of m.p. 69-70°C.
b) 3-( 3- acetyl - 3- hydroksy- 5- propyl- fenoksy)- propyl- trifenyl-fosfoniumbromid b) 3-(3-acetyl-3-hydroxy-5-propyl-phenoxy)-propyl-triphenyl-phosphonium bromide
Forbindelsen i overskriften fremstilles analogt eksempel lc) fra 3-(3-acetyl-4-hydroksy-5-propyl-fenoksy)propylbromid og trifenylfosfin; smp. 103-105'C. The compound in the title is prepared analogously to example lc) from 3-(3-acetyl-4-hydroxy-5-propyl-phenoxy)propyl bromide and triphenylphosphine; m.p. 103-105'C.
c) ( IR. 2R)- l. 2- epoksy- l- f 3- trifluormetylfenvl)- 8-( 3- acetvl- 3-hvdroksy- 5- propyl- fenoksy)- okta- 3( E). 5( Z)- dien c) ( IR. 2R)- 1. 2- epoxy- 1- f 3- trifluoromethylphenyl)- 8-( 3- acetvl- 3-hydroxy- 5- propyl- phenoxy)- octa- 3( E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(3-acetyl-4-hydroksy-5-propyl-fenoksy)-propyl-trifenyl-fosfoniumbromid og (4R,5R)-4,5-epoksy-5-(3-trifluormetylfenyl )-pent-2(E)-enal ; Rf = 0,54 (heksan/eddikester = 2:1). The compound in the title is prepared analogously to example ld) from 3-(3-acetyl-4-hydroxy-5-propyl-phenoxy)-propyl-triphenyl-phosphonium bromide and (4R,5R)-4,5-epoxy-5-(3- trifluoromethylphenyl)-pent-2(E)-enal; Rf = 0.54 (hexane/acetic ester = 2:1).
Eksempel 69: ( IR . 2S )- l- hvdroksv- 1-( 3- trl f luormetvlfenvl )- 8-( 3- acetvl- 4-hvdroksv- 5- propvl- fenoksv)- okta- 3( E). 5( Z)- dien- 2- vl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksvlsvre- natriumsalt Example 69: ( IR . 2S )-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(3-acetyl-4-hydroxy-5-propyl-phenoxy)-octa-3(E). 5( Z)-diene- 2- yl- 7- thio- 4-oxo- 4H- 1- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra (IR, 2S)-l-hydroksy-l-(3-trifluormetylfenyl)-8-(3-acetyl-4-hydroksy-5-propyl-fenoksy)-okta-3(E),5(Z)-dien-2-yl-7-tio-4-okso-4H-l-benzopyran-2-karboksylsyremetylester, gult skum; IH-NMR (CD30D): S = 7,91, 7,76-7,56, 7,50, 7,36, 7,05, 6,82, 6,41, 6,00, 5,75, 5,47, 5,12, 4,45, 3,78, 2,65-2,35, 1,88, 1,58, 0,94 ppm. The compound in the title is prepared analogously to example 2 from (IR, 2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(3-acetyl-4-hydroxy-5-propyl-phenoxy)-octa-3(E) ,5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester, yellow foam; 1H-NMR (CD30D): S = 7.91, 7.76-7.56, 7.50, 7.36, 7.05, 6.82, 6.41, 6.00, 5.75, 5 .47, 5.12, 4.45, 3.78, 2.65-2.35, 1.88, 1.58, 0.94 ppm.
Eksempel 70: ( IR . 2S)- 1- hvdroksv- 1-( 3- klorfenvl)- 8- f4- acetvl- 3- hvdroksv- 2-propyl- f enoksy )- okta- 3( E ) . 5( Z)- dien- 2- yl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsyrenretviester Example 70: ( IR . 2S )-1-hydroxy-1-(3-chlorophenyl)-8-β-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3( E ). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid enretviester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (IR,2R)-l,2-epoksy-l-(3-klorfenyl)-8-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-okta-3(E),5(Z)-dien; smp. 76-77°C; [cx]D20 (kloroform, 0,215$) = 51,2 ± 4,7°; UV (kloroform): <x>max (c) - 271 (28160); 285 (sh). The compound in the title is prepared analogously to example 1 from (IR,2R)-1,2-epoxy-1-(3-chlorophenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3( E),5(Z)-diene; m.p. 76-77°C; [cx]D 2 O (chloroform, 0.215$) = 51.2 ± 4.7°; UV (chloroform): <x>max (c) - 271 (28160); 285 (sh).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 1R. 2R1- 1. 2- epoksv- l-( 3- klorfenvl)- 8-( 4- acetvl- 3- hvdroksv-2- propylfenoksy)- okta- 3( E). 5( Z)- dien a) (1R.2R1-1.2-epoxy-1-(3-chlorophenyl)-8-(4-acetyl-3-hydroxy-2-propylphenoxy)-octa-3(E).5(Z)-diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-propyl-trifenyl-fosfoniumbromid (eksempel lc) og (4R,5R)-4,5-epoksy-5-(3-klorfenyl )-pent-2(E)-enal; klar, gul olje; [cx]])<20> (kloroform, 0,541$) = 63,9 ± 1,8°. The compound in the title is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-propyl-triphenyl-phosphonium bromide (example 1c) and (4R,5R)-4,5-epoxy-5 -(3-chlorophenyl)-pent-2(E)-enal; clear, yellow oil; [cx]])<20> (chloroform, 0.541$) = 63.9 ± 1.8°.
b) ( 4R. 5R)- 4. 5- epoksv- 5-( 3- klorfenvl)- pent- 2( E)- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) b) (4R.5R)-4.5-epoxy-5-(3-chlorophenyl)-pent-2(E)- enal The compound in the title is prepared analogously to example lb)
fra (2R,3R)-2,3-epoksy-3-(3-klorfenyl)-propanol; mørkt gul olje; Rf = 0,23 (heksan/eddikester = 4:1). [ot]D<20> (kloroform, 0,30$) - 184,7 ± 3,3. from (2R,3R)-2,3-epoxy-3-(3-chlorophenyl)-propanol; dark yellow oil; Rf = 0.23 (hexane/acetic ester = 4:1). [ot]D<20> (chloroform, 0.30$) - 184.7 ± 3.3.
c) ( 2R. 3R)- 2. 3- epoksv- 3-( 3- klorfenvl)- propanol c) (2R.3R)-2.3-epoxy-3-(3-chlorophenyl)-propanol
Forbindelsen i overskriften fremstilles analogt eksempel la) The compound in the heading is prepared analogously to example la)
fra 3-(3-klorfenyl)-prop-2(E)-enol; klar, gul olje; Rf = 0,22 (heksan/eddikester = 7:3). IR (metylenklorid): 3580, 3040, 2980, 2910, 2860, 1600, 1570, 1070 cm-<1>. [oc]D<20> (kloroform, 0,334$) = 47,3 ± 3,0°. from 3-(3-chlorophenyl)-prop-2(E)-enol; clear, yellow oil; Rf = 0.22 (hexane/acetic ester = 7:3). IR (methylene chloride): 3580, 3040, 2980, 2910, 2860, 1600, 1570, 1070 cm-<1>. [oc]D<20> (chloroform, 0.334$) = 47.3 ± 3.0°.
Eksempel 71: Example 71:
( IR . 2S )- l- hvdroksv- ( 3- klorf envl )- 8-( 4- acetvl- 3- hvdroksv- 2-propyl- fenoksv)- okta- 3( E) . 5( Z)- dien- 2- yl- 7- tio- 4- okso- 4H- l-benzopvran- 2- karboksvlsvre- natriumsalt ( IR . 2S )- 1-hydroxy- ( 3- chlorophenoxy )- 8-( 4- acetyl- 3- hydroxy- 2-propyl- phenoxy)- octa- 3( E) . 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 70); smp. 217-219°C; [oc]D<20>= (metanol, 0,160$) = 107,5 ± 6,3°; UV (metanol): Xmax (c) = 219 (55060); 235 (sh); 267 (27340); 284 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 70); m.p. 217-219°C; [oc]D<20>= (methanol, 0.160$) = 107.5 ± 6.3°; UV (methanol): Xmax (c) = 219 (55060); 235 (sh); 267 (27340); 284
(23920); 320 (16500). (23920); 320 (16500).
Eksempel 72: ( lR. 2S)- l- hvdroksv- l-( 3- klorfenvl)- 10-( 4- acetvl- 3- hvdroksv- 2-propvl- f enoksy )- deka- 3( E ) . 5( Z )- dien- 2- vl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsyremetylester Example 72: (1R.2S)-1-hydroxy-1-(3-chlorophenyl)-10-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-deca-3(E). 5(Z)-diene-2-vl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-klorfenyl)-10-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-deka-3(E),5(Z)-dien; smp. 61-62°C; [a]D2<0> (kloroform, 0,170$) = 52,9 ± 5,9°; UV (kloroform): <X>max (c) = 271 (27120); 286 (24800); 322 (15400). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-chlorophenyl)-10-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-deca-3( E),5(Z)-diene; m.p. 61-62°C; [α]D2<0> (chloroform, 0.170$) = 52.9 ± 5.9°; UV (chloroform): <X>max (c) = 271 (27120); 286 (24800); 322 (15400).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( IR. 2R)- l . 2- epoksv- l-( 3- klorfenvl)- 10-( 4- acetvl- 3-hvdroksy- 2- propvl- fenoksy)- deka- 3( E). 5( Z )- dien a) ( IR. 2R)- l . 2-epoxyl-1-(3-chlorophenyl)-10-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-deca-3(E). 5( Z )- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)pentyl-trifenyl-fosfoniumbromid (eksempel 29a) og (4R,5R)-4,5-epoksy-5-(3-klorfenyl)-pent-2(E)-enal (eksempel 70b); klar, gul olje; [oc]D<20> (kloroform, 0,391$) = 61,4 <+> 2,5°. The compound in the title is prepared analogously to example ld) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)pentyl-triphenyl-phosphonium bromide (example 29a) and (4R,5R)-4,5-epoxy-5- (3-Chlorophenyl)-pent-2(E)-enal (Example 70b); clear, yellow oil; [oc]D<20> (chloroform, 0.391$) = 61.4 <+> 2.5°.
Eksempel 73; Example 73;
( IR. 2S)- 1- hvdroksy- l-( 3- klorfenvl)- 10-( 4- acetvl- 3- hvdroksv- 2-propyl- fenoksy)- deka- 3( E). 5( Z )- dien- 2- yl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsyre- natriumsalt ( IR. 2S )- 1- hydroxy- 1-( 3- chlorophenyl)- 10-( 4- acetyl- 3- hydroxy- 2-propyl- phenoxy)- deca- 3( E). 5( Z )-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 72); smp. 204-206°C; [a]D<20> (metanol, 0,205$) = 58,5 ± 4,9°; UV (MeOH): xmax (c) = 218 (27940); 267 (13141); 285 (11600); 320 (sh). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 72); m.p. 204-206°C; [α]D<20> (methanol, 0.205$) = 58.5 ± 4.9°; UV (MeOH): x max (c) = 218 (27940); 267 (13141); 285 (11600); 320 (sh).
Eksempel 74: ( lR. 2S)- l- hydroksy- l-( 3- metoksvfenvl)- 8-( 4- acetyl- 3- hydroksv-2- propyl- fenoksy)- okta- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksvlsyremetylester Example 74: (1R.2S)-1-hydroxy-1-(3-methoxyphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-metoksyfenyl)-8-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-okta-3(E),5(Z)-dien; smp. 65-67°C; UV (kloroform): Xmax (c) = 271 (30360); 285 (sh); 323 The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-methoxyphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3( E),5(Z)-diene; m.p. 65-67°C; UV (chloroform): Xmax (c) = 271 (30360); 285 (sh); 323
(16600). (16600).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( IR . 2R ) - 1 . 2- epoksv- l - ( 3- metoksvf envl )- 8-( 4- acetyl- 3-hydroksv- 2- propyl- fenoksy)- okta- 3( E). 5( Z)- dien a) ( IR . 2R ) - 1 . 2- epoxyv-l - (3- methoxyvf envl )- 8-( 4- acetyl- 3-hydroxyv- 2- propyl- phenoxy)- octa- 3( E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)propyl-trifenyl-fosfoniumbromid (eksempel lc) og (4R,5R)-4,5-epoksy-5-(3-me tok sy f enyl )-pent-2(E)-enal; klar, gul olje; [oc]d<20> (kloroform, 0,315$) = 78,4 ± 3,2. The compound in the title is prepared analogously to example ld) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)propyl-triphenyl-phosphonium bromide (example lc) and (4R,5R)-4,5-epoxy-5- (3-me toxy phenyl )-pent-2(E)-enal; clear, yellow oil; [oc]d<20> (chloroform, 0.315$) = 78.4 ± 3.2.
b) ( 4R. 5R)- 4. 5- epoksy- 5-( 3- metoksyfenvl)- pent- 2( E)- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) b) ( 4R. 5R)- 4. 5- epoxy- 5-( 3- methoxyphenvl)- pent- 2( E)-enal The compound in the title is prepared analogously to example lb)
fra (2R,3R)-2,3-epoksy-3-(3-metoksyfenyl)-propanol; gul olje; Rf = 0,42 (heksan/eddikester = 3:2); [a]D<20> (kloroform, 0,567$) = 168,9 ± 1,8°. from (2R,3R)-2,3-epoxy-3-(3-methoxyphenyl)-propanol; yellow oil; Rf = 0.42 (hexane/acetic ester = 3:2); [α]D<20> (chloroform, 0.567$) = 168.9 ± 1.8°.
c ) ( 2R. 3R)- 2. 3- epoksy- 3-( 3- metoksyfenvl)- propanol Forbindelsen i overskriften fremstilles analogt eksempel la) fra 3-(3-metoksyfenyl)-prop-2(E)-enol; klar, gul olje; Rf = 0,31 (heksan/eddikester = 3:2). IR (metylenklorid): 3550, 2890, 1580, 1565, 1465, 1445, 1130 cm-<1>. c) (2R.3R)-2.3-epoxy-3-(3-methoxyphenyl)-propanol The compound in the title is prepared analogously to example la) from 3-(3-methoxyphenyl)-prop-2(E)-enol; clear, yellow oil; Rf = 0.31 (hexane/acetic ester = 3:2). IR (methylene chloride): 3550, 2890, 1580, 1565, 1465, 1445, 1130 cm-<1>.
Eksempel 75: ( IR. 2S)- l- hvdroksv- l-( 3- metoksyfenvl)- 8-( 4- acetyl- 3- hvdroksv-2- propyl- fenoksv)- okta- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksvlsvre- natriumsalt Example 75: (IR. 2S)-1-hydroxy-1-(3-methoxyphenoxy)-8-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 74); smp. 206-208°C; [oc]D<20> (metanol, 0,293$) = 99,7 ± 3,4°; UV (metanol): <X>max (c) = 221 (57840); 235 (sh); 268 (29360); 282 (26400); 320 (16800). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 74); m.p. 206-208°C; [oc]D<20> (methanol, 0.293$) = 99.7 ± 3.4°; UV (methanol): <X>max (c) = 221 (57840); 235 (sh); 268 (29360); 282 (26400); 320 (16800).
Eksempel 76: ( IR. 2S)- l- hvdroksy- l-( 3- metoksyfenvl ) - 10-( 4- acetvl- 3-hvdr oksy- 2- propyl- fenoksy)- deka- 3( E). 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyrernetylester Example 76: (IR. 2S)-1-hydroxy-1-(3-methoxyphenyl)-10-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-deca-3(E). 5(Z)-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (IR,2R)-l,2-epoksy-l-(3-metoksyfenyl)-10-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-deka-3(E),5(Z)-dien; smp. 53°C (sublimerer delvis); UV (kloroform): Xmax (c) = 272 (29920); 285 (sh); 323 (15540); [oc]D<20> (kloroform, 0,180$) = 44,4 5,6° . The compound in the title is prepared analogously to example 1 from (IR,2R)-1,2-epoxy-1-(3-methoxyphenyl)-10-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-deca-3( E),5(Z)-diene; m.p. 53°C (sublimes partially); UV (chloroform): Xmax (c) = 272 (29920); 285 (sh); 323 (15540); [oc]D<20> (chloroform, 0.180$) = 44.4 5.6° .
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( IR . 2R)- l . 2- epoksv- l- f3- metoksvfenvl)- 10-( 4- acetvl- 3-hydroksy- 2- propyl- fenoksy)- deka- 3( E) . 5( Z )- dien a) ( IR . 2R)- l . 2-epoxy-1-f3-methoxyphenyl)-10-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-deca-3( E) . 5( Z )- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)pentyl-trifenyl-fosfoniumbromid (eksempel 29a) og (4R,5R)-4,5-epoksy-5-(3-metoksyfenyl)-pent-2(E)-enal (eksempel 74b); klar, gul olje; [a]D20 (kloroform, 0,375$) = 72,5 ± 2,7. The compound in the title is prepared analogously to example ld) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)pentyl-triphenyl-phosphonium bromide (example 29a) and (4R,5R)-4,5-epoxy-5- (3-Methoxyphenyl)-pent-2(E)-enal (Example 74b); clear, yellow oil; [a]D 2 O (chloroform, 0.375$) = 72.5 ± 2.7.
Eksempel 77: ( IR. 2S)- 1- hvdroksv- 1-( 3- metoksvfenvl ) - 10-( 4- acetyl- 3-hydroksy- 2- propyl- fenoksy)- deka- 3( E). 5( Z )- dien- 2- yl- 7- tio- 4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 77: (IR. 2S)-1-hydroxy-1-(3-methoxyphenyl)-10-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-deca-3(E). 5( Z )-dien-2-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 76); smp. 187-188°C; [a]D<20> (metanol, 0,150$) = 72,0 ± 6,7°; UV (metanol): xmax (c) = 222 (55780); 268 (27820); 282 (25200); 321 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 76); m.p. 187-188°C; [α]D<20> (methanol, 0.150$) = 72.0 ± 6.7°; UV (methanol): xmax (c) = 222 (55780); 268 (27820); 282 (25200); 321
(16200). (16200).
Eksempel 78: ( IR. 2S)- l- hvdroksv- l-( 3- trifluormetvlfenvl)- 8-( 4- trifluorace-tvl - 3- hvdroksv- f enoksy )- okta- 3( E). 5 ( Z )- dien- 2- vl- 7- tio- 4-okso- 4E- l- benzopyran- 2- karboksylsyrernetylester Example 78: (IR. 2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(4-trifluoroacetyl-3-hydroxy-phenoxy)-octa-3(E). 5 ( Z )-diene-2-vl-7-thio-4-oxo-4E-l- benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (IR,2R)-l,2-eoksy-l-(3-trifluormetylfenyl)-8-(4-trifluoracetyl-3-hydroksy-fenoksy)-okta-3(E),5(Z)-dien; Rf 0,23 (heksan/eddikester = 3:2). The compound in the title is prepared analogously to example 1 from (IR,2R)-1,2-eoxy-1-(3-trifluoromethylphenyl)-8-(4-trifluoroacetyl-3-hydroxy-phenoxy)-octa-3(E),5 (Z)-diene; Rf 0.23 (hexane/acetic ester = 3:2).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) 3-( 4- trifluoracetyl- 3- hvdroksv- fenoksy) propylbromid Forbindelsen i overskriften fremstilles analogt eksempel 68a) a) 3-(4-trifluoroacetyl-3-hydroxyphenoxy)propyl bromide The compound in the title is prepared analogously to example 68a)
fra 2,4-dihydroksy-trifluoracetofenon og oppstår som klar gul from 2,4-dihydroxy-trifluoroacetophenone and occurs as clear yellow
olje; IR (klormetan): 3150, 2940, 1645, 1625, 1380, 1210, 1150, 1125, 1020, 940 cm-<1>. oil; IR (chloromethane): 3150, 2940, 1645, 1625, 1380, 1210, 1150, 1125, 1020, 940 cm-<1>.
b) 3-( 4- trifluoracetyl- 3- hvdroksv- fenoksy) propyl- trifenylfos-foniumbromid b) 3-(4-trifluoroacetyl-3-hydroxy-phenoxy)propyl-triphenylphosphonium bromide
Forbindelsen i overskriften fremstilles analogt eksempel lc) fra 3-(4-trifluoracetyl-3-hydroksy-fenoksy)propylbromid og trifenylfosfon; smp. 125-130°C. The compound in the title is prepared analogously to example lc) from 3-(4-trifluoroacetyl-3-hydroxy-phenoxy)propyl bromide and triphenylphosphone; m.p. 125-130°C.
c) ( IR . 2R )- 1. 2- epoksy- l-( 3- trifluormetvlfenvl)- 8-( 4- trifluoracetyl- 3- hvdroksy- fenoksy)- okta- 3( E). 5( Z)- dien c) ( IR . 2R )- 1. 2- epoxy- 1-( 3- trifluoromethylphenyl)- 8-( 4- trifluoroacetyl- 3- hydroxyphenoxy)- octa- 3( E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-trifluoracety1-3-hydroksy-fenoksy)propyl-trifenyl-fosfoniumbromid og (4R,5R)-4,5-epoksy-5-(3-trifluormetylfenyl)-pent-2(E)-enal; Rf = 0,56 (heksan/eddikester 2:1). The compound in the title is prepared analogously to example 1d) from 3-(4-trifluoroacetyl-3-hydroxy-phenoxy)propyl-triphenyl-phosphonium bromide and (4R,5R)-4,5-epoxy-5-(3-trifluoromethylphenyl)-pent- 2(E)-enal; Rf = 0.56 (hexane/acetic ester 2:1).
Eksempel 79: ( IR. 2S)- l- hvdroksy- l-( 3- trifluormetylfenvl)- 8-( 4- trifluorace-tvl- 3- hvdroksv- fenoksy)- okta- 3( E). 5( Z)-dien-2-vl-7-tio-4-okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 79: (IR. 2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(4-trifluoroacetyl-3-hydroxyphenoxy)-octa-3(E). 5( Z )-dien-2-vl-7-thio-4-oxo- 4H- 1- benzopyran- 2- carboxylic acid sodium salt
Til en til 10°C avkjølt oppløsning av 708 mg av metylesteren av forbindelsen i overskriften (kfr. eksempel 78) i 25 ml tetrahydrofuran tilsettes det 10 ml 0,1 N vandig natronlut. Reaksjonsblandingen omrøres i 24 timer ved romtemperatur, befris for oppløsningsmiddel i vakuum og resten opptas i vann. Etter filtrering til klarhet lyofiliseres oppløsnin-gen. Forbindelsen i overskriften oppnås som ollvengrønt, amorft pulver; To a cooled to 10°C solution of 708 mg of the methyl ester of the compound in the title (cf. Example 78) in 25 ml of tetrahydrofuran is added 10 ml of 0.1 N aqueous sodium hydroxide solution. The reaction mixture is stirred for 24 hours at room temperature, freed of solvent in vacuo and the residue taken up in water. After filtering until clear, the solution is lyophilized. The title compound is obtained as an olive green, amorphous powder;
<i>H-NMR (CD3OD): 5 = 7,94, 7,78-7,46, 7,36, 6,90, 6,36, 6,04, 5,74, 5,42, 5,12, 4,42, 3,86 ppm. <i>H-NMR (CD 3 OD): δ = 7.94, 7.78-7.46, 7.36, 6.90, 6.36, 6.04, 5.74, 5.42, 5, 12, 4.42, 3.86 ppm.
Eksempel 80: ( IR. 2S)- l- hvdroksy- l-( 3- trifluormetylfenvl)- 8-( 4- trifluorace-tvl- 3- h vdroksv- 2- propyl- fenoksy)- okta- 3( E). 5( Z)- dien- 2- yl- 7-tio- 4- okso- 4H- l-" benzopvran- 2- karboksvlsvremetvlester Example 80: (IR. 2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(4-trifluoroacetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E). 5( Z )- dien- 2- yl- 7-thio- 4- oxo- 4H- 1-" benzopyran- 2- carboxyl methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (1R,2R)-1,2-epoksy-l-(3-trifluormetylfenyl)-8-(4-trif luor acetyl- 3-hydr oksy-2-propyl-f enoksy )-okta-3(E) ,5(Z)-dien; Rf = 0,18 (toluen/eddikester 5:1). The compound in the title is prepared analogously to example 1 from (1R,2R)-1,2-epoxy-1-(3-trifluoromethylphenyl)-8-(4-trifluoroacetyl-3-hydroxy-2-propyl-phenoxy)- octa-3(E),5(Z)-diene; Rf = 0.18 (toluene/acetic ester 5:1).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) 3 - ( 4- trif luorac etyl- 3- h vdroksy- 2- propvl- f enoksy)- propylbromid a) 3 - (4-trifluoroethyl-3-hydroxy-2-propvl- f enoxy)- propyl bromide
Forbindelsen i overskriften fremstilles analogt eksempel 68a) fra 2,4-dihydroksy-3-propyl-trifluoracetofenon og oppstår som gul olje; IR (diklormetan): 3150, 2950, 2860, 1640, 1620, 1500, 1295, 1210, 1150, 1120, 1070 cm-<1>. The compound in the title is prepared analogously to example 68a) from 2,4-dihydroxy-3-propyl-trifluoroacetophenone and occurs as a yellow oil; IR (dichloromethane): 3150, 2950, 2860, 1640, 1620, 1500, 1295, 1210, 1150, 1120, 1070 cm-<1>.
b ) 3- ( 4- tr i f luor acetyl - 3- hy dr ok sy- 2- propyl- f enoksy ) propyl-trifenylfosfoniumbromid b) 3-(4-trifluoroacetyl-3-hydroxy-2-propyl-phenoxy)propyl-triphenylphosphonium bromide
Forbindelsen i overskriften fremstilles analogt eksempel lc) fra 3-(4-trifluoracetyl-3-hydroksy-2-propyl-fenoksy)propylbromid og trifenylfosfin; smp. 170-190°C. The compound in the title is prepared analogously to example lc) from 3-(4-trifluoroacetyl-3-hydroxy-2-propyl-phenoxy)propyl bromide and triphenylphosphine; m.p. 170-190°C.
c) ( IR . 2R)- l. 2- epoksy- 1-( 3- trifluormetvlfenvl)-8-(4-trifluor acetyl - 3- hy dr oksy- 2- propyl- f enoksy )- okta- 3( E). 5( Z )-dien c) (IR.2R)-1.2-epoxy-1-(3-trifluoromethylphenyl)-8-(4-trifluoroacetyl-3-hydroxy-2-propyl-phenoxy)-octa-3(E) . 5( Z )-diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-trifluoracetyl-3-hydroksy-2-propyl-fenoksy)propyl-trifenylfosfoniumbromid og (4R,5R)-4,5-epoksy-5-(3-trifluormetylfenyl)-pent-2(E)-enal; Rf = 0,55 (heksan/eddikester 2:1). The compound in the title is prepared analogously to example ld) from 3-(4-trifluoroacetyl-3-hydroxy-2-propyl-phenoxy)propyl-triphenylphosphonium bromide and (4R,5R)-4,5-epoxy-5-(3-trifluoromethylphenyl)- pent-2(E)-enal; Rf = 0.55 (hexane/acetic ester 2:1).
Eksempel 81: ( IR. 2S)- l- hvdroksv- 1-( 3- trifluormetylfenvl)- 8-( 4- trifluorace-tvi- 3- hvdroksv- l- propyl- fenoksv)- okta- 3( E). 5( Z)- dien- 2- vl- 7-tio- 4- okso- 4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 81: (IR. 2S)-1-hydroxy-1-(3-trifluoromethylphenyl)-8-(4-trifluoroacetvi-3-hydroxy-1-propyl-phenoxy)-octa-3(E). 5( Z)-diene- 2- vl- 7-thio- 4- oxo- 4H- l- benzopyran- 2- carboxylic acid sodium salt
Til en til 10°C avkjølt oppløsning av 500 mg av metylesteren av forbindelsen i overskriften (kfr. eksempel 80) i 20 ml tetrahydrofuran tilsettes det 6,6 ml 0,1 N vandig natronlut. Reaksjonsblandingen omrøres i 1 time ved 10°C, befris i vakuum for tetrahydrofuran, og den gjenværende oppløsningen lyofiliseres. Forbindelsen i overskriften oppnås som gulgrønt, amorft pulver; ^-H-NMR (CD3OD): S = 7,93, 7,77-7,60, 7,50, 7,36, 6,92, 6,43, 6,04, 5,73, 5,47, 4,47, 4,00, 2,50, 2,38, 0,72 ppm. To a cooled to 10°C solution of 500 mg of the methyl ester of the compound in the title (cf. example 80) in 20 ml of tetrahydrofuran is added 6.6 ml of 0.1 N aqueous sodium hydroxide solution. The reaction mixture is stirred for 1 hour at 10°C, freed from tetrahydrofuran in vacuo, and the remaining solution is lyophilized. The title compound is obtained as yellow-green, amorphous powder; 3 H NMR (CD 3 OD): S = 7.93, 7.77-7.60, 7.50, 7.36, 6.92, 6.43, 6.04, 5.73, 5.47 , 4.47, 4.00, 2.50, 2.38, 0.72 ppm.
Eksempel 82: ( IR . 2S)- 1- hvdroksv- 1-( 3- trif luormetvlfenvl l- 8-( 4- acetvl- 3-hvdroksv- 2- propyl- fenyltio)- okta- 3( E). 5( Z l- dlen^- yl^- tio^-okso^ H- l- benzopyran^- karboksylsyremetylester Example 82: ( IR . 2S )- 1- hydroxy- 1-( 3- trifluoromethylphenyl 1- 8-( 4- acetvl- 3- hydroxy- 2- propyl- phenylthio)- octa- 3( E). 5( Z l- dlen^- yl^- thio^-oxo^ H- l- benzopyran^- carboxylic acid methyl ester
Forbindelsen i overskriften oppnås analogt eksempel 1 fra (1R,2S)-1,2-epoksy-l-( 3-trif luormetylfenyl )-8-(4-acetyl-3-hydroksy-2-propyl-fenyltio)-okta-3(E),5(Z)-dien; Rf = 0,19 (heksan/eddikester 3:2). The compound in the title is obtained analogously to example 1 from (1R,2S)-1,2-epoxy-1-(3-trifluoromethylphenyl)-8-(4-acetyl-3-hydroxy-2-propyl-phenylthio)-octa-3 (E),5(Z)-diene; Rf = 0.19 (hexane/acetic ester 3:2).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) 3-( 4- acetvl- 3- hydroksy- 2- propyl- fenyltioIpropylbromid Forbindelsen i overskriften fremstilles analogt eksempel 68a) a) 3-(4-acetyl-3-hydroxy-2-propyl-phenylthiopropyl bromide The compound in the title is prepared analogously to example 68a)
fra 2-hydroksy-4-merkapto-acetofenon; klar, gul olje. from 2-hydroxy-4-mercapto-acetophenone; clear, yellow oil.
b) 3-( 4- acetyl- 3- hydroksy- 2- propyl- fenyltio) propyl- trifenvl-fosfoniumbromid b) 3-(4-acetyl-3-hydroxy-2-propyl-phenylthio)propyl-triphenyl-phosphonium bromide
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra 3-(4-acetyl-3-hydroksy-2-propyl-fentyltio)propylbromid og trifenylfosfin. The compound in the title is prepared analogously to example 1 from 3-(4-acetyl-3-hydroxy-2-propyl-phentylthio)propyl bromide and triphenylphosphine.
c) ( IR. 2S1- 1. 2- epoksy- l-( 3- trifluormetylfenvl1-8-( 4- acetvl- 3-hvdroksy- 2- propyl- fenyltio)- okta- 3( E). 5( Z)- dien c) ( IR. 2S1- 1. 2- epoxy- 1-( 3- trifluoromethylphenyl1-8-( 4- acetvl- 3- hydroxy- 2- propyl- phenylthio)- octa- 3( E). 5( Z)- the day
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenyltio)propyl-trifenyl-fosfoniumbromid og (4R,5R)-4,5-epoksy-5-(3-trifluormetylfenyl )-pent-2(E)-enal. The compound in the title is prepared analogously to example ld) from 3-(4-acetyl-3-hydroxy-2-propyl-phenylthio)propyl-triphenyl-phosphonium bromide and (4R,5R)-4,5-epoxy-5-(3-trifluoromethylphenyl) )-pent-2(E)-enal.
Eksempel 83: ( IR . 2S1 - 1- hvdroksv- 1-( 3- trif luormetvlfenvl )- 8-( 4- acetvl- 3-hvdroksv- 2- propyl- fenvltiol- okta- 3( El. 5( Z)- dlen- 2- vl- 7- tio- 4-okso- 4H- benzopyran- 2- karboksylsyre- natriumsalt Example 83: ( IR . 2S1 - 1- hydroxy- 1-( 3- trifluoromethylphenyl )- 8-( 4- acetvl- 3- hydroxy- 2- propyl- phenylthiol- octa- 3( El. 5( Z)- dlene - 2- vl- 7- thio- 4-oxo- 4H- benzopyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 82). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 82).
Eksempel 84: ( IR . 2S l- l- hvdroksy- l- O- trifluormetvlfenvl l- 10-( 4- acetvl- 3-hvdroksv- 2- propyl- fenvltiol- deka- 3( E). 5( Z)- dien- 2- vl- 7- tio- 4-okso- 4H- benzopyran- 2- karboksylsyremetylester Example 84: ( IR . 2S 1- 1- hydroxy- 1- O- trifluoromethylphenyl 1- 10-( 4-acetvl- 3-hydroxy- 2- propyl- phenylthiol- deca- 3( E). 5( Z)-diene - 2- vl- 7- thio- 4-oxo- 4H- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (IR,2S)-l,2-epoksy-l-(3-trifluormetylfenyl)-10-(4-acetyl-3-hydroksy-2-propyl-fenyltio)-deka-3(E),5(Z)-dien; Rf = 0,17 (heksan/eddikester 3:2). The compound in the title is prepared analogously to example 1 from (IR,2S)-1,2-epoxy-1-(3-trifluoromethylphenyl)-10-(4-acetyl-3-hydroxy-2-propyl-phenylthio)-deca-3( E),5(Z)-diene; Rf = 0.17 (hexane/acetic ester 3:2).
Utgangsmaterialet kan f.eks. fremstilles som følger: The starting material can e.g. produced as follows:
a) 5-( 4- acetvl- 3- hydroksy- 2- propyl- fenyltioIpentylbromid Forbindelsen i overskriften fremstilles analogt eksempel 68a) a) 5-(4-acetyl-3-hydroxy-2-propyl-phenylthioIpentyl bromide The compound in the title is prepared analogously to example 68a)
fra 2-hydroksy-4-merkapto-acetofenon; klar, gul olje. from 2-hydroxy-4-mercapto-acetophenone; clear, yellow oil.
b ) 5 -( 4- acetyl - 3- hydroksy- propyl- fenvltio 1- pentvl- trlfenvl-fosfoniumbromid b ) 5 -( 4- acetyl - 3- hydroxy- propyl- phenylthio 1- pentyl- triphenyl- phosphonium bromide
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra 5-(4-acetyl-3-hydroksy-2-propyl-fenyltio)pentylbromid og trifenylfosfin. The compound in the title is prepared analogously to example 1 from 5-(4-acetyl-3-hydroxy-2-propyl-phenylthio)pentyl bromide and triphenylphosphine.
c) ( IR . 2S )- l. 2- epoksv- l-( 3- trifluormetylfenvl)- 10-( 4- acetvl-3- hvdroksv- 2- propvl- fenvltio)- deka- 3( E). 5( Z)- dien c) (IR.2S)-1.2-epoxy-1-(3-trifluoromethylphenyl)-10-(4-acetyl-3-hydroxy-2-propyl-phenylthio)-deca-3(E). 5(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 5-(4-acetyl-3-hydroksy-2-propyl-fenyltio)pentyl-trifenyl-fosfoniumbromid og (4R,5R)-4,5-epoksy-5-(3-trlfluormetyl-fenyl)-pent-2(E)-enol. The compound in the title is prepared analogously to example 1d) from 5-(4-acetyl-3-hydroxy-2-propyl-phenylthio)pentyl-triphenyl-phosphonium bromide and (4R,5R)-4,5-epoxy-5-(3-trifluoromethyl) -phenyl)-pent-2(E)-enol.
Eksempel 85: ( IR . 2S)- 1- hvdroksy- l-( 3- trif luormetylf envl )- 10-( 4- acetvl- 3-hvdr oksy- 2- propyl- fenyltio- deka- 3( E), 5( Z)- dien- 2- yl- 7- tio- 4-okso- 4H- ben20pyran- 2- karboksvlsyre- natriumsalt Example 85: ( IR . 2S)- 1- hydroxy- 1-( 3- trifluoromethylphenyl )- 10-( 4- acetvl- 3- hydroxy- 2- propyl- phenylthio- deca- 3( E), 5( Z)- dien- 2- yl- 7- thio- 4-oxo- 4H- ben20pyran- 2- carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 84). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 84).
Eksempel 86; Example 86;
( 5R . 6S )- l. 1. 1- trifluor- 5- hvdroksv- 12-( 4- acetyl- 3- hvdroksv- 3-hydroksy- 2- propyl- fenoksy)- dodeka- 7( E). 9( Z)- dien- 6- yl- 7- tio-4- okso- 4H- l- benzopyran- 2- karboksylsyremetylester ( 5R . 6S )- l. 1. 1- trifluoro- 5- hydroxy- 12-( 4- acetyl- 3- hydroxy- 3- hydroxy- 2- propyl- phenoxy)- dodeca- 7( E). 9( Z)-dien- 6- yl- 7- thio-4- oxo- 4H- 1- benzopyran- 2- carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (5R,6R)-5,6-epoksy-l,1,l-trifluor-12-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-dodeka-7(E),9(Z)-dien; klart, gult skum; Rf = 0,24 (heksan/eddikester = 3:2). The compound in the title is prepared analogously to example 1 from (5R,6R)-5,6-epoxy-1,1,1-trifluoro-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-7( E),9(Z)-diene; clear, yellow foam; Rf = 0.24 (hexane/acetic ester = 3:2).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 2R. 3R)- 2. 3- epoksv- 7. 7. 7- trifluor- heptanol a) ( 2R. 3R)- 2. 3- epoxyv- 7. 7. 7- trifluoro-heptanol
Forbindelsen i overskriften fremstilles analogt eksempel la) The compound in the heading is prepared analogously to example la)
fra 7,7,7-trifluor-hept-2(E)-enol; klar, gul olje; Rf = 0,38 (heksan/eddikester = 3:2). [oc]d<20> (kloroform, 0,490$) = 15,3 2,0°. IR (metylenklorid): 3550, 3430, 2900, 1180, 1125. from 7,7,7-trifluoro-hept-2(E)-enol; clear, yellow oil; Rf = 0.38 (hexane/acetic ester = 3:2). [oc]d<20> (chloroform, 0.490$) = 15.3 2.0°. IR (methylene chloride): 3550, 3430, 2900, 1180, 1125.
b) ( 4R. 5R)- 4. 5- epoksv- 9. 9. 9- trifluor- non- 2( E)- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) b) ( 4R. 5R)- 4. 5- epoxyv- 9. 9. 9- trifluoro- non- 2( E)- enal The compound in the title is prepared analogously to example lb)
fra (2R,3R)-2,3-epoksy-7,7-7-trifluor-heptanol; olje, som from (2R,3R)-2,3-epoxy-7,7-7-trifluoroheptanol; oil, which
krystalliserer i kjøleskap. Rf = 0,63 (heksan/eddikester = 1:1). [a]D<20> (kloroform, 0,210$) = 19,5 <+> 4,8°. crystallizes in a refrigerator. Rf = 0.63 (hexane/acetic ester = 1:1). [a]D<20> (chloroform, 0.210$) = 19.5 <+> 4.8°.
c ) ( 5R. 6R)- 5. 6- epoksy- l. 1. 1- trifluor- 12-( 4- acetyl- 3- hydroksy-2- propyl- fenoksy)- dodeka- 7( E). 9( Z)- dien c) (5R.6R)-5.6-epoxy-1.1.1-trifluoro-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-7(E). 9(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)propyltrifenyl-fosfoniumbromid (eksempel lc) og (4R,5R)-4,5-epoksy-9,9,9-trifluor-non-2(E)-enal; gul olje; Rf = 0,56 (heksan/- eddikester = 3:2). The compound in the title is prepared analogously to example ld) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)propyltriphenyl-phosphonium bromide (example lc) and (4R,5R)-4,5-epoxy-9,9, 9-trifluoro-non-2(E)-enal; yellow oil; Rf = 0.56 (hexane/acetic ester = 3:2).
Eksempel 87: ( 5R . 6S )- l. 1. 1- trifluor- 5- hvdroksy- 12- f4- acetvl- 3- hydroksv- 2-propyl- fenoksy)- dodeka- 7( E). 9( Z)- dien- 6- yl- 7- tio- 4- okso- 4E- l-benzopyran- 2- karboksylsyre- natriumsalt Example 87: (5R.6S)-1.1.1-trifluoro-5-hydroxy-12-f4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-7(E). 9(Z)-dien-6-yl-7-thio-4-oxo-4E-l-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 86); smp. 190-191°C; [a]D<20> (metanol, 0,268$) = 105,2 <+> 3,7°; UV (metanol): Xmax (c) = 222 (48800); 235 (sh); 267 (25920); 285 (22920); 320 (16000). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 86); m.p. 190-191°C; [α]D<20> (methanol, 0.268$) = 105.2 <+> 3.7°; UV (methanol): Xmax (c) = 222 (48800); 235 (sh); 267 (25920); 285 (22920); 320 (16000).
Eksempel 88: ( 4R . 5S )- l . 1 . 1- trif luor- 4- hy droksv- 12-( 4- acetvl- 3- hvdroksy-2- propyl- fenoksy)- trideka- 6( E) . 8( Z)- dien- 5- vl- 7- tio- 4- okso-4H- l- benzopyran- 2- karboksylsyremetviester Example 88: ( 4R . 5S )- l . 1. 1-trifluoro-4-hydroxy-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-trideca-6(E). 8( Z)-diene- 5- vl- 7- thio- 4- oxo-4H- 1- benzopyran- 2- carboxylic acid metviester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (4R,5R)-4,5-epoksy-l,1,l-trifluor-13-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-trideka-6(E),8(Z)-dien; gul olje. The compound in the title is prepared analogously to example 1 from (4R,5R)-4,5-epoxy-1,1,1-trifluoro-13-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-trideca-6( E),8(Z)-diene; yellow oil.
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 4R. 5R)- 4. 5- epoksv- 8. 8. 8- trifluor- okt- 2( E)- enal Forbindelsen i overskriften fremstilles analogt eksempel lb) a) ( 4R. 5R)- 4. 5- epoxyv- 8. 8. 8- trifluoro- oct- 2( E)- enal The compound in the title is prepared analogously to example lb)
fra (2R,3R)-2,3-epoksy-6,6,6-trifluor-heksanol; klar, gul olje, som krystalliserer i kjøleskap; Rf = 0,53 from (2R,3R)-2,3-epoxy-6,6,6-trifluorohexanol; clear, yellow oil, which crystallizes in a refrigerator; R f = 0.53
(heksan/eddikester = 3:2). [a]D<20> (kloroform, 0,290$) = 21,7 ± 3,4°. IR (metylenklorid): 3050, 2980, 2930, 2810, 2730, 1690, 1640, 1145 cm-<1>. (hexane/acetic acid = 3:2). [α]D<20> (chloroform, 0.290$) = 21.7 ± 3.4°. IR (methylene chloride): 3050, 2980, 2930, 2810, 2730, 1690, 1640, 1145 cm-<1>.
b) ( 4R. 5R)- 4. 5- epoksv- l♦ 1. 1- trifluor- 13-( 4- acetvl- 3- hvdroksv-2- propyl- fenoksy)- trideka- 6( E). 8( Z)- dien b) (4R.5R)-4.5-epoxy-1♦ 1.1-trifluoro-13-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-trideca-6(E). 8(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)pentyl-trifeny1-fosfoniumbromid (eksempel 29a) og (4R,5R)-4,5-epoksy-8,8,8-trifluor-okt-2(E)-enal; gul olje; Rf = 0,69 (heksan/eddikester = 3:2). The compound in the title is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)pentyl-triphenyl-1-phosphonium bromide (example 29a) and (4R,5R)-4,5-epoxy-8, 8,8-trifluoro-oct-2(E)-enal; yellow oil; Rf = 0.69 (hexane/acetic ester = 3:2).
Eksempel 89: ( 4R . 5R )- l. 1. l- trifluor- 4- hvdroksv- 13- f4- acetvl- 3- hvdroksv- 2-propvlf enoksv)- tr i deka- 6 ( E) . 8( Z )- dien- 5- vl- 7- tio- 4- okso- 4H-benzopyran- 2- karboksylsvre- natriumsalt Example 89: (4R.5R)-l.1.l-trifluoro-4-hydroxyl-13-f4-acetvl-3-hydroxl-2-propvlf enoxl)-tr in deca- 6 (E) . 8( Z )-diene- 5- vl- 7- thio- 4- oxo- 4H- benzopyran- 2- carboxyl disulfide sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 88); smp. 150-152°C; [a]D<20> (metanol, 0,265$) = 72,5 ± 3,8°; UV (metanol): Xmax (c) = 221 (44680); 231 (sh); 266 (22560); 285 (20560); 330 (sh). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 88); m.p. 150-152°C; [α]D<20> (methanol, 0.265$) = 72.5 ± 3.8°; UV (methanol): Xmax (c) = 221 (44680); 231 (sh); 266 (22560); 285 (20560); 330 (sh).
Eksempel 90: ( 4R . 5S )- l . 1. 1- trifluor- 4- hydroksy- 12-( 4- acetvl- 3- hvdroksy- 2-propvl- fenoksy)- dodeka- 6( E). 8( Z)- dien- 5- vl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsyremetylester Example 90: ( 4R . 5S )- l . 1. 1-trifluoro-4-hydroxy-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-6(E). 8(Z)-diene-5-vl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (4R,5R)-4,5-epoksy-l,1,l-trifluor-12-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-dodeka-6(E),8(Z)-dien; gul olje; Rf = 0,31 (heksan/eddikester = 3:2). The compound in the title is prepared analogously to example 1 from (4R,5R)-4,5-epoxy-1,1,1-trifluoro-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-6( E),8(Z)-diene; yellow oil; Rf = 0.31 (hexane/acetic ester = 3:2).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 4R. 5R)- 4. 5- epoksv- l. 1. l- trifluor- 12-( 4- acetyl- 3- hvdroksy-2- propyl- fenoksy)- dodeka- 6( E). 8( Z)- dien a) ( 4R. 5R)- 4. 5- epoxyv- l. 1. l- trifluoro- 12-( 4- acetyl- 3- hydroxy-2- propyl- phenoxy)- dodeca- 6( E). 8(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)butyl-trifenyl-fosfoniumbromid (eksempel 62b) og (4R,5R)-4, 5-epoksy-8,8,8-trifluor-okt-2(E)-enal (eksempel 86b); gul olje; Rf = 0,64 (heksan/eddikester = 3:2). The compound in the title is prepared analogously to example ld) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)butyl-triphenyl-phosphonium bromide (example 62b) and (4R,5R)-4, 5-epoxy-8, 8,8-trifluoro-oct-2(E)-enal (Example 86b); yellow oil; Rf = 0.64 (hexane/acetic ester = 3:2).
Eksempel 91: ( 4R. 5S)- l. 1. 1- trifluor- 4- hvdroksv- 12-( 4- acetvl- 3- hvdroksv- 2-propyl- fenoksy)- dodeka- 6( E). 8( Z)- dien- 5- yl- 7- tio- 4- okso- 4H- l-benzopyran- 2- karboksylsyre- natriumsalt Example 91: (4R.5S)-1.1.1-trifluoro-4-hydroxy-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-6(E). 8(Z)-dien-5-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 90); smp. 180-182°C; [a]D<20> (metanol 0,292$) = 77,1 ± 3,4°; UV (metanol): xmax (c) " 222 (47480), 231 (sh); 267 (24840); 285 (22120); 321 (15800). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 90); m.p. 180-182°C; [α]D<20> (methanol 0.292$) = 77.1 ± 3.4°; UV (methanol): xmax (c) " 222 (47480), 231 (sh); 267 (24840); 285 (22120); 321 (15800).
Eksempel 92: ( 5R. 6S)- 5- hydroksy- 12-( 4- acetyl- 3- hydroksy- 2- propyl- fenoksy)-dodeka- 7( E ) . 9( Z )- dien- 5- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2-karboksylsyremetylester Example 92: (5R.6S)-5-hydroxy-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-7( E ) . 9( Z )-dien-5-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (5R,6R)-5,6-epoksy-12-(4-acetyl-3-hydroksy-2-propylfenoksy)-dodeka-7(E),9(Z)-dien; klart, gult skum; Rf = 0,43 (heksan/eddikester = 1:1); [a]j)20 (metanol, 0,150$) = 22,0 ± 6,7°; IR (metylenklorid): 3580, 2950, 1745, 1655, 1625, 1600 cm~l. The compound in the title is prepared analogously to example 1 from (5R,6R)-5,6-epoxy-12-(4-acetyl-3-hydroxy-2-propylphenoxy)-dodeca-7(E),9(Z)-diene; clear, yellow foam; Rf = 0.43 (hexane/acetic ester = 1:1); [α]j)20 (methanol, 0.150$) = 22.0 ± 6.7°; IR (methylene chloride): 3580, 2950, 1745, 1655, 1625, 1600 cm-1.
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 4R. 5R)- 4. 5- epoksy- non- 2( E)- enal a) ( 4R. 5R)- 4. 5- epoxy- non- 2( E)-enal
Forbindelsen i overskriften fremstilles analogt eksempel lb) The compound in the heading is prepared analogously to example lb)
fra (2R,3R)-2,3-epoksy-heptanol; gul olje; Rf = 0,29 (heksan/eddikester = 4:1); [a]D<20> (kloroform, 0,390$) = 21,3 from (2R,3R)-2,3-epoxyheptanol; yellow oil; Rf = 0.29 (hexane/acetic ester = 4:1); [a]D<20> (chloroform, 0.390$) = 21.3
± 2,6°; IR (metylenklorid): 2950, 2920, 2860, 1690, 1640, 1100, 970 cm-<1>. ± 2.6°; IR (methylene chloride): 2950, 2920, 2860, 1690, 1640, 1100, 970 cm-<1>.
b ) ( 5R . 6R )- 5 . 6- epoksy- 12-( 4- acetyl- 3- hydroksy- 2- propylfenoksy)- dodeka- 7( E). 9( Z)- dlen b) (5R. 6R)-5. 6- epoxy- 12-( 4- acetyl- 3- hydroxy- 2- propylphenoxy)- dodeca- 7( E). 9(Z)- part
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksyJpropyl-trifenyl-fosfoniumbromid (eksempel lc) og (4R,5R)-4,5-epoksy-non-2(E)-enal; klar, gul olje; [a]D<20> (kloroform, 0,650 $) = 23,7 1,5° . The compound in the title is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy-propyl-triphenyl-phosphonium bromide (example 1c) and (4R,5R)-4,5-epoxy-non-2( E)-enal; clear, yellow oil; [a]D<20> (chloroform, $0.650) = 23.7 1.5° .
Eksempel 93: ( 5R. 6S)- 5- hydroksv- 12-( 4- acetyl- 3- hydroksy- 2- propyl- fenoksy)-dodeka- 7( E) . 9( Z )- dien- 6- vl- 7- tio- 4- okso- 4H- l- benzopyran- 2-karboksvlsvre- natriumsalt Example 93: (5R.6S)-5-hydroxy-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-7(E). 9( Z )-diene- 6- yl- 7- thio- 4- oxo- 4H- 1- benzopyran- 2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 92); smp. 205-207°C; [a]D<20> (metanol, 0,278$) = 115,1 ± 3,6°; UV (metanol): Xffiax (c) = 222 (50960); 232 (sh); 267 (27400); 285 (24000); 321 (16400). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 92); m.p. 205-207°C; [α]D<20> (methanol, 0.278$) = 115.1 ± 3.6°; UV (methanol): Xffiax (c) = 222 (50960); 232 (sh); 267 (27400); 285 (24000); 321 (16400).
Eksempel 94: ( 5R. 6S)- 5- hvdroksy- 12-( 4- acetyl- 3- hydroksy- 2- propyl- fenoksy)-dodeka- 7( E ) . 9( Z )- dien- 6- vl- 7- tio- 4- okso- 4H- l- benzopvran- 2-karboksvlsyremetvlester Example 94: (5R.6S)-5-hydroxy-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-7( E ). 9( Z )-diene- 6- yl- 7- thio- 4- oxo- 4H- 1- benzopyran- 2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (5S,6S)-5,6-epoksy-12-(4-acetyl-3-hydroksy-2-propylfenoksy)-dodeka-7(E),9(Z)-dien; fargeløst skum; [a]D<20 >(metanol, 0,260$) = 136,2 ± 3,8°; UV (metanol): Xmax (c) = 221 (48040); 271 (28320); 327 (13200). The compound in the title is prepared analogously to example 1 from (5S,6S)-5,6-epoxy-12-(4-acetyl-3-hydroxy-2-propylphenoxy)-dodeca-7(E),9(Z)-diene; colorless foam; [α]D<20 >(methanol, 0.260$) = 136.2 ± 3.8°; UV (methanol): Xmax (c) = 221 (48040); 271 (28320); 327 (13200).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 4S. 5S)- 4. 5- epoksy- non- 2( E)- enal a) ( 4S. 5S)- 4. 5- epoxy- non- 2( E)- enal
Forbindelsen i overskriften fremstilles analogt eksempel lb) The compound in the heading is prepared analogously to example lb)
fra (2S,3S)-2,3-epoksy-heptanol; gul olje; Ef = 0,27 (heksan/eddikester =5:1); [a]j)<20> (kloroform, 0,325$) = 23,1 3,0° . from (2S,3S)-2,3-epoxyheptanol; yellow oil; Ef = 0.27 (hexane/acetic ester =5:1); [a]j)<20> (chloroform, 0.325$) = 23.1 3.0° .
b) ( 5S. 6S )- 5 . 6- epoksy- 12-( 4- acetyl- 3- hvdroksy- 2- propyl-fenoksv)- dodeka- 7( E). 9( Z)- dien b) ( 5S. 6S )- 5 . 6- epoxy- 12-( 4- acetyl- 3- hydroxy- 2- propyl-phenoxy)- dodeca- 7( E). 9(Z)- diene
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)propyltrifenyl-fosfoniumbromid (eksempel lc) og (4S,5S)-4,5-epoksy-non-2(E)-enal; klar, gul olje; [oc]D20 (kloroform, 0,600$) = 24,8 ± 1,6° . The compound in the title is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)propyltriphenyl-phosphonium bromide (example 1c) and (4S,5S)-4,5-epoxy-non-2( E)-enal; clear, yellow oil; [oc]D 2 O (chloroform, 0.600$) = 24.8 ± 1.6° .
Eksempel 95: ( 5S. 6R )- 5- hydroksy- 12-( 4- acetyl- 3- hydroksy- 2- propyl- fenoksy)-dodeka- 7( E) . 9( Z )- dien- 6- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2-karboksylsvre- natriumsalt Example 95: (5S.6R)-5-hydroxy-12-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-dodeca-7(E). 9( Z )-dien- 6- yl- 7- thio- 4- oxo- 4H- 1- benzopyran- 2-carboxylase- sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 94); smp. 204-206°C; [a]D<20> (metanol, 0,570$) = 121,1 ± 1,8°; UV (metanol): Xffiax (c) = 222 (51240); 235 (sh); 267 (27360); 284 (21400); 320 (16400). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 94); m.p. 204-206°C; [α]D<20> (methanol, 0.570$) = 121.1 ± 1.8°; UV (methanol): Xffiax (c) = 222 (51240); 235 (sh); 267 (27360); 284 (21400); 320 (16400).
Eksempel 96: ( 5R. 6S)- 5- hydroksv- 14-( 4- acetyl- 3- hydroksv- 2- propyl- fenoksy)-tetradeka- 7( E). 9( Z)- dien- 6- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2-karboksvlsyremetylester Example 96: (5R.6S)-5-hydroxy-14-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-tetradeca-7(E). 9(Z)-dien-6-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (5R,6R)-5,6-epoksy-14-(4-acetyl-3-hydroksy-2-propylfenoksy)-tetradeka-7(E),9(Z)-dien; klar, gul seig olje; [a]D2<0> (kloroform, 0,424$) = 66,5 ± 2,4°; UV (kloroform): <x>max (c) - 270 (28560); 288 (sh); 325 (15240). The compound in the title is prepared analogously to example 1 from (5R,6R)-5,6-epoxy-14-(4-acetyl-3-hydroxy-2-propylphenoxy)-tetradeca-7(E),9(Z)-diene; clear, yellow viscous oil; [α]D2<0> (chloroform, 0.424$) = 66.5 ± 2.4°; UV (chloroform): <x>max (c) - 270 (28560); 288 (sh); 325 (15240).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 5 R , 6 R ) - 5 . 6- epoksy- 14-( 4- acetyl- 3- hydroksy- 2- propylfenoksy)- tetradeka- 7( E). 9( Z)- dien a) ( 5 R , 6 R ) - 5 . 6- epoxy- 14-( 4- acetyl- 3- hydroxy- 2- propylphenoxy)- tetradeca- 7( E). 9(Z)- diene
Forbindelsen 1 overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksyJpentyl-trifenyl-fosf oniumbromid (eksempel 29a) og (4R,5R)-4,5-epoksy-non-2(E)-enal (eksempel 92a); klar, gul olje; [a]D<20> (kloroform, 0,441$) = 20,6 ± 2,3°. The title compound 1 is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxyJpentyl-triphenyl-phosphonium bromide (Example 29a) and (4R,5R)-4,5-epoxy-non-2 (E)-enal (Example 92a); clear, yellow oil; [α]D<20> (chloroform, 0.441$) = 20.6 ± 2.3°.
Eksempel 97: ( 5R. 6S)- 5- hydroksy- 14-( 4- acetyl- 3- hydroksy- 2- propyl- fenoksy)-tetradeka- 7( E). 9( Z)- dien- 6- yl- 7- tlo- 4- okso- 4H- l- benzopyran- 2-karboksylsyre- natriumsalt Example 97: (5R.6S)-5-hydroxy-14-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-tetradeca-7(E). 9( Z )- dien- 6- yl- 7- tlo- 4- oxo- 4H- 1- benzopyran- 2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 96); smp. 193-195°C; [a]D<20> (metanol, 0,284$) = 71,1 ± 3,5°. UV (metanol): xmax (c) = 222 (49320), 232 (sh); 267 (25520), 286 (22680); The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 96); m.p. 193-195°C; [α]D<20> (methanol, 0.284$) = 71.1 ± 3.5°. UV (methanol): xmax (c) = 222 (49320), 232 (sh); 267 (25520), 286 (22680);
321 (16000). 321 (16000).
Eksempel 98: ( 5S. 6R)- 5- hydroksy- 14-( 4- acetyl- 3- hydroksy- 2- propyl- fenoksy)-tetradeka- 7( E), 9( Z)- dien- 6- yl- 7- tio- 4- okso- 4H- l- benzopyran- 2-karboksvlsyrernetylester Example 98: (5S.6R)-5-hydroxy-14-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-tetradeca-7(E),9(Z)-dien-6-yl-7 - thio- 4- oxo- 4H- 1- benzopyran- 2-carboxylic acid ethyl ester
Forbindelsen i overskriften fremtilles analogt eksempel 1 fra (5S,6S)-5,6-epoksy-14-(4-acetyl-3-hydroksy-2-propyl-fenoksy)-tetradeka-7(E) ,9(Z)-dien; klar, gul seig masse; [cx]d<20 >(kloroform, 0,463$) = 79,0 ± 2,2°. UV (kloroform): Xmax (<c>) = 270 (27120); 288 (sh); 326 (14960). The compound in the title is prepared analogously to example 1 from (5S,6S)-5,6-epoxy-14-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-tetradeca-7(E),9(Z)- dien; clear, yellow chewy pulp; [cx]d<20 >(chloroform, 0.463$) = 79.0 ± 2.2°. UV (chloroform): Xmax (<c>) = 270 (27120); 288 (sh); 326 (14960).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 5S , 6S )- 5 . 6- epoksy- 14-( 4- acetyl- 3- hydr oksy- 2- propyl-fenoksv)- tetradeka- 7( E). 9( Z)- dien a) ( 5S , 6S )- 5 . 6- epoxy- 14-( 4- acetyl- 3- hydroxy- 2- propyl-phenoxy)- tetradeca- 7( E). 9(Z)- diene
Forbindelsen i overskriften fremtilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)pentyl-trifenyl-fosfoniumbromid (eksempel 29a) og (4S,5S)-4, 5-epoksy-non-2(E)-enal (eksempel 94a); klar, gul olje; [a]])20 (kloroform, 0,472$) = 18,8 ± 2,1°. The compound in the title is prepared analogously to example 1d) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)pentyl-triphenyl-phosphonium bromide (example 29a) and (4S,5S)-4,5-epoxy-non- 2(E)-enal (Example 94a); clear, yellow oil; [a]])20 (chloroform, 0.472$) = 18.8 ± 2.1°.
Eksempel 99: ( 5S. 6R)- 5- hydroksy- 14-( 4- acetvl- 3- hydroksy- 2- propyl- fenoksy)-tetradeka- 7( E). 9( Z )- dien- 6- vl- 7- tio- 4- okso- 4H- l- benzopyran- 2-karboksylsyre- natriumsalt Example 99: (5S.6R)-5-hydroxy-14-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-tetradeca-7( E). 9( Z )-diene- 6- vl- 7- thio- 4- oxo- 4H- l- benzopyran- 2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 98); smp. 193-195°C; [a]D<20> (metanol, 0,296$) = 65,9 ± 3,4°. UV (metanol): xmax (c) = 222 (49760); 232 (sh); 267 (25800); 285 (22520); 320 (16000). The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 98); m.p. 193-195°C; [α]D<20> (methanol, 0.296$) = 65.9 ± 3.4°. UV (methanol): xmax (c) = 222 (49760); 232 (sh); 267 (25800); 285 (22520); 320 (16000).
Eksempel 100: ( 5R . 6S)- 1 . 1. 1- trifluor- 5- hydroksv- 14-( 4- acetvl- 3- hvdroksv- 2-propyl- f enoksy)- tetradeka- 7( E). 9( Z )- dien- 6- yl- 7- tio- 4- okso-4H- l- benzopyran- 2- karboksvlsyremetylester Example 100: ( 5R . 6S)- 1 . 1. 1-trifluoro-5-hydroxy-14-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-tetradeca-7(E). 9( Z )-dien-6-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid methyl ester
Forbindelsen i overskriften fremstilles analogt eksempel 1 fra (5R,6R)-5,6-epoksy-l,1,l-trifluor-14-(4-acetyl-3-hydroksy-2-propylfenoksy)-tetradeka-7(E),9(Z)-dien; klar, gul olje; Rf = 0,32 (heksan/eddikester = 3:2). The compound in the title is prepared analogously to example 1 from (5R,6R)-5,6-epoxy-1,1,1-trifluoro-14-(4-acetyl-3-hydroxy-2-propylphenoxy)-tetradeca-7(E) ,9(Z)-diene; clear, yellow oil; Rf = 0.32 (hexane/acetic ester = 3:2).
Utgangsmaterialet fremstilles f.eks. som følger: The starting material is produced e.g. as follows:
a) ( 5R. 6R1- 5. 6- epoksv- l. 1. 1- trifluor- 14-( 4- acetyl- 3- hvdroksv-2- propyl- fenoksy)- tetradeka- 7( E). 9( Z)- dien a) ( 5R. 6R1- 5. 6- epoxy- l. 1. 1- trifluoro- 14-( 4- acetyl- 3- hydroxy-2- propyl- phenoxy)- tetradeca- 7( E). 9( Z) - the day
Forbindelsen i overskriften fremstilles analogt eksempel ld) fra 3-(4-acetyl-3-hydroksy-2-propyl-fenoksy)pentyl-trifenyl-fosfoniumbromid (eksempel 29a) og (4R,5R)-4,5-epoksy-9,9,9-trifluor-non-2(E)-enal (eksempel 86b); gul olje; Rf = 0,72 (heksan/eddikester = 3:2). The compound in the title is prepared analogously to example ld) from 3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)pentyl-triphenyl-phosphonium bromide (example 29a) and (4R,5R)-4,5-epoxy-9, 9,9-trifluoro-non-2(E)-enal (Example 86b); yellow oil; Rf = 0.72 (hexane/acetic ester = 3:2).
Eksempel 101: ( 5R . 6S )- l. 1. l- trifluor- 5- hvdroksy- 14-( 4- acetvl- 3- hydroksy- 2-propvl- f enoksy )- t etradeka- 7( E). 9( Z )- dien- 6- yl- 7- tio- 4- okso-4H- l- benzopyran- 2- karboksylsyre- natriumsalt Example 101: (5R.6S)-1.1.1-trifluoro-5-hydroxy-14-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-tetradeca-7(E). 9( Z )-dien-6-yl-7-thio-4-oxo-4H-1-benzopyran-2-carboxylic acid sodium salt
Forbindelsen i overskriften fremstilles analogt eksempel 2 fra den tilsvarende metylesteren (eksempel 100); TJV (metanol): Xmax (c) = 222 (48000); 235 (sh); 267 (25920); 285 The compound in the title is prepared analogously to example 2 from the corresponding methyl ester (example 100); TJV (methanol): Xmax (c) = 222 (48000); 235 (sh); 267 (25920); 285
(22920); 320 (16000). (22920); 320 (16000).
BILAG - FARMAKOLOGISKE FORSØKSFREMGANGSMÅTER APPENDIX - PHARMACOLOGICAL EXPERIMENTAL PROCEDURES
Marsvin- bronchokonstriks. lonsforsøk ( in vivo. aerosol) Guinea pig - bronchoconstriction. lon experiments (in vivo. aerosol)
Man "bedøver mannlige, 400-700 g tunge marsvin intraperitone-alt med 1,4 g/kg uretan og innfører en polyetylenkanyle i Vena jugularis. En andre polyetylenkanyle innføres i luftrøret. Ved hjelp av en i spiserøret innført kanyle, som er forbundet med en Statham-trykk-transduktor, opptegnes trykket i spiserøret. Dyret legges i et lufttett lukket kammer av pleksiglass som med et Fleisch'er rør nr. 000 er forbundet med en "Validyne-transducer MP 45-1". Med denne anordningen måles strømningen. Male guinea pigs weighing 400-700 g are anesthetized intraperitoneally with 1.4 g/kg urethane and a polyethylene cannula is inserted into the vena jugularis. A second polyethylene cannula is inserted into the trachea. Using a cannula inserted into the esophagus, which is connected to a Statham pressure transducer, the pressure in the esophagus is recorded. The animal is placed in an airtight plexiglass chamber which is connected by a Fleisch'er tube No. 000 to a "Validyne transducer MP 45-1". With this device the flow is measured .
Etter den kirurgiske prepareringen av forsøksdyrene venter man en viss tid for at den pulmonale funksjonen skal kunne stabilisere seg. Forbindelsen som skal undersøkes administreres deretter ifølge den etterfølgende protokollen. Forsøksdyrene utsettes i løpet av 1 minutt for en 1% aerosoloppløsning av forbindelsen som skal undersøkes (vekt/volum) eller destillert vann (for kontrollformål). For alle forsøksforbindelsene som administreres ved inhalering, anvender man et Monoghan-ultralyd-sprayapparat (modell 670) hvis partikkelstørrelse beveger seg mellom 1 og 8 pm, med en hovedandel på 3 pm. After the surgical preparation of the experimental animals, a certain time is waited for the pulmonary function to stabilise. The compound to be examined is then administered according to the following protocol. The experimental animals are exposed for 1 minute to a 1% aerosol solution of the compound to be investigated (weight/volume) or distilled water (for control purposes). For all test compounds administered by inhalation, a Monoghan ultrasonic nebulizer (model 670) is used whose particle size ranges between 1 and 8 µm, with a major proportion of 3 µm.
Vandige oppløsninger nyfremstilles og innføres med en "On-stream"-legemiddelflaske i kammeret av sprayapparatet. Den produserte spraytåken administreres til forsøksdyrene via et glasskammer av innhold 65 ml som med en kanyle er forbundet med luftrøret. Etter forløpet av behandlingstiden administreres med en andre Monoghan-ultralyd-sprayinnretning (modell 670) og via et tilsvarende glasskammer LTD 4 (0,3 pg/ml) i løpet av 2 minutter. Aqueous solutions are freshly prepared and introduced with an "On-stream" drug bottle into the chamber of the spray apparatus. The produced spray mist is administered to the test animals via a glass chamber with a content of 65 ml which is connected to the trachea with a needle. After the expiration of the treatment time, administer with a second Monoghan ultrasonic spray device (model 670) and via a corresponding glass chamber LTD 4 (0.3 pg/ml) within 2 minutes.
Reduksjonen av Compliance avleses i det 3. minutter etter LTD4-tilførsel og middelverdien for 3 dyr sammenlignes med middelverdien for 3 kontrolldyr, og den prosentvise hemmingen av Compliance beregnes etter følgende formel: The reduction in Compliance is read in the 3rd minute after LTD4 administration and the mean value for 3 animals is compared with the mean value for 3 control animals, and the percentage inhibition of Compliance is calculated according to the following formula:
Dersom forskjellige konsentrasjoner av virksomt stoff undersøkes, så opptegnes den prosentvise hemmingen for hver konsentrasjon, og logkonsentrasjonen avsettes på abscissen mot den prosentvise hemmingen på ordinaten. Ic50 hestemmes deretter ved lineær regressjonsanalyse. If different concentrations of active substance are examined, the percentage inhibition is recorded for each concentration, and the log concentration is plotted on the abscissa against the percentage inhibition on the ordinate. The Ic50 is then estimated by linear regression analysis.
In vitro- test for bestemmelse av hemmingen av fosfolipase Ao fra menneskelige leukocytter. In vitro test for determining the inhibition of phospholipase Ao from human leukocytes.
Neutrofile polymorf-kjernede menneskelige leukocytter isoleres med utgangspunkt fra "Buffy coats" ved flertrinns fraksjonert sedimentasjon og dypfryses. Fosfolipase A2 ekstraheres fra cellesuspensjonen ved homogenisering under tilsats av iskald 0,36 N H2SO4 i 2N NaCl, og den etter sentrifugering ved 10000 x g oppnådde supernatanten dialy-seres mot natriumacetatbuffer, pE 4,5. Neutrophil polymorph-nucleated human leukocytes are isolated starting from "Buffy coats" by multi-step fractional sedimentation and deep frozen. Phospholipase A2 is extracted from the cell suspension by homogenization with the addition of ice-cold 0.36 N H2SO4 in 2N NaCl, and the supernatant obtained after centrifugation at 10,000 x g is dialyzed against sodium acetate buffer, pE 4.5.
For bestemmelsen av enzymaktiviteten inkuberes enzym (10-30 For the determination of the enzyme activity, enzyme is incubated (10-30
>jg protein) i 0,1 M Tris/HCl-buf f er pH 7 under tilsats av 1 mM CaCl2 og substrat, bestående av biosyntetisk med ^<4>C-oljesyre radioaktivt merkede fosfolipider (2 jjM) av Escherichia coli ved 37°C i 1 time. Reaksjonen stoppes ved tilsats av Dole-reagens (Isopropanol/heptan/lN H2SC"4 40:10:1, v/v) og den ved fosfolipase A2 selektivt frigitte <14>C-oljesyren ekstraheres. Eventuelt medekstrahert substrat fjernes fullstendig ved filtrering av ekstraktet gjennom en søyle av kiselgel. Bestemmelsen av <*4>C-oljesyren i eluatet foregår ved radiometri. >jg protein) in 0.1 M Tris/HCl-buf f is pH 7 with the addition of 1 mM CaCl2 and substrate, consisting of biosynthetically with ^<4>C-oleic acid radioactively labeled phospholipids (2 jjM) of Escherichia coli at 37 °C for 1 hour. The reaction is stopped by the addition of Dole reagent (Isopropanol/heptane/lN H2SC"4 40:10:1, v/v) and the <14>C-oleic acid selectively released by phospholipase A2 is extracted. Any co-extracted substrate is completely removed by filtering the extract through a column of silica gel The determination of the <*4>C-oleic acid in the eluate takes place by radiometry.
For bestemmelse av en hemmevirkning av stoffene som under-søkes på fosfolipase A2 tilsettes disse som oppløsninger i vann, dimetylsulfoksyd (sluttkonsentrasjon i blanding inntil 5$, v/v) eller etanol (sluttkonsentrasjon i blanding inntil 2,5$ v/v) til inkubasjonsblandingen. Virkningsstyrken av stoffene som undersøkes uttrykkes ved IC50, dvs. konsentrasjonen som bevirker en hemming på 50$ av kontrollaktiviteten. IC5Q bestemmes grafisk ved avsetning av den prosentvise hemmingen av ordinaten som funksjon av log av konsentrasjonen (jjM) på abscissen. To determine an inhibitory effect of the substances being investigated on phospholipase A2, these are added as solutions in water, dimethylsulfoxide (final concentration in mixture up to 5%, v/v) or ethanol (final concentration in mixture up to 2.5% v/v) to the incubation mixture. The potency of the substances under investigation is expressed by the IC50, i.e. the concentration which causes an inhibition of 50% of the control activity. IC5Q is determined graphically by plotting the percentage inhibition of the ordinate as a function of log of the concentration (jjM) on the abscissa.
Under de angitte forsøksbetingelsene hemmer mepakrin fosfolipase A2 med en IC50 på 1600 jjM. Under the indicated experimental conditions, mepacrine inhibits phospholipase A2 with an IC50 of 1600 µM.
In vitro- forsøk for bestemmelse av hemmingen av fosfolipase C fra menneskelige trombocytter In vitro assay for determining the inhibition of phospholipase C from human platelets
Menneskelige trombocytter utvinnes som "Buffy coats" ved fraksjonert sentrifugering og dypfryses deretter. Fosfolipase C settes fri ved ultralydsbehandling ved cellesuspensjonen, og befinner seg etter ultrasentrifugering (150000 x g i 1 time) i oppløslig form i supernatanten. Human platelets are recovered as "Buffy coats" by fractional centrifugation and then deep frozen. Phospholipase C is set free by ultrasound treatment of the cell suspension, and is found after ultracentrifugation (150,000 x g for 1 hour) in soluble form in the supernatant.
For bestemmelse av enzymaktiviteten inkuberes enzym (20-100 pg protein) i 0,025 M Tris/Maleat-buffer, pH 6, under tilsats av 0,2 mM CaCl2 og 0,02 mM radioaktivt merket substrat, fosfatidyl-[<14>C]-inosit, ved 37°C i 5 minutter. Reaksjonen stoppes ved utristing med CHCI3/CH3OH 2:1 (v/v). Derved ekstraheres uforbrukt substrat i den organiske fasen, mens reaksjonsproduktet <14>C-inositfosfat forblir i den vandige fasen og kan måles ved radiometri av en porsjon. To determine the enzyme activity, enzyme (20-100 pg protein) is incubated in 0.025 M Tris/Maleate buffer, pH 6, with the addition of 0.2 mM CaCl2 and 0.02 mM radioactively labeled substrate, phosphatidyl-[<14>C] -inositol, at 37°C for 5 minutes. The reaction is stopped by shaking out with CHCI3/CH3OH 2:1 (v/v). Thereby, unused substrate is extracted in the organic phase, while the reaction product <14>C-inositol phosphate remains in the aqueous phase and can be measured by radiometry of a portion.
For bestemmelse av en hemmevirkning av stoffene som under-søkes på fosfolipase C tilsettes disse som oppløsninger i vann, dimetylsulfoksyd (sluttkonsentrasjon i blanding inntil 5$, v/v) eller etanol (sluttkonsentrasjon i blanding inntil 2,5$, v/v) til inkubasjonsblandingen. Virkningsstyrken for stoffene som undersøkes uttrykkes ved IC5Q, dvs. den konsentrasjonen som bevirker en hemming på 50$ av kontrollaktiviteten. IC50 bestemmes grafisk ved avsetning av den prosentvise hemmingen på ordinaten mot log av konsentrasjonen (jjM) på abscissen. To determine an inhibitory effect of the substances being investigated on phospholipase C, these are added as solutions in water, dimethylsulfoxide (final concentration in mixture up to 5$, v/v) or ethanol (final concentration in mixture up to 2.5$, v/v) to the incubation mixture. The potency of the substances under investigation is expressed by IC5Q, i.e. the concentration which causes an inhibition of 50$ of the control activity. The IC50 is determined graphically by plotting the percentage inhibition on the ordinate against the log of the concentration (jjM) on the abscissa.
Under de angitte forsøksbetingelsene hemmer mepakrin fosfolipase C med en IC50 på 20 pM. Under the stated experimental conditions, mepacrine inhibits phospholipase C with an IC50 of 20 pM.
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH118688 | 1988-03-29 | ||
CH385788 | 1988-10-14 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO891286D0 NO891286D0 (en) | 1989-03-28 |
NO891286L NO891286L (en) | 1989-10-02 |
NO171555B true NO171555B (en) | 1992-12-21 |
NO171555C NO171555C (en) | 1993-03-31 |
Family
ID=25686932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO891286A NO171555C (en) | 1988-03-29 | 1989-03-28 | ANALOGY PROCEDURE FOR THE PREPARATION OF NEW, THERAPEUTIC-ACTIVE, SUBSTITUTED ALKANPHENONES |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0335315B1 (en) |
JP (1) | JP2777183B2 (en) |
KR (1) | KR0125933B1 (en) |
AT (1) | ATE107639T1 (en) |
AU (1) | AU623383B2 (en) |
CA (1) | CA1340463C (en) |
CY (1) | CY1967A (en) |
DE (1) | DE58907920D1 (en) |
DK (1) | DK148989A (en) |
ES (1) | ES2056137T3 (en) |
FI (1) | FI94342C (en) |
HK (1) | HK192696A (en) |
HU (2) | HU202852B (en) |
IE (1) | IE66248B1 (en) |
IL (1) | IL89713A0 (en) |
NO (1) | NO171555C (en) |
NZ (1) | NZ228477A (en) |
PT (1) | PT90125B (en) |
YU (1) | YU63089A (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0419411A3 (en) * | 1989-09-19 | 1991-09-04 | Ciba-Geigy Ag | Additional alkanophenones |
EP0419410A3 (en) * | 1989-09-19 | 1991-08-14 | Ciba-Geigy Ag | Alkanophenones |
US6596260B1 (en) * | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
EE04004B1 (en) | 1995-04-14 | 2003-04-15 | Glaxo Wellcome Inc. | Fluticasone propionate metered dose inhaler |
ATE258813T1 (en) | 1995-04-14 | 2004-02-15 | Smithkline Beecham Corp | DEVICE FOR THE DOSED INHALATION OF BECLOMETHASONE DIPROPRIONATE |
TR199701167T1 (en) | 1995-04-14 | 1998-03-21 | Glaxo Wellcome Inc. | Metered dose inhaler for albuterol. |
EP1366777B1 (en) * | 1995-04-14 | 2005-06-15 | SmithKline Beecham Corporation | Metered dose inhaler for salmeterol |
IT1320162B1 (en) | 2000-02-09 | 2003-11-18 | Rotta Research Lab | DERIVATIVES OF THYROSIN WITH ANTI LEUKOTRIENIC ACTIVITY, PROCEDURES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE. |
ATE358672T1 (en) * | 2000-10-23 | 2007-04-15 | Arizona Biomedical Res Commiss | ANTITUMOR COMPOUNDS BASED ON REGULATION OF PROTEIN PRENYLATION |
JP4691988B2 (en) | 2002-10-03 | 2011-06-01 | 小野薬品工業株式会社 | LPA receptor antagonist |
ATE528276T1 (en) * | 2003-12-19 | 2011-10-15 | Ono Pharmaceutical Co | LYSOPHOSPHATIDYL ACID RECEPTOR ANTAGONIST COMPOUNDS AND THEIR APPLICATIONS |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3070912D1 (en) * | 1979-03-20 | 1985-09-05 | Fisons Plc | Pharmaceutical heterocyclic compounds, processes for their preparation and compositions containing them |
US4474788A (en) * | 1981-11-12 | 1984-10-02 | Fisons Plc | Anti-SRSA quinoline carboxylic acid derivatives |
AU548450B2 (en) * | 1983-08-08 | 1985-12-12 | G.D. Searle & Co. | Substituted dihydrobenzopyrans |
CA1288107C (en) * | 1983-12-27 | 1991-08-27 | Yves Girard | Leukotriene antagonists |
US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
US4546194A (en) * | 1984-05-29 | 1985-10-08 | G. D. Searle & Co. | Substituted chromanon-2-yl alkanols and derivatives thereof |
US4785004A (en) * | 1985-12-23 | 1988-11-15 | Ciba-Geigy Corporation | Aromatic thioethers |
US4889871A (en) * | 1987-05-29 | 1989-12-26 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
EP0419411A3 (en) * | 1989-09-19 | 1991-09-04 | Ciba-Geigy Ag | Additional alkanophenones |
-
1989
- 1989-03-22 IL IL89713A patent/IL89713A0/en not_active IP Right Cessation
- 1989-03-22 FI FI891362A patent/FI94342C/en not_active IP Right Cessation
- 1989-03-23 NZ NZ228477A patent/NZ228477A/en unknown
- 1989-03-23 CA CA000594712A patent/CA1340463C/en not_active Expired - Fee Related
- 1989-03-23 IE IE93589A patent/IE66248B1/en not_active IP Right Cessation
- 1989-03-27 YU YU00630/89A patent/YU63089A/en unknown
- 1989-03-28 ES ES89105427T patent/ES2056137T3/en not_active Expired - Lifetime
- 1989-03-28 DK DK148989A patent/DK148989A/en not_active Application Discontinuation
- 1989-03-28 DE DE58907920T patent/DE58907920D1/en not_active Expired - Fee Related
- 1989-03-28 AT AT89105427T patent/ATE107639T1/en not_active IP Right Cessation
- 1989-03-28 EP EP89105427A patent/EP0335315B1/en not_active Expired - Lifetime
- 1989-03-28 PT PT90125A patent/PT90125B/en not_active IP Right Cessation
- 1989-03-28 HU HU891536A patent/HU202852B/en not_active IP Right Cessation
- 1989-03-28 NO NO891286A patent/NO171555C/en not_active IP Right Cessation
- 1989-03-28 JP JP1074125A patent/JP2777183B2/en not_active Expired - Lifetime
- 1989-03-28 KR KR1019890003870A patent/KR0125933B1/en not_active IP Right Cessation
- 1989-03-29 AU AU32252/89A patent/AU623383B2/en not_active Ceased
-
1994
- 1994-11-15 HU HU94P/P00046P patent/HU210531A9/en unknown
-
1996
- 1996-10-17 HK HK192696A patent/HK192696A/en not_active IP Right Cessation
-
1997
- 1997-07-04 CY CY196797A patent/CY1967A/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK192696A (en) | 1996-10-25 |
HU210531A9 (en) | 1995-04-28 |
NO171555C (en) | 1993-03-31 |
ATE107639T1 (en) | 1994-07-15 |
HU202852B (en) | 1991-04-29 |
EP0335315A1 (en) | 1989-10-04 |
CY1967A (en) | 1997-07-04 |
FI94342B (en) | 1995-05-15 |
JPH01299283A (en) | 1989-12-04 |
FI891362A (en) | 1989-09-30 |
KR0125933B1 (en) | 1997-12-26 |
DK148989A (en) | 1989-09-30 |
AU623383B2 (en) | 1992-05-14 |
AU3225289A (en) | 1989-10-12 |
JP2777183B2 (en) | 1998-07-16 |
IE890935L (en) | 1989-09-29 |
FI891362A0 (en) | 1989-03-22 |
IL89713A0 (en) | 1989-09-28 |
KR890014511A (en) | 1989-10-24 |
PT90125B (en) | 1994-10-31 |
NO891286D0 (en) | 1989-03-28 |
FI94342C (en) | 1995-08-25 |
EP0335315B1 (en) | 1994-06-22 |
NO891286L (en) | 1989-10-02 |
PT90125A (en) | 1989-11-10 |
HUT49599A (en) | 1989-10-30 |
NZ228477A (en) | 1990-11-27 |
DK148989D0 (en) | 1989-03-28 |
ES2056137T3 (en) | 1994-10-01 |
YU63089A (en) | 1990-12-31 |
DE58907920D1 (en) | 1994-07-28 |
IE66248B1 (en) | 1995-12-27 |
CA1340463C (en) | 1999-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4386096A (en) | Antihypertensive 4-thiazolidinecarboxylic acids (furyl and thienyl derivatives) | |
NZ206338A (en) | L -(indol-2-yl)- b , w -dihydroxyalkanoates and pharmaceutical compositions | |
NO178764B (en) | Process for the preparation of oxetanones | |
NO171555B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF NEW, THERAPEUTIC-ACTIVE, SUBSTITUTED ALKANPHENONES | |
JPH02237985A (en) | New compound,preparation thereof,and drug composition containing same | |
HU206714B (en) | Process for producing pyridazine derivatives | |
CA2321146A1 (en) | Novel acetamide derivative and use thereof | |
JPH0443917B2 (en) | ||
NO300686B1 (en) | Analogous Process for the Preparation of Therapeutically Active 6-Aminoctahydroindolizine Triol Derivatives | |
JPS6338026B2 (en) | ||
NO161177B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIOETERS. | |
JPH0536436B2 (en) | ||
US5646183A (en) | Phenyl amidine alkanoic acids useful as platelet aggregation inhibitors | |
US5145868A (en) | Alkanophenones useful for treating allergies | |
WO1986000066A1 (en) | N-substituted butyramide derivatives | |
NO864896L (en) | ALFA-hydroxythioether. | |
JP2765001B2 (en) | Protease inhibitor | |
US5149717A (en) | Alkanophenones useful for treating allergies | |
PT87927B (en) | 7- (1H-PYRROL-3-YLO) ACIDS, OF ITS CORRESPONDING DELTA-LACTONES AND SALTS, AND OF PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
JP2802996B2 (en) | Production method of optically active compound | |
NO174927B (en) | Analogous Process for the Preparation of Therapeutically Active Benzopyrans | |
HU182338B (en) | Process for producing bis-hydroxybenzyl derivatives and pharmaceutical compositions containing them | |
JPH03176487A (en) | Dibenzoxepin derivative | |
US4625032A (en) | Tetrahydro-β-carboline derivatives | |
US5612355A (en) | Phenyl amidine lactones useful as platelet aggregation inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN SEPTEMBER 2003 |